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S U M M A R Y
The purpose of this study was to test the hypothesis that Breast 
Cyst Fluid (BCF) is a secretion from the "pink’1 epithelial cells found 
to line such cysts.
A series of BC fluids specially collected over a period of 18 
months from a local hospital clinic, as well as routinely sent samples, 
were investigated for their cell content, proteins, and various chemical 
parameters compared with milk and serum. Histological and cytological 
material was examined by light and electron microscopy with various 
stains, and by immunohistochemical techniques using an antiserum raised 
against whole BCF.
The aspirates could be divided into two groups based on cell 
content and cellulose acetate electrophoresis of the fluid. These 
methods correlated well. The lack of immunoglobulins in one group 
was examined and possible reasons for this suggested.
The chemical content was found to be very variable; for all 
parameters a large range was found, and for most, levels were close to 
those of serum. The exceptions are urate, cholesterol and potassium 
which tended to be high. Cholesterol often reached enormous levels 
and was found to be mainly present in a particulate fraction of the 
whole fluid.
The particulate fraction was separated by density gradient 
centifugation and analysed for cholesterol, protein, and various 
membrane marker enzymes, which suggested a possible origin from cell 
membranes^
The antiserum to BCF was found to contain antibodies to 2 
BCF-specific proteins after absorption to remove antibodies to serum 
and milk proteins. The specific proteins were found by
i
*In this study,”cell membranes” is taken to mean membranes from cell 
organelles generally and does not refer solely to plasma membrane.
immunohistochemistry to locate in the Golgi complex of the ’pink* 
cell, and also in apocrine glands from axillary skin.
Whilst the process of secretion was never observed, electron 
microscopy showed the ’pink’ cell to have secretory characteristics.
ABBREVIATIONS 
AMP Adenosine-5’-monophosphate
anti-(x) Antiserum to x
ATP Adenosine-5’-triphosphate
BCF Breast cyst fluid
BUN Blood urea nitrogen
CAB Cetyltrimethylammonium bromide
EDTA Ethylenediaminetetra-acetic acid
FITC Fluorescein iso-thiocyanate
FSH Follicle-stimulating hormone
HE Haematoxylin and eosin
MFGM Milk fat globule membrane •
PAS Periodic acid - Schiff
PCA Perchloric acid
p.m. Plasma membrane
r.e.r. Rough endoplasmic reticulum
SC Secretory component
SGOT Glutamate-oxalacetate transaminase
SGPT Glutamate-pyruvate transaminase
TBS Tris-buffered saline
TCA Trichloroacetic acid
Tris Tris(hydroxymethyl) methylamine
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I STRUCTURE AND FUNCTION OF HUMAN BREAST
1.1 DEVELOPMENT
About the sixth week of embryonic life?the ectoderm of the 
foetus becomes thickened along the ’’milk lines” running from axilla to 
groin. The epithelial cells have the ability to grow into the 
mesenchyme at any point on this line to eventually form the breast bud.
In the human^this usually occurs at one point on each line, although 
supernumary breasts or nipples do occur. At these points,the epithelial 
cells form a small cluster from which approximately 15 to 25 separate 
cords of epithelial cells push into the mesenchyme. Each of these 
develops into a separate compound exocrine gland. During foetal life, 
the cords branch to some extent, developing equally in male and female.
As puberty approaches,the female gland begins to develop and 
enlarge. The increase in size is largely due to fat accumulating in 
the connective tissue. There is some increase in glandular tissue, but 
probably not beyond the duct stage, i.e. not secretory units. These 
changes are largely due to oestrogen produced by the maturing ovarian 
follicles under the stimulation of gonadotrophins, mainly FSH, from the 
anterior pituitary.
1.2 GROSS STRUCTURE
The mature breast is dome-shaped with a circular pigmented skin 
area 2 to 3 cm in diameter, the areola mammae, located at its centre 
(Fig.l). It has three major structures; the skin, subcutaneous tissue, 
and corpus mammae.
The skin is thin and elastic and adheres to the fat-laden 
subcutaneous tissue. It has hair, and sebaceous and exocrine sweat 
glands. The areola mammae is pigmented reddish brown and surrounds
1
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Fig. 1 Gross structure of the human mammary gland.
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the nipple. It enlarges during pregnancy and lactation,and contains 
sweat glands, sebaceous glands not attached to hair, and a specialised 
gland type called Montgomery’s glands which have ducts opening onto 
the skin surface at Morgagni's tubercle. The nipple contains the 15 
to 25 milk duct outlets, and abundant sebaceous and apocrine glands, 
again with no hair.
The corpus mammae consists of parenchyma set in a stroma of 
connective tissue and fat with blood vessels, nerves and lymphatics.
The parenchyme comprises of the ductular-lobular-aveolar structures.
The 15 to 25 lobes, each served by one of the major milk ducts, are 
arranged like the spokes of a wheel converging on the nipple. Each 
lobe is subdivided into 20 to 40 lobules, which each contain 10 to 100 
alveoli (secretory units). These are approximately 0.12 mm in 
diameter, the main ducts being 2 mm, enlarging to 5 to 8 mm in the 
lactiferous sinuses at the nipple base.
The alveoli are enveloped in a collagenous sheath, forming the 
basement membrane, and this continues round the collecting duct.
This sheath is a loose type of collagen and contains small blood 
vessels and lymphatics. The lobule is surrounded by a thicker denser 
collagen envelope. These are called intralobular and interlobular 
connective tissue, respectively.
1.3 MONTGOMERY GLANDS
These are phylogenetically derived from skin apocrine glands. 
They open onto the areolar skin in the form of a funnel shaped terminal 
duct, closely connected with hair papillae and sebaceous glands,which 
open into the infundibular part of the duct. They undergo hypertrophy 
during pregnancy, and are hormonally stimulated in the newborn. Their
3
thysiological function is unclear, but they may be analogous to the 
accessory tissue of sexual glands and function as a scent organ„ Like
breast tissue they undergo post-menopausal involution, unlike apocrine 
glands which do regress in old age but seemingly not in relation to 
hormones (Montagna, 1959; Hurley & Shelley, 1960)„
I „ 4 HISTOLOGY AND CYTOLOGY
The epithelium of the lactiferous ducts at their orifices is 
like that which covers the nipple, i.e. squamous. Deeper in the nipple, 
this becomes a double layer of columnar epithelial cells resting on a 
basement membrane. The main ducts branch to form intralobular ducts.
The ducts are surrounded by a very cellular connective tissue continuous 
with the papillary layer of the dermis which abuts directly on the 
epidermis. These are set in a matrix of substantial non-cellular 
connective tissue,extending down from the reticular layer of the 
dermis,to separate and tightly hold the lobes and lobules. The larger 
of these bundles are called the "suspensory ligaments of Cooper".
They also contain accumulations of fat.
The walls of the intralobular ducts are generally composed of 
two layers of epithelial cells,having pale cytoplasm and pale oval 
nuclei, resting on a basement membrane.
The resting breast probably consists only of a duct system.
In pregnancy, this develops and branches further, and secretory” alveoli 
form at the ends of ductules within lobules. The intralobular 
connective tissue becomes very thin, due to stretching, but nonetheless 
contains many blood vessels. The alveoli contain a single layer of 
columnar cells. Epithelial development is finished by the end of the 
sixth month, and the continued size increase of the breast is due to •
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secretion.
In the resting breast,the ducts and ductules are lined by two 
main types of cell: a layer of epithelial cells surrounded peripherally
by a discontinuous layer of myoepithelial cells in the ductules,and a 
continuous layer in the ducts (Ahmed, 1978).
4.1 Epithelium
Bassler (1970) has described two types of epithelial cells: a
dark cell (A-cells) and a clear type (B-cells). The two are 
morphologically similar, having numerous free ribosomes, scattered 
vesicles of rough endoplasmic reticulum (r.e.r.), a few mitochondria, 
and a small Golgi complex displaying no signs of secretory activity. 
Membrane-bound lipid bodies, glycogen particles and lysosomes may be 
present. Tonofilaments are located randomly, and the apical plasma 
membrane has microvilli. The nucleus is generally oval, central, with 
variable invaginations.
The dark A-cells are eosinophilic,and contain numerous ribosomes 
causing the dark appearance of the cytoplasm. They tend to have a 
more secretory character than light cells. The light B-cells are 
the major type and probably represent a different functional stage 
(Ozzello, 1971), or even a stem cell from which both A-cells and 
myoepithelial cells arise. The cytoplasm is transparent, and the 
nucleus has more equal chromatin distribution than that of A-cells.
4.2 Myoepithelium
This forms a basket-like network round alveoli, and runs along 
the long axis of the ducts. It can be demonstrated with Masson's 
trichrome or silver stains, and its function is to cause ejection of 
milk when stimulated to contract by oxytocin - a posterior pituitary 
hormone. The cells lie between the epithelium and the basement
membrane, and*under normal conditions, do not approach the lumen. The 
cytoplasm contains numerous fine filaments (5.7 nm in diameter) along 
the cell axis, resembling the myofilaments of smooth muscle.
1.5 LACTATION
In pregnancy, there is considerable development of the breast, 
especially the lobulo-alveolar system. The ducts proliferate and 
branch, and alveoli are formed on the ends of the terminal ducts.
The alveoli are lined by a single layer of cells, surrounded by a 
myoepithelial network. The basal region of the alveolar cells abuts 
on the myoepithelial cells or the basement membrane, and is indented 
to form clefts between the cell plasma membrane and the basal lamina
(Ahmed, 1978). This may be to allow increased surface area for
uptake of nutrients.
The epithelial cell nucleus is round or oval, large, and may be 
indented. There is a well developed rough endoplasmic reticular system, 
arranged in parallel and stretching from the base of the cell almost 
to the apex, often arranged around mitochondria. The Golgi complex 
is very prominent and located in the supranuclear area, and consists 
of parallel flattened smooth-membrane stacks, with many small vesicles and 
a few vacuoles. Mitochondria are numerous and of variable size and
shape. (Cowie & Tindal, 1971).
I*6 SECRETION OF MILK
Milk is produced by the breast after parturition. For the 
first three days the secreted material is rich in protein, especially 
immunoglobulins, and lipid; but the levels gradually reduce as more 
copious quantities of mature milk are produced. The process of
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secretion begins in the third trimester of pregnancy, but until full 
secretion is commenced the quantity produced is very small.
The suppression of full lactation during pregnancy is generally 
believed to be due to oestrogen and progesterone, produced by the 
ovaries and placenta, acting on mammary epithelium and the anterior 
pituitary. Progesterone is believed to inhibit prolactin secretion 
and action. After parturition, and loss of the placenta, the inhibitory 
levels of these hormones are removed thus promoting lactation (Cowie & 
Tindal, 1971). In mice, lactose synthesis is observed to be inhibited 
by suppression of lactalbumin (part of the lactose-producing enzyme 
system) by progesterone (Turkington & Hill, 1969).
The main constituents of milk are protein, both serum-derived
+ +
and milk-specific; lipid, mostly triglyceride; lactose; ions, Na , K and
2Ca ; and water. The mode of secretion of these compounds has been 
controversial (Cowie & Tindal, 1971) but there is now general agreement 
on the basic mechanisms.
The synthesis of the milk fat globule takes place in the lactating 
epithelial cell3as does synthesis of lactose and the milk-specific 
proteins.
1.6.1 Lipids
More than 95% of milk lipid is triglyceride contained in milk 
fat globules. The fatty acids are derived from triglycerides of 
chylomicrons and low density lipoproteins from serum, and de novo 
synthesis in mammary tissue (Patton & Keenan, 1975). The triglycerides 
are synthesised in the r.e.r. (Stein & Stein, 1967), and forming milk 
fat droplets are consistently seen in r.e.r. at the basal end of the 
cell.
The forming droplet, which may have a bounding membrane, 
increases in size as it moves, by an unexplained mechanism, to the
apex of the cell. One possible explanation is the distortion of 
the cell produced by distension of the alveolus by secretion (cells 
flattened) and relaxation after milk ejection (cells elongated). The 
droplet is then gradually pushed out of the cytoplasm, becoming 
enfolded by plasma membrane which surrounds the droplet. The formed 
globule is thus released when the plasma membrane rejoins beneath it 
(Fig.2). The free milk fat globule therefore consists of a core of 
milk fat surrounded by a milk fat globule membrane. Keenan et al.
(1970) have shown this membrane to be derived from plasma membrane on 
the basis of their similarity of composition of phospholipids, 
cholesterol esters, fatty acids, and protein.
The attraction of the droplet to the plasma membrane is another 
unresolved problem. Patton and Fowkes (1967) suggested sufficient 
attractive force would arise from London-Van der Waals forces, when 
the membrane lipid separation was 2 nm, to snap the droplet across 
the membrane. Wooding (1971), on ultrastructural evidence, disagreed, 
never finding the membrane droplet separation to be less than 10 - 20 nm. 
He suggested an alternative mechanism whereby Golgi vesicles surround 
the droplet and by fusing with the plasma membrane, provide the excess 
membrane to allow the droplet to cross easily the cell boundary.
1.6.2 Protein
Milk contains at least 18 serum proteins, some only in trace 
amounts (Hanson & Johansson, 1970), and at least 13 proteins specific 
for milk. These latter are synthesized in the r.e.r. of the lactating 
epithelium. They then proceed to the Golgi complex by a mechanism 
which is uncertain but probably involves the flow of membranes from 
r.e.r. to Golgi complex. In this organelle,the r.e.r. membrane is 
transformed to Golgi-type membrane and the addition of carbohydrate
8
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Fig. 2 Secretory epithelial cell of the lactating mammary gland.
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to secretory glycoproteins is completed. The membrane-flow hypothesis 
suggests that the now complete proteins are packaged in Golgi vesicles 
which bud off from the cisternae, the membrane by now having been 
transformed to plasma membrane. The vesicles then move to the cell 
apex and fuse with the plasma membrane, releasing their contents into 
the alveolar lumen. The membrane flow hypothesis is supported by the 
fact that Golgi membrane has a phospholipid composition intermediate 
between that of r.e.r. and plasma membrane (Keenan & Morre, 1970).
I L #
Also, in rats, the time for C cholesterol to move from blood to milk 
(where cholesterol is almost entirely in the form of membranes) is 17 
hours (Easter 1971). The author suggests that this seems too long 
for simple equilibration of the cholesterol with plasma membrane (p.m.) 
and probably represents the time for its incorporation into r.e.r. and 
the conversion to p.m. However, whilst this might fit in with the 
membrane-flow hypothesis, it is hard to reconcile with the fact that 
r.e.r. is low in cholesterol compared with p.m. (Thines-Sempoux, 1974; 
Morre et al., 1974).
1.6.3 Lactose
This carbohydrate of milk is synthesised from glucose in the 
Golgi complex by an enzyme system consisting of two proteins, A and B. 
The A protein is galactosyl transferase, a Golgi enzyme which catalyses 
the addition of carbohydrate to glycoproteins; the B protein is 
a-lactalbumin, a milk protein which interacts with the A protein to 
specify glucose as the substrate for galactose addition:
UDP-galactose + glucose —a-c--°f e y^fi.fo^ 'fcase > lactose + UDP.
(i.e. A+B)
In the absence of a-lactalbumin, lactose is only found in small 
amounts (as in colostrum) and thus the protein controls the synthesis. 
Brew (1969) has suggested that the reason for the secretion of
10
a-lactalbumin into milk is to allow rapid control of lactose synthesis 
since part of the enzyme thus has a high throughput. The lactose, 
being unable to pass through the membrane of Golgi vesicles, is then 
secreted with the protein. It has been suggested that the effect of 
lactose synthesis is to draw water osmotically into the Golgi complex 
(Linzell & Peaker, 1972) to act as a carrier for secretions and form the 
aqueous phase of milk.
IMMUNOGLOBULINS IN MILK
The relative concentrations of IgG, and IgA are not the same 
in milk as in blood. In the latter, IgG predominates whereas in milk 
IgA is the major immunoglobulin, as in all secreted fluids. Therefore, 
since the breast stroma contains mainly IgG, which is presumably serum 
derived, the immunoglobulins in milk do not arrive by simple diffusion. 
Also,the IgA in milk is in a different form from that in plasma, and 
IgM, which is also found in milk, has a much higher molecular weight 
than IgG and occurs in the stroma in lower concentrations than IgG.
Using immunofluorescense on saline-extracted tissue, Brandtzaeg 
(1977) has shown that immunoglobulin-producing cells are present in the 
epithelium of secretory tissues, and that 70 to 97% of them produce IgA. 
The IgA from these immunocytes is the dimeric form, rather than the 
serum-type monomer, linked by a polypeptide called the "J-chain".
In milk, as with other secretions, the IgA dimer is bound by 
a small glycoprotein called‘secretor piece'or‘secretory component* (SC). 
This makes the molecule much more stable and resistant to proteolysis. 
The secretory component is shown by immunohistochemistry in rabbit 
mammary gland to occur in the Golgi complex and vesicles at the apical 
end of the epithelial cells. IgA however is found only in the
vesicles, suggesting SC is produced in the cells and IgA is produced 
extracellulary (Kraehenbuhl et al., 1975). Antigenic properties by 
the same technique suggest that SC is in free form in the Golgi 
complex, but bound to IgA in the apical cytoplasm (Brandtzaeg, 1974).
Based on this and other evidence, Brandtzaeg (1977) has proposed 
a model for immunoglobulin transport at epithelial surfaces. (Fig.3).
1. SC produced by the epithelial cells accumulates in the Golgi
complex, where some final addition of carbohydrate may take place.
2. The SC is distributed to the cell cytoplasm and plasma membrane.
3. Dimeric IgA, linked by J-chain, is produced by local immunocytes.
4. The membrane-associated SC acts as an epithelial receptor for
the dimeric IgA. Such SC has an affinity for dimeric IgA 
probably due to characteristics imparted by the J-chain.
5. The complex is mobilised to the lateral region of the p.m.
6. Disulphide bridges are formed to stabilise the complex.
7. The complex is transported to the Golgi region by pinocytosis.
8. The quaternary structure is completed and the complex secreted
together with free SC.
9. Some complex may pass the tight junction between cell apices and
not enter the cytoplasm.
Pentameric IgM may be secreted by the same system, the five 
monomer molecules are also joined by J-chains. However the complex is 
not as stable as secretory IgA. The free SC may be secreted in order 
to maintain the complexes after secretion.
1.8 MEMBRANES IN MILK
Plantz & Patton (1973) in a study of the fractions obtained from 
from skimmed bovine and caprine milks, after centrifugation by differential
12
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Fig. 3 Immunoglobulin secretion at epithelial surfaces according 
to the model of Brandtzaeg (1977).
and density gradient methods, found that virtually all the lipid 
phosphorus and unesterified cholesterol is contained in membrane 
fragments and vesicles. In bovine skimmed milk, 85% of cholesterol 
is unesterified and therefore the great majority is associated with 
membranes. They found the membrane fraction to be of density from
1.10 to 1.15 and to contain over half the 5 ’-nucleotidase activity, 
and most of the nucleotide pyrophosphatase activity of skimmed milk.
The majority of work on membranes of milk has involved the 
milk fat globule membrane (MFGM), which was suggested on strong 
evidence by Keenan et al., (1970) to be derived from plasma membrane 
of mammary cells. Specimens have mainly been obtained from animals, 
with few results available for human milk. One such piece of work 
(Martel-Pradal & Got, 1972) showed 5'-nucleotidase to be absent from 
human skimmed milk, though other p.m. markers (Mg -ATPase and alkaline 
phosphodiesterase) were found. In addition, enzyme markers for Golgi 
complex, endoplasmic reticulum, and plasma membrane were shown to be 
present in human skimmed milk. Thus, membrane marker enzymes consistent 
with the types of membrane found in bovine skimmed milk by Plantz &
Patton (1973) are also found in human skimmed milk, with the exception 
of 5'-nucleotidase. Thines-Sempoux (1974) has suggested inactivation 
of 5’-nucleotidase in rat liver endocytotic vesicles, which are also 
derived from plasma membrane, and possibly the same inactivation may 
occur in human skimmed milk. Martel-Pradal & Got, (1972) also found 
the Golgi and endoplasmic reticulum markers were present in MFGM preparations 
from human milk. This might possibly be further evidence for the 
membrane flow hypothesis.
The fat-free fraction of milk therefore contains membranes 
(sometimes referred to as the'"fluff" fraction) which, like MFGM,
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apparently derive from plasma membrane with the possibility of some 
arising from other sources. Ultrastructural evidence (Stewart et al.. 
1972; Plantz & Patton, 1973) bears this out and suggests the main 
constituents to be relatively large structures rather than discrete 
subunits (also suggested by their exclusion from Sepharose 4B gel) 
and derived primarily from plasma membrane, including microvilli.
1.9 SECRETION AND ABSORPTION IN NON-LACTATING BREAST
Although secretion is externally evident only after parturition, 
there is evidence that the mature breast is continuously secreting. 
Histological studies of normal lobules in mature non-lactating breasts 
invariably show acini and ducts containing secretion (Bonser et al.,
1961). If stained by the periodic acid-Schiff procedure (PAS) those 
secretions show two components, one brilliant violet, the other a pale 
pink. This PAS-positive substance is also present in the basement 
membrane, but not in the normal involuting lobule where presumably 
secretion has stopped. Alcian blue stain gives the same general 
picture but differentiates the two components more clearly into a 
homogenous red material and a blue green mucinous substance. In the 
resting breast the components are roughly equal, but the mucinous 
material decreases in pregnancy. Since the secretion does not accumulate 
and distend the resting breast, nor escape to the exterior, it must be 
assumed there is an equal process of resorbtion.
The pathway of absorption has been demonstrated by injecting 
fluid containing small carbon particles, or a mixture of ferrous 
ammonium citrate and potassium ferrocyanide (which is precipitated 
as Prussian blue on acid fixation) into the lactiferous ducts of 
virgin adult rabbits. Three hours after injection of carbon, small
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particles were found in the epithelial cells of ducts and alveoli*, 
after 24 hours,they were in the lymphatics. The same occurred with 
Prussian blue, but much more rapidly. After five minutes it was in 
the lymphatics, and after 30 minutes most had left the breast. Bonser 
et al. (1961) repeated this work using high titre diptheria antitoxin, 
being a more physiological marker and easier to quantitate. They 
found that approximately half the antitoxin was absorbed,and absorption 
continued for at least 24 hours.
Browne(1946) showed that lactosuria is common at the end of 
pregnancy. This is most easily explained as reabsorption of secretion 
by the breast. Also,the initial secretion after parturition, colostrum, 
is high in protein but low in lactose, whereas milk is high in lactose 
but lower in protein. This would be compatible with reabsorption, the 
small molecular weight lactose being more easily removed than protein.
Cowie and Tindal (1971) pointed out that milk may also be altered 
in composition of water and water-soluble constituents in the alveoli 
and fine ducts. This may be attributable to variations in the osmotic 
pressure of blood. Linzell and Peaker (1976) add that milk stored in 
ducts and cisternae apparently remains unchanged for long periods since 
these structures are impermeable to the main constituents of milk.
10 involution
Involution is the term used to describe regression of the mammary 
gland parenchyma. It is of two types; post-lactational and senile, 
which have different features.
10.1 Post-Lactational Involution
This type of involution is sometimes referred to as regression 
in order to distinguish it from senile involution. It covers the 
process whereby after cessation of lactation the remaining secreted
milk is removed, and the secretory tissue is decreased. This leaves 
the breast tissue in much the same degree of development as before 
pregnancy. For obvious reasons most biochemical and ultrastructural 
studies of post-lactational involution have been made on animals.
The course of the process varies with the cause of cessation 
of lactation, since the total volume and secretory activity of the 
parenchyma may decline gradually, following a rise to maximal activity, 
as lactation proceeds (Cowie & Tindal, 1971). Thus in enforced stasis 
of the gland, or premature weaning, the secretory tissue is at a 
different stage of development from that at the normal time of weaning. 
The effects of enforced stasis or premature weaning depend upon the 
current phase of secretion (i.e. increasing, maximal, or decreasing 
activity), and, in the former, upon whether lactation is continued 
in other glands of the same animal (i.e. hormonal stimulation of 
lactation continues) (Helminen & Ericsson, 1971)*
In general, the biochemical changes begin within hours after 
cessation of suckling or milking (Cowie & Tindal, 1971). Metabolic 
activity, shown by respiratory activity of gland tissue and lactate 
accumulation, declines within 8 to 12 hours in animals. There is a 
considerable increase in gland weight, lactose and DNA content, and 
free ribonuclease and 3-glucuronidase; and a reduction in RNA and 
anabolic enzymes. The increasing DNA appears to be correlated 
with invasion of the tissue by leucocytes, and the enzymes may arise 
from ruptured lysosomes. These organelles are greatly involved in 
involution; both in autophagocytic processes, which reduce the 
cytoplasm of the epithelial cells, and heterophagocytic processes 
whereby macrophages remove cell debris and secretion. (Cowie &
Tindal, 1971; Helminen & Ericsson,1971). Jones (1969) showed the
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reduction of enzymes involved in milk synthesis to include glucose-6- 
phosphate dehydrogenase, 6-phosphogluconate dehydrogenase, 
phosphoglucomutase, UDP-glucose pyrophosphorylase, phosphofructokinase,
ATP citrate lyase, and acetyl CoA carboxylase.
The tissue structural changes are similar for all animals, the 
only variation being the time for completion thereof. This takes 
15 days in the mouse, 36 in the rat and 48 days in the goat. For 
humans, Dawson (1935) estimates the time to be 9 to 12 months.
Initially the alveoli are distended by milk and the epithelium 
flattened. There follow cytolytic changes which may result in rupture 
of the alveolar basement membrane (Bassler, 1961), and disposal of cell 
and secretory products into the interstitial spaces. These may be 
removed by macrophages and/or via the lymphatic vessels. In enforced 
milk stasis the cytolysis, increase in lysosomes, and release of lysosomal 
enzymes, occur to a lesser degree and later than in normal involution 
(Helminen & Ericsson, 1971).
Dawson (1935) described the histological changes in the human 
gland as follows (in summary).
1) Distension of acini and rupture of adjacent walls to form 
large lumina.
2) Distension flattens the epithelium, inhibits secretion, 
and by interfering with capillary secretion furthers retrogression.
3) Phagocytic cells migrate to the lumen.
4) Secretion is removed by phagocytosis and distension 
diminishes. Epithelial cells are desquamated and begin to disintegrate. 
The basement membrane disappears, and the lobule loses definition.
5) Fibrous tissue replaces the disappearing alveoli.
6) Fatty tissue reappears in the stroma around the fifth
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month after lactation ceases.
Involution may be delayed or incomplete, especially if pregnancy 
re-occurs rapidly; and lactating tissue may remain, and can form small 
cysts (Dawson, 1935).
1.10.2 Senile Involution
The senile type of involution begins around the menopause from 
the age of about 35 years. It occurs regardless of whether there has 
been previous lactation.
It is a very uneven process; in the same breast some segments 
may be fully involuted while others show a normal pattern. The cells 
lining the tubules and acini are gradually lost, and the basement membrane 
at the same time thickens and contracts down on the decreasing tubules 
and acini. Eventually,all that remains of the lobule is a series of 
rings representing basement membrane. These fuse and the lobule is 
obliterated, leaving only altered basement membrane which has lost 
its characteristic staining reactions. At the same time the dense 
interlobular connective tissue becomes atrophied and sometimes replaced 
by adipose tissue, often enough to cause the breast to enlarge, despite 
regression of the parenchyma. The time taken for the process to 
complete is not known with certainty but probably does not exceed 5 
years. At the end,all that remains is the main ducts and their major 
branches.
In some cases,terminal acini at the periphery of lobules may 
dilate and join with adjacent acini to form small intralobular cysts.
The loose intralobular connective tissue persists round these cysts 
until they shrink as their epithelium is lost. The pattern is then 
that of normal involution. The main difference in these cases is that 
secretion is usually present,unlike normal involution. It is
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postulated that this cystic lobular involution may be due to hormonal 
conditions (Bonser et al., 1961). Hayward and Parks (1958) first 
suggested this type of involution as a normal, as opposed to 
pathological, part of involution, and showed how the cysts develop 
before the menopause, and gradually disappear afterwards.
I.11 CYCLICAL CHANGES IN BREAST TISSUE
The mature human breast undergoes changes during the menstrual 
cycle. Variations in size and number of microvilli were noted (Waugh 
& van der Hoeven, 1962), and Fanger and Ree (1974) classified epithelial 
cells into two types based on ultrastructural differences. Phase I 
epithelium occurs in the pre-ovulatory phase, is non-secretory, and 
has free ribosomes, occasional strands of rough endoplasmic reticulum 
and a small Golgi complex. Phase II epithelium (potentially secretory) 
occurs predominantly in the post-ovulatory period and has dilated 
cisternae of rough endoplasmic reticulum, well developed Golgi complex, 
glycogen deposits and numerous apical microvilli.
Ozzello and Speer (1958), in an histological study of breast 
biopsy and mastectomy specimens from patients with known menstrual 
histories, showed cyclical variations of the mucopolysaccharides of 
breast stroma. They observed no changes in the interlobular connective 
tissue, which was consistently PAS-positive (neutral mucopolysaccharides) 
throughout the menstrual cycle. The intralobular stroma showed 
variations in neutral and acid mucopolysaccharides, stained by PAS 
and Hale’s technique (HS) respectively. In the "resting" (pre­
ovulatory) phase the intralobular stroma appeared to be in part PAS- 
and in part HS-positive, the former predominating somewhat. As the 
"evolutional" (post-ovulatory) phase began,the HS positivity increased
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up to the time of menstruation, while PAS-positive material disappeared 
more rapidly. This rise in acid mucopolysaccharide was accompanied 
by an increase in the number of fibroblasts. During the last few 
days of the post-ovulatory phase PAS-positive secretory granules 
appeared in the acinar cells^and similarly staining material in' the 
lumen. Both were diastase-resistant.
In mammary dysplasia these cyclical changes tended to be 
abolished; the interlobular stroma was mainly PAS-positive, although 
sometimes HS positivity remained (but unrelated to menstrual phase).
In contiguous normal breast tissue, the cyclical characteristics were 
manifest.
Thus the breast is a continuously changing organ, both 
structurally and in its chemical composition, and the levels of acid 
mucopolysaccharides are increased by oestrogen stimulation.
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2 CYSTIC DISEASE OF THE BREAST
2.1. CLINICAL PRESENTATION
Cystic disease of the breast occurs in women in the years leading 
up to, and during, the menopause. It is only very exceptionally found 
after the menopause. It is clinically the most frequently seen lesion 
of the breast.
The patient usually presents having discovered a lump in the 
breast. The lump is invariably symptomless, although occasionally 
some local tenderness or turgidity is felt, and thus is usually found 
by palpation. The discovery usually leads to considerable anxiety.
On examination the lump is found to be firm and rounded, and 
somewhat mobile with no tethering to the skin or adjacent tissue.
The size is very variable, from less than one centimetre to about 
ten centimetres. Cooper (1829) reports examples weighing nine pounds, 
but such sizes are not found today.
Often more than one cyst is found, sometimes in the opposite 
breast to the initial discovery. There may also be increased 
nodularity of one or both breasts, which may be due to numbers of very 
small cysts, or another related condition such as fibroadenosis.
Patients who develop a cyst will often have others, until they pass 
the menopause.
2.2. MANAGEMENT
If the cyst is palpable the treatment is simple (Bradbeer, 1974). 
The contents are aspirated using an hypodermic syringe and needle.
Local anaesthetic is not really necessary but some surgeons will use 
it (e.g. Haagensen, 1971).
The needle is passed through the cleaned skin of the breast
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and into the cyst, which is immobilised with the free hand. The 
fluid content is slowly aspirated until no more can be removed.
Complete disappearance of the cyst is then checked. If some thickening 
of the tissue still remains,Haagensen (1971) recommends biopsy of the 
site to ensure there is no neoplastic lesion. He also suggests the 
same course if the fluid aspirated is very bloodstained or has the 
appearance of old blood.
If the patient has multiple cysts, these are all aspirated at 
the same time.
The cysts will usually disappear completely on aspiration but 
may refill and in this case biopsy is recommended (Haagensen, 1971). 
Howeve^distinction of a refilled cyst from a nearby new cyst must be 
extremely difficult.
2.3. AETIOLOGY
The aetiology of cystic disease of the breast, and especially 
the so-called ’pink* cell metaplasia (q.v., page 30) which is so 
closely related to it, have been the source of debate for almost a 
century.
The first comprehensive studies of mammary cystic disease 
were made by Reclus in 1883 and Brissaud in 1884. The former stated 
that such lesions were frequently bilateral, involved most of the gland, 
and being very small were mainly impalpable. He also regarded them 
as new formations, unlike Brissaud who thought they arose from existing 
alveoli by proliferation of the epithelium which then underwent necrosis 
to form a cyst. This view was supported by Schimmelbusch (1890) who 
suggested the name "cystadenoma” as being preferable to Reclus1 "maladie 
kystique des mamelles” since there was proliferation of glandular
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tissue.
In 1893, Konig introduced his inflammatory concept of the origin 
of breast cysts. He thought that epithelial proliferation and changes 
in the interstitial tissue were a reaction to an inflammatory irritant.
The idea that the lesion may be related to senile involution 
was first proposed by Tietze (1900). Bloodgood (1906) also agreed 
with this view, regarding cysts as the result of hypertrophy during 
involution. This theory has become very popular since then. McFarland 
(1922) took the idea one stage further and suggested that all the forms 
of the disease mentioned by previous workers were "no more than 
variations in the involutional process in which residual lactational 
acini appear in various conditions of retrogressive change". Unfortunately 
he only found cysts in the breasts of women who had lactated and this 
led him to believe that lactation was a necessary criterion of cystic 
disease. Ironically, the type of "residual lactational acini" that 
McFarland described have since been seen in nulliparous women (three 
out of eleven cases; Bonser et al., 1961).
This confusion serves to highlight a basic problem with the 
investigation of cystic disease. The condition is a complex of several 
seemingly different lesions and these may appear singly, or together 
in various degrees. This results in a variety of different terms} 
often used to describe the same disease type, many authors inventing 
their own terminology. Bonser et al. (1961) classify the main 
components as lobular sclerosis, cystic lobular sclerosis, and cystic 
lobular degeneration, complicated by hyperplasia and metaplasia. They 
suggest "abnormal involution" as a name to cover all these lesions 
since it refers to their probable aetiology. They do stress that 
these are purely artificial divisions, and do not suggest different
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aetiologies. They may possibly even be different stages of the same 
disease.
2.3.1 Lobular Sclerosis
This is characterised by fibrous tissue proliferation within 
the lobule before the loss of epithelial cells^ and usually in the 
absence of cystic dilatation. A scarred lobule results^with constricted 
acini as small clumps of cells, and basement membrane retaining its 
staining reactions until much later than in normal involution. *Pink’ 
cell metaplasia may also be found within the sclerosed lobule. This 
is probably a metaplastic change of the normal breast epithelium to a 
type of cell, sometimes called an apocrine cell due to its histological 
resemblance to the cells in the cutaneous apocrine glands. The name 
merely describes its cytoplasmic colour after haematoxylin and eosin
staining (see also page 30).
It is not a common disease. Bonser (1961) found it in 59 
patients out of 330 with breast disease, most commonly around the 
menopause. Karpas (1965) found it in 35% of patients, mostly the
40 - 49 years age group, Cameron (1965) in 54% of patients with 85% in
the 35 - 55 age group. The parousrnulliparous ratio of sufferers 
was higher before the menopause than after (2.5: 1 and 1.1: 1 respectively), 
suggesting that post-lactational involution may play a part. The 
disease is frequently found in cystic breasts, which show an even more 
marked fall in parous:nulliparous ratio after the menopause (3.8: 1 
and 1.8: 1) when this factor no longer operates. Thus there may be 
a common factor in the aetiology of the two conditions.
2.3.2 Cystic Lobular Sclerosis
This is the counterpart of lobular sclerosis where the excessive 
fibrosis affects the lobule undergoing cystic involution. The loose
25
intralobular connective tissue is replaced by dense fibrous tissue 
which fuses with the basement membrane. This leaves a collection 
of microcysts in dense connective tissue,with no remaining trace of 
the lobule from which they derived. Thus it is a very persistent 
condition. 'Pink' cell metaplasia sometimes takes place. This 
condition parallels lobular sclerosis in incidence, increasing as the 
menopause is reached. However, it continues beyond the menopause 
frequently up to 20 or 30 years later, unlike normal cystic involution.
The intralobular fibrosis seems to petrify the cystic epithelial 
component.
2.3.3 Cystic Lobular Degeneration
This is an extension of the process of normal cystic involution. 
Instead of just the terminal acini, several tubules and acini run 
together and form a large cyst. The loose intralobular connective tissue 
is diminished, thus losing vascular and lymphatic access, and the cyst 
presses out against the dense interlobular connective tissue. When 
this change occurs, the epithelium usually undergoes ’pink’ cell metaplasia. 
Semb (1928) found the point of origin of ’pink’cells to be the junction 
of the cyst and its duct, but occasionally it was inside the cyst and 
both types of epithelium co-exist.
2.4 TENSION CYSTS
The tension cyst is probably the final stage in cyst formation.
The fluid content is under considerable pressure and the cysts cannot 
be collapsed, as the usual type of degeneration cysts can, by pressing on 
them and forcing the contents into the duct- system through the ductule.
The neck of tension cysts at the ductule is blocked by the epithelial 
hyperplasia or kinking of the duct during involution. Consequently,
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the majority of tension cysts arise around the menopause during 
involution.
As the pressure builds up, due to continued fluid secretion, 
the cyst expands and the epithelium becomes stretched out over the 
cyst wall. At the neck,expansion is restricted by the more substantial 
connective tissue. There is little evidence that the cyst, if left, 
is a decaying structure which will disappear. Cooper (1829) found 
that secretion continues and the cyst increases in size. He found 
examples weighing 9 lbs.
This mode of development may have implications for cysts in 
general. Breast epithelium is capable of secretion and absorption and 
in ’pink'-epithelial cysts this absorption function is impaired, either 
due to the different type of epithelium, or the change in the connective 
tissue removing lymphatic drainage.
In 1928,Semb discounted McFarland’s theory that breast cysts 
were residual lactation acini, and divided breast lesions into three 
categories in an attempt to unify terminology. The first group 
corresponded to normal involution,characterised by microscopic cysts, 
the other two to cystic disease with larger cysts. However,he 
reverted to the old theory and postulated the cysts as completely new 
formations, on the basis that they resembled gynaecomastia (male breast 
development due to hormone irregularities).
Geschickter (1943) subdivided cystic disease into several 
artificial groups and introduced new terminology. The result is 
that today people either use confusing terminology which is out of 
date, or describe the lesion accurately, without using such names.
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2.5 HORMONES
The aetiology of cystic disease has often been quoted to be 
hormonal (Haagensen, 1971). There is little evidence for any specific 
hormone abnormality in cyst patients, but since the majority of breast 
cysts occur near the menopause there must obviously be associated 
endocrine changes. However,this is no indication of a causal 
relationship. Fechner (1970, 1972) has shown neither oral 
contraceptives nor oestrogen therapy to have any effect on either the 
incidence of benign breast disease, including cysts, or the characteristics 
of such conditions. However,the numbers of patients studied were 
only small to moderate (43 and 258), but nonetheless must indicate 
that there is no marked effect of such hormones. England et al. (1974) 
claim to have shown that serum 17$-oestradiol is increased in the 
luteal phase of women with cystic disease. They measured the 
concentrations daily through one cycle in 31 women with cystic disease 
and 32 normal controls, and found the elevation to be greater in the 
40 - 49 years age group than the 30 - 39 years group. The statistical 
significance for these groups was p<0.01 and p<0.001 respectively, but 
did vary markedly with the method of analysis used.
There is also evidence, mostly in animals, for the effects of 
hormones on mammary epithelium and particularly 'pink' cell metaplasia 
(q.v., page 36). This too tends to suggest oestrogen as the hormone 
mainly involved.
2 .6 INCIDENCE
I
The estimation of incidence of cystic disease is very difficult 
for a number of reasons, and is subject to many variables. Any 
hospital-based study is bound to be biased in favour of patients with
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breast disease, and efficient diagnosis usually requires a biopsy 
unless macrocysts are present. As mentioned before, the cysts may 
be transitory or disappear on pressing, and are in general asymptomatic. 
Also, many women are too frightened of cancer to present themselves 
at breast clinics and many will never appear if the cyst should 
regress of its own accord.
Thus the studies of incidence have relied mainly on examination 
of material obtained at autopsy or from surgery. As would be expected, 
there is much variation in the reported results, which are often 
culled from far too low a number of cases.
The best study is probably that of Frantz et al. (1951). They 
reviewed material from 225 autopsies, and found gross cysts in 19% 
and microcysts in 53% of breasts from adult females. Devitt (1972) 
reviewed 2,281 breast biopsies performed over five years and found that 
22% of breasts with carcinoma had an associated diagnosis of "fibrocystic 
disease”. However this value is probably low since he did not re­
examine histological material,only the reports, and in carcinoma 
cases any associated condition may often not be reported. Also, 
being based on a hospital study the results are obviously biased to 
abnormal material, unlike those of Frantz et al. (1951) and Sloss 
et al. (1957) who both found more frequent occurrence of cysts in
normal breasts.
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3 "PINK" CELLS 
In cystic disease of the breast "pink" epithelial cells are an 
invariable finding. The cells were first clearly noted by Borst in 
1904, although they had been mentioned previously. Borst called 
them "atypische Epithelien1, and they have since been accorded a variety 
of names, such as "blasse Zellen", "helle rosige Epithelien","eosinophile 
Epithelien", "oxyphile Epithelien","cellules claires", "idrosadenoid 
epithelium",’’pale epithelium", "clear cells", and "pink cells". The 
morphological similarity of these cells to those found in apocrine 
glands in the skin has led to them also being referred to as "apocrine 
metaplastic cells", "apocrine cells", or "sweat gland epithelium". In 
this work the term 'pink* cells will be used since it suggests no 
aetiology or function (merely referring to the colour of the cytoplasm 
on staining by haematoxylin and eosin) and avoids confusion between 
cells in the breast and the cutaneous organs.
3.1. MORPHOLOGY
3.1.1 Microscopic
’Pink* cells are easily distinguishable from normal mammary 
epithelium. They are cuboidal or columnar in shape with an eosinophilic 
cytoplasm and a small basally located nucleus (Pier et al., 1970).
In cysts they often appear very flattened due to stretching of 
the epithelium as the cyst grows. The apical end of the cytoplasm 
often bulges out into the lumen of the gland, giving a scalloped 
appearance to the epithelium, which is also very prone to hyperplasia, 
frequently forming papillary projection. Speert (1942) describes 
the nuclei as being round, vesicular and hypochromatic, and centrally 
located, and the cells as two to four times the size of those in
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normal mammary epithelium.
The cytoplasm contains numerous granules, first clearly 
demonstrated by Lendrum (1945) using a carbacid fuchsin stain of his 
own modification. They are also visible in toluidine blue-stained 
sections from resin-embedded material (Pier et al., 1970). The granules 
are mainly located in the supranuclear region and collect near the 
apical plasma membrane. Lendrum (1945) suggested that they are 
secretory granules. Higginson and McDonald (1949) noted several 
types of granules, the majority being eosinophilic, occurring generally; 
whilst others were found in only a few cells of each acinus and had a 
yellow or brownish colour and did not stain. Another variety, also 
not common to all cells, gave a fat reaction with Sudan III, and a 
fourth type which gave a positive reaction for iron using Berlin blue 
stain. Whether this last type was identical with any of the others 
they did not establish, but large numbers of eosinic granules appeared 
to preclude iron-positive granules, which were found in variable numbers 
in cells from different acini.
3.1.2 Ultramicroscopic
On electron microscopy,'pink' cells were found by Pier et al.
(1970) to have distinct margins, with infolding of the plasma membrane 
at the basal end. The cells rest on a basement membrane, except where 
a myoepithelial cell intervenes. The apical plasma membrane has 
numerous short microvilli. Junctional complexes are seen between 
cells and there is little intercellular space (Pier et al., 1970).
The cytoplasm is rich in organelles, and there is an increase in 
the number of mitochondria compared with normal mammary epithelium 
(Murad and von Haam, 1968; Pier, et al., 1970; Ahmed, 1975). The 
mitochondria are mostly at the basal end of the cell and just above
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the nucleus. They are variable in size and usually round or oval, 
but sometimes very irregular in shape. The cristae are few in number,
usually long and thin, extend to the centre of the mitochondria and 
are often incomplete.
The increased numbers of mitochondria led Archer and Omar (1969) 
to compare ’pink’ cells with oncocytes, previously suggested by 
Fasanotti (1950) as. being the origin of 'pink* cells. Oncocytes 
(Hamperl, 1962) are transformed epithelial cells of various tissues, 
including salivary and parathyroid glands, characterised histologically 
by numerous acidophilic granules, which are mitochondria. Tremblay 
(1968) found low activity of succinate dehydrogenase, a mitochondrial 
enzyme, by histochemical methods in ’pink* cells, and thus suggested 
they were not oncocytes. Ahmed (1975) found high levels of this 
enzyme by histochemistry. However, the electron microscope shows the 
two cell types are not really similar; oncocytes are packed with 
mitochondria, seemingly to the exclusion of other cytoplasmic organelles, 
but this is not true of 'pink' cells. Also, in oncocytes the cristae 
of mitochondria are increased in number and extend the full length of 
the organelles (Ahmed, 1975). Thus their resemblance is superficial.
Rough endoplasmic reticulum is present, often parallel to the 
surface of mitochondria, adjacent to the nucleus and at the base of 
the cell (Pier et al., 1970), and vesicles of smooth endoplasmic 
reticulum are scattered throughout the cytoplasm. There is a prominent 
Golgi complex located above the nucleus. Free ribosomes are seen in 
the cytoplasm (Ahmed, 1978), and Pier et al. (1970) reported finding 
glycogen particles in the cytoplasm and endoplasmic reticulum of ’pink' 
cells f!rom an intracystic papilloma, but not in others.
Two types of rounded osmiophilic granules have been observed by
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electron microscopy (Pier et al., 1970). Large granules are found 
typically grouped at the apex of the cell,with a margin of cytoplasm 
separating them from the plasma membrane. In some cells there 
appeared to be transitional forms between these structures and mitochondria. 
The other type of osmiophilic granule is smaller and found immediately 
beneath the microvilli. They are also seen closer to the nucleus in 
the region of the Golgi complex, suggesting they may arise from this 
organelle.
Hence the structure of ’pink' cells of the breast is very 
similar to that of apocrine skin glands. They both have extensive 
infolding of the basal plasma membrane, a prominent Golgi complex, 
numerous mitochondria, apical microvilli, rough and smooth endoplasmic 
reticulum, all with a very similar distribution. However, the most 
distinctive relationship is the type of granules found in both cells, 
both at the light and electron microscope levels, particularly the 
large osmiophilic variety which may have an origin from mitochondria 
and are almost certainly those seen in the pink cells by Lendrum (1945).
3.2 AETIOLOGY
The aetiology of ’pink* cells has been the subject of debate 
for almost a century. The hypotheses put forward fall into two 
groups. One is an origin by metaplastic alteration of normal mammary 
epithelium, the other that the cells are a new growth, or an existing 
one which becomes prominent.
The mammary glands have long been regarded as modified "sweat”
(i.e. apocrine) glands (Benda, 1894). In 1907, von Saar pointed out
the similarity of ’pink' epithelium to that of cutaneous apocrine glands
and regarded this as further evidence for the phylogenetic development
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of mammary glands from apocrine glands. Creighton (1902) had earlier 
emphasized the relationship of apocrine skin glands to mammary development. 
He believed that apocrine gland cells were commonly found in normal 
breasts by accidentally arrested development of the normal epithelium 
from the "lower type". Krompecher (1916) took the view that 'pink' 
cells were a reversion and either arose from apocrine glands in the 
skin which were incorporated into breast tissue, or were due to arrested 
development of breast tissue at a phylogenetically earlier stage.
Like Creighton he believed the latter was most probable.
Such views have since been refuted by many workers who preferred 
the first hypothesis, mentioned above, that ’pink’ cells arise by 
metaplasia of normal breast tissue. Cheatle and Cutler (1931) stated ✓ 
that whenever apocrine glands resembling mammary structures were found 
they were always in the subcutaneous tissue and never in the gland
itself. These authors never failed to trace a direct anatomical
/
continuity between structures containing ’pink' epithelium and the 
duct system of the mammary tissue. Dawson (1932) concluded that 
the 'pink' cells were derived from normal mammary tissue by metaplasia, 
and found no evidence of inclusion of apocrine skin glands. Her 
evidence was largely that ’pink’ cells and normal epithelium could be 
observed merging directly into each other in the same acinus, as has 
also been reported since by Bonser et al. (1961). Krompecher (1924) 
had earlier described the same phenomenon and sometimes found almost 
imperceptible transitions between the two types of tissue. He also 
stated that the similarity of ’pink' cells to those of apocrine skin 
glands was so striking that they must be identical. However, he 
revised his previous views and considered ’pink’ cells to be derived 
from normal epithelium.
The cause of a metaplastic alteration of normal tissue to ’pink’ 
epithelium is not known. Hypotheses as to the cause include degeneration, 
deranged cellular nutrition, and hormonal variations.
3.2.1 Degeneration
The main protagonist of the degeneration theory was Dawson (1932). 
She attributed the morphological alterations to degenerative changes 
following stimulation of the epithelium to rapid proliferation.
Finding 'pink'-cell-lined cysts predominantly associated with the 
glandular involution of the menopause, she regarded the metaplasia as 
evidence of receding epithelial activity.
Berka (1912) had expressed a somewhat similar view, but, unlike 
Dawson, believed such tissue to result from incomplete post-lactational 
involution. McFarland (1922) also only found ’pink’ epithelial cysts 
in women who had previously lactated,and thus assumed the cysts to be 
residual lactation acini. That this is not true was clearly demonstrated 
by Dawson (1932) and by many others since (Bonser et al., 1961; Higginson 
& McDonald, 1949).
Considerable doubt has since been cast on this theory. Many 
authors (e.g. Higginson & McDonald, 1949; Speert 1942; Pier et al., 1970; 
Bonser et al., 1961) have noted proliferation of 'pink' epithelium, 
including papillary formation. This is not characteristic of a 
degenerative cell. In 1971,Izuo et al. found by microdensitometry 
of breast tissue reacted by the Feulgen method,that 'pink' cells have 
a tetraploid nuclear DNA population. This they suggest is also not 
characteristic of degeneration but rather of proliferation. They 
used apocrine skin glands from vulvectomy specimens as controls and 
found they had a restricted diploid distribution curve of DNA.
The suggestion by Pier et al. (1970) that the 'pink1 cells are 
secretory, and the work of Lendrum (1945) who suggested high cellular 
metabolic activity of 'pink' cells, tend to support the view that
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degeneration is not occurring.
The theory that deranged nutrition is the cause of 'pink' cell 
metaplasia was put forward by Bonser et al. (1961). They found that 
as the loose intralobular connective tissue disappears during involution, 
and is replaced by the denser interlobular type, the associated capillaries 
and lymphatics are also lost. Thus the access of the epithelium to 
blood-borne nutrients is decreased by the loss of capillaries and the 
barrier formed by the less-permeable connective tissue. However, this 
cannot be the sole cause since 'pink' cells are often found in otherwise 
normal lobules. Ahmed (1975) found prominent blood vessels in the 
stroma adjacent to 'pink' epithelium.
3.2.2. Hormonal variation
The possible involvement of hormonal abnormalities in ’pink* 
cell metaplasia is often quoted. The evidence is largely based on 
animal studies.
Fifer, in 1934, described cysts with hyperplastic and altered 
epithelium in the breasts of rabbits undergoing post-lactational 
involution, but not during functional activity. This would tend to 
support Dawson’s theory of degeneration. . However, he also found 
similar changes in the breasts of males and virgin females. McDonald 
(1936) reported areas of intracanalicular hyperplasia, some of which 
resembled ’pink* epithelium, in the mammary glands of castrated rabbits 
receiving 25 to 200 rat units of oestrogenic hormones daily. In 
1937, Herold and Effkeman injected castrated male and female rabbits 
for periods up to three months with oestrogen in amounts from 150 to
1,000 international units daily. They found similar changes occurring 
in mammary cysts, but these were rarely produced in similarly treated 
non-castrated females. Speert (1942) reports that Hartman, Geschickter, 
and Speert (1941) found a similar result in the mammary glands of 
rhesus monkeys. The animals were injected weekly with oestrone pellets,
36
resulting in mammary development. However, only in castrated animals 
(they used females only) were cells similar to 'pink' cells found, 
with one exception in the non-castrates. No such change was seen in 
any of 304 other monkeys, both male and female, under various physiological 
and experimental conditions. They therefore suggest that the unopposed 
action of oestrogen (i.e. in castrates), in large quantities, is 
required for production of ’pink’-type epithelium in animals.
The dangers of applying the results of animal experiments, 
particularly those using non-physiological amounts of hormones, to 
humans are many. This is especially true when studying an organ which 
is affected differently in its normal function by the same hormone in 
various animals (Cowie & Tindal, 1971). However, there is some slight 
evidence of a similar effect of oestrogen in human females (England, 1974), 
those with cystic disease having an elevated serum level of oestrogen, 
albeit slight. This does not necessarily imply that oestrogen is 
involved in the causing of ’pink’ cell metaplasia. Fechner (1970) 
found no qualitative difference in the tissue from breasts of women 
receiving oral contraceptives and that of age-matched controls, and 
an insignificant increase of 'pink* cell metaplasia in women receiving 
oestrogen therapy compared with controls (Fechner, 1972).
3.3 INCIDENCE
The criticisms of the estimation of cystic disease incidence
also apply to 'pink* cell occurrence, with the added difficulty that
such cells are only visible microscopically whereas cysts can be
seen with the naked eye. Therefore the observations recorded in
the literature may well underestimate the frequency with which ’pink*
epithelium occurs. Higginson and McDonald (1949) considered this
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epithelium to he a normal, rather than abnormal, finding in the breast 
since the organ is not static but undergoes monthly cyclical changes. 
Indeed,they go so far as to say "It is our impression that pale 
epithelium could be found in every breast if diligently sought after.". 
This they later qualify by adding "....female breasts after the age 
of puberty.".
Other workers have been somewhat less outspoken. Dawson 
(1932) said that ’pink’-cell structures are to be expected in 
practically every pathologic and cystic condition of the breast, 
malignant or not. She found such structures in 116 of 120 breasts 
with malignant lesions, and in all of 48 cystic breasts. Pink epithelium 
was found in 73 (75%) of 97 unselected mastectomy specimens by Higginson 
and McDonald (1949), and was visible to the naked eye, as pinkish or 
bluish tissue often with cysts, in 75% of cases when it was present.
They saw 'pink* cells in 76% of carcinomatous breasts, in 74% of 
benign ones, and always in those with chronic cystic mastitis. It 
must be pointed out that these studies are all of breasts which were 
abnormal enough to require mastectomy and are therefore a selected 
group with regard to the whole population.
Howeverjboth Berka (1912) and Prym (1928) have reported ’pink’ 
epithelium in otherwise normal breasts, and its occurrence in the 
mammary glands of children was commented on by Kuru (1909).
4 HISTOCHEMISTRY
The morphological and histological staining similarity of ’pink1 
cells and those in cutaneous apocrine glands has been pointed out by 
many authors (e.g. Bonser et al., 1961; Speert, 1942; Higginson & 
McDonald, 1949). This similarity is also very noticeable at the
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ultrastructural level. However,this is not full proof of identity; 
biochemical evidence is also needed.
Some enzymes have been examined in fpinkf cells and in skin 
apocrine glands, and a compilation of the results of several workers 
is in Table 1. All the results were given as visual estimation of 
the enzyme reaction products and are therefore rather subjective. 
However general trends can be followed.
Tremblay (1968) considered his finding of a similar distribution 
of four oxidative enzymes (NADH and NADPH diaphorases, succinate 
dehydrogenase, and cytochrome oxidase) added further support to the 
theory that the two cell types are identical. He found the enzyme 
levels to be different from those of normal breast tissue and eccrine 
sweat glands. The differences between workers for the activity of 
some enzymes may reflect variability in the methods used. For example, 
Tremblay (1968) found much higher levels of succinate dehydrogenase 
(bringing his results more into line with those of other workers) when 
using the method of Wattenberg and Leong (1960), which involves adding 
menadione to the incubation medium.
Harcourt-Webster and Truman (1969) only obtained results for 
mammary gland and therefore did not compare them with apocrine gland. 
However, they did suggest that the high levels of dehydrogenases which 
they found in ’pink’ cells were not consistent with the view that they 
are degenerate. They felt that 'pink' cell characteristics were 
similar to those of Askanazy cells in the thyroid and oxyphil cells 
in the parathyroid, and that they arose by metaplasia. Ahmed (1975) 
obtained similar results to other workers’ for the enzymes he studied, 
and supported the view that 'pink* cells arise by metaplasia and show 
a similarity to skin apocrine gland cells.
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Table 10 SOME ENZYMES DEMONSTRATED HISTOCHEMICALLY IN "PINK" CELLS
AND APOCRINE SKIN GLAND SECRETORY CELLS
ENZYME
Succinate
dehydrogenase
Cytochrome oxidase
Monoamine oxidase
Acid phosphatase
Aminopeptidase
Non-specific esterase
Lipase
3-Glucuronidase
Lactate
dehydrogenase
Phosphohexose
isomerase
a-Glycerophosphate
dehydrogenase
Glucose-6-phosphate
dehydrogenase
ATPase
Alkaline
phosphatase
Glutamate
dehydrogenase
Amylophosphorylase
NADH diaphorase
"PINK" CELLS
low2 strong1 3
weak - moderate'
strong (apical)
low2 strong1 3*
high6
moderate - strong1 *
strong1 ***
absent;
moderate - strong1 *
high2 intense3
APOCRINE GLAND CELLS
1 5low moderate
weak2 strong5
strong
moderate (apical) 
strong5
strong - intense5 
.5strong'
strong'
low
intense'
weak (apical)
absent'
high2
1Harcourt-Webster and Truman (1969), 2Tremblay (1968), 3Ahmed (1975),
c
Cohen (1964), Montagna (1974) quoting various authors, 6Muir et al. (1965)
♦enzyme activity reduced in "pink" cells lining cysts (Harcourt-Webster
& Truman, 1969)
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One finding seems to be consistent when noted. Activities 
of enzymes are mostly higher in the more proliferative of 'pink* 
epithelia. The general conclusion is that the results in Table 1 do 
not disprove the hypothesis that ’pink’ and apocrine gland cells are 
similar.
Of relevance here is the work of Hilf et al.,(1970) who 
measured RNA, DNA, cholesterol, free fatty acids, triglycerides, 
glucose-6-phosphate dehydrogenase, isocitrate dehydrogenase, 
phosphoglucomutase, glutamate dehydrogenase, and hexokinase in 
homogenates of carcinoma, cystic and normal tissue from human breast. 
They found only phosphoglucomutase was higher in cystic compared with 
normal tissue. This would seem to contradict the results of Cohen 
(1964) who found increased glucose-6-phosphate dehydrogenase in cells 
from cysts compared with those from normal breast tissue. However, 
Hilf et al., expressed their results in terms of activity/mg DNA, but 
Izuo et al. (1971), as previously mentioned, found that fpink’ cells 
had a tetraploid population of DNA distribution (and thus could have 
a higher tissue concentration of DNA), whereas true apocrine cells 
had a restricted diploid population. Unfortunately they did not 
also measure the DNA of normal epithelium. Also Nass et al. (1965) 
have claimed that apocrine cells have numerous mitochondria containing 
DNA.
Thus there may be an apparent lowering of DNA-based enzyme 
activities in 'pink' cells since they have more DNA than normal breast 
epithelium. The validity of the results is also questionable because 
of the difficulty of obtaining relatively homogenous cell samples from 
breast tissue, which has large amounts of stroma and, in cystic areas, 
relatively close proximity of different cell types (normal and fpink’).
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4 SKIN APOCRINE GLANDS
These glands are found in the skin of many mammals, though they 
are often somewhat different from those found in man. For example,in 
the horse they are all over the body and produce a clear sweat as well 
as a turbid fluid. They are thus thought to be an intermediate 
between human apocrine and eccrine glands (Hurley & Shelley, 1960).
In man,the apocrine glands are mostly localised in the axilla, 
pubis, perianal region, and the external auditary meatus, although 
they are sometimes found on the rest of the body associated with hair 
follicles. Their fine structure probably varies in the different 
areas. (Ellis, 1967).
The name apocrine derives from the assumed mode of secretion 
of the glands, involving the loss of the apical tip of the cell 
containing secretion products which have gathered there. This contrasts 
with merocrine (e.g. eccrine sweat glands), where secretion diffuses 
through the plasma membrane, and holocrine (e.g. sebaceous gland) where 
the entire cell is secreted.
The glands only develop fully and functionally at, or just 
before, sexual maturity (Montagna, 1959), and in the female may exhibit 
changes through the menstrual cycle. However, such changes are 
hard to see, especially since there are often marked histological 
differences in adjacent glands in the same patient which mask any 
minor variations (Hurley & Shelley, 1960). Weiner and Heilman (1960) 
regarded the glands as accessory sexual organs.
Apocrine glands are often incorrectly referred to as sweat 
glands. In fact they have nothing to do with sweating in man. This 
is the function of a different gland, the eccrine type, which produces 
the characteristic clear watery secretion.
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4.1 EMBRYOLOGY
The skin apocrine gland develops from the primary epithelial 
germ, as do sebaceous glands and hair follicles (Hurley & Shelley,
1960). It grows downwards from the upper end of the hair follicle 
and eventually forms a coil which develops a lumen. By seven months 
of embryological life,the glandular and ductular parts are differentiated. 
At birth, only the ear canal (ceruminous) glands are functional, 
suggesting they are under different endocrine control from other skin 
apocrine glands. These glands do not become functional until puberty.
4.2 MORPHOLOGY
The skin apocrine gland is a simple tubular gland with shunts 
and diverticuli (Fig. 4). A single duct proceeds from a coiled 
secretory element and empties usually, but not always, into a hair 
follicle. The secretory coil is not a simple coiled tube but has 
small pouch-like projections and is bridged by small shunts. It 
lies in the deep dermis and subcutaneous tissue and has an average 
diameter of 1 mm.
4.3 CELLS
4.3.1 Duct
The epithelium of the duct is a double layer of cuboidal cells.
The luminal layers have a poorly developed cuticular border of meshed 
tonofilaments containing some mitochondria. The basal cells have 
few mitochondria, unlike eccrine sweat ducts, and do not appear highly 
specialised, suggesting that apocrine secretion is not modified in 
the duct as is eccrine sweat (Munger, 1965).
4.3.2 Secretory cells.
The secretory coil is lined with a single layer of cuboidal
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Hair
Apocrine gland 
duct Sebaceous gland
-Apocrine gland- 
secretory coil
Fig. 4 . Human skin, showing apocrine and sebaceous glands and a 
hair follicle
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or columnar cells, the shape depending on the secretory activity of 
the cell (Montes et al., 1960; Montagna, 1962). Between these cells 
and the thick hyaline basement membrane are myoepithelial cells. The 
coil is surrounded by loose connective tissue which is well supplied with 
blood vessels. The diameter of the coil, however, is larger than that 
of the duct, and their transition is abrupt.
The secretory cells are eosinophilic, and have a round basal 
nucleus with prominent nucleolus. The apical cytoplasm often appears 
to be "pinched off", suggesting apocrine secretion. In fact this 
appearance is due to the tip of adjacent cells, as shown by serial 
sectioning. Under high power the luminal border shows a "fringe" of 
small vacuoles. These are also visible in the electron microscope, and 
may represent secretory material(Munger, 1965).
The cells contain variable numbers of pigmented and colourless 
granules. The pigmented granules are brownish yellow and histochemically 
of the lipofuschin family (Hurley & Shelley, 1960). They are responsible 
for the colour of the secretion, and are found in large numbers in 
the cells of ceruminous glands. They sometimes give a positive 
histochemical reaction for iron, but this is never found in the gland 
lumen. Sudan black stain produces a stippling of the cytoplasm, 
probably due to mitochondria. Many PAS-positive granules are also 
found, mainly between the nucleus and the apical end of the cell.
They are not glycogen, but the reaction is abolished by prior incubation 
with diastase.
ULTRASTRUCTURE OF APOCRINE GLAND CELLS
The secretory cells are either columnar or cuboidal in shape, 
and both types may be found in the same gland. They have a highly
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folded villous base/'and the folds of adjacent cells intermesh.
Between the myoepithelial cells they rest on the basement membrane, and 
thus allow exchange of metabolites. Biempica and Montes (1965) report 
a high activity of ATPase at this surface.
At the apical end, adjacent cells are joined by strong junctional 
complexes, causing the tip of the cell to bulge into the glandular 
lumen. This surface has abundant microvilli. There is no evidence 
of apocrine secretion, i.e. pinching off of the cell cap, and it has 
been suggested that the secretory mechanism is merocrine (Munger, 1965; 
Biempica & Montes, 1965).
The cytoplasm contains various organelles (Ellis, 1967) 
including mitochondria, rough and smooth endoplasmic reticulum, a large 
Golgi complex, fibrils and tubules, and small vesicles - some with 
dense inclusions. There are also three types of granule, and microvesicles 
(Ellis, 1967), as listed below.
4.4.1 Abnormal mitochondria
These are found above the nucleus; those below are of normal 
structure, generally closely surrounded by rough endoplasmic reticulum. 
Transitional stages are found.
The abnormal types are much larger with a granular matrix and 
sparse characteristic curved cristae. They stain with the PAS reaction 
and are identical with the non-pigmented granules seen by light microscopy.
.4.2 Large dark granules
These are found mainly around the Golgi complex. In the early . 
stages they are bounded by a single membrane. This membrane becomes 
less obvious, the later stages having a rough outline. The granules 
contain extremely dense variable-sized globules, fine dense grains of 
approximately 3 nm diameter, locules containing opaque substance and
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surrounded by denser material, large or small pale areas, and a 
moderately dense ground substance. They appear to be the basophilic 
granules containing pigment, lipid and iron, mentioned earlier.
4.4.3 Microbodies
These are smaller, spherical vacuoles with a single membrane 
containing an eccentric dense mass in a matrix of light material.
They may be the precursors of the large dark granules (Kurosumij1959).
4.4.4 Microvesicles
Small clear vesicular bodies are found throughout the cell, 
and abundantly around the Golgi complex and in the apical cap of the 
cytoplasm. Occasionally they contain fuzzy material and are generally 
around 50 nm in diameter. Kurosumi et al. (1959) did not regard 
them as secretory, but rather water-carrying vesicles, derived from 
pinocytotis at the basal infoldings of the plasma membrane. Hibbs 
(1962), however, concluded that they are the principal secretory 
vesicles of apocrine cells. This view has since been supported by 
other workers (Yasuda et al., 1962; Munger, 1965).
4.5. SECRETION AND EXCRETION BY SKIN APOCRINE GLANDS
The term excretion will be used here to denote the passage of 
material out of the glandular duct, secretion to denote either the 
cellular process or its product.
In their study of the axillary apocrine glands, Hurley and Shelley
(1960) found that fluid was excreted in response to stress - 
particularly fear and apprehension - pain, manual expression by 
squeezing the skin and, occasionally, stroking the skin. The volume 
produced by each gland is very small - about 1 yl per stimulation - 
and no further response can be elicited during a subsequent 24 to
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48 hours. This suggests that on stimulation the myoepithelial cells 
surrounding the gland contract and force out the contained material. 
During the refractory period more secretion is produced in readiness 
for excretion. Montagna (1974) denies this suggestion but offers 
no alternative explanation.
Little is known about the secretory process in apocrine glands 
(Montagna,1974). It is not known which of the granules in the cells 
are secretory granules or even if any of them are secreted. The 
process has never been seen to occur in the electron microscopic
observations of these cells. The mode of secretion is unknown, though
many processes (apocrine, apocrine-merocrine, merocrine, holocrine) 
have been suggested. As Montagna says (1974), "The whole matter of 
the mechanism of apocrine secretion has been obfuscated by too many 
senseless arguments. When all the evidence is in, all the mechanisms 
of secretion from merocrine to holocrine seem to be present..".
4.6. COMPOSITION OF APOCRINE GLAND SECRETION
The lack of knowledge about the mode of secretion extends to
the composition of the secretion. This is almost certainly due to the
difficulty of obtaining anything other than small amounts of such 
secretion.
However, Hurley and Shelley (1960) found the fluid to have
a. pH of between 5 and 6, and to contain protein (using the 2-nitroso 
{3-naphthol test for tyrosine). They also demonstrated,by other 
spot tests,that carbohydrate (reducing sugars using silver nitrate) 
and ammonia (manganese nitrate, silver nitrate) were present.
Although histochemical studies showed lipids to be present in the 
gland cells (Sudan black), they were unable to detect such compounds
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in the fluid using spot tests. They did find slight amounts of 
ferric iron in the secretion, using a,  a ’-dipyridyl, despite Montagna's
(1961) assertion that it is not present histochemically outside the 
epithelium. Richter (1932) found cholesterol in the secretion, but 
Montagna (1974) felt this was debatable. In 1954,Rothman suggested 
the presence of fatty acids but only on the basis of the "caprylic 
odours" of the areas of skin rich in apocrine glands.
The secretion is typically turbid and may be of a thick creamy
consistency, especially in negroes (Hurley & Shelley, 1960). It is 
usually colourless, but may be pale yellow or, occasionally, even blue, 
green, or black (Hurley & Shelley, 1960). The ceruminous glands, 
however, excrete a strongly pigmented secretion (usually yellow to 
dark orange).
An undoubtedly important feature of the glands is the odour 
produced by their secretion, especially in the axilla. Hurley and 
Shelley (1960) found this to be due to bacterial decomposition of 
the excreted material on the skin surface. They detected no odour 
in the sterile product. The reasons for, or uses of, this odour 
production are largely conjectural, but the possibility of its being 
part of a signalling or pheromone system is . not to be dismissed
lightly. This view is supported by the release of apocrine secretion
under emotional stress.
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5 DIRECTION OF RESEARCH
5.1. OBJECTIVES
The problem to be investigated was by what mechanism do cysts 
arise in the human female breast around the time of the menopause, and 
what is the nature of ’pink’ epithelium in relation to these cysts.
It seemed obvious that one way of tackling the problem was to examine 
the fluid aspirated from breast cysts and to see if its chemical and 
cellular components revealed any clues as to its origin. For this 
study, the hypothesis was set up that breast cyst fluid represented, 
at least partially, a secretion by the ’pink’ cells reported to line 
such cysts. At the time there were no chemical studies of BCF 
reported in the literature, and the cytopathology books were mainly 
concerned with the detection of malignancy, and therefore rather 
offhand about breast cysts.
5.2. MEANS
In our laboratory we had been electrophoresing, on cellulose 
acetate, serous fluids sent for cytological examination, and thus 
studying their protein composition. It became apparent that BCF 
had a completely atypical pattern compared with the other fluids, 
particularly a lack of y-globulin, and this stimulated the interest 
in cystic disease.
The line of research was therefore initially to concentrate 
on an investigation of the protein content of BCF, and to see how this 
compared with the composition of milk and plasma. This comparison 
might give some clue as to the origin of the proteins, and would also 
be made for other chemical components of the fluid.
The absence of y-globulin would also be studied and the various
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immunoglobulin classes estimated. Again,the levels found would be 
compared with those of milk and plasma, and an attempt made to explain 
their apparent lack as well as the absence of other serum proteins.
An effort was to be made to see whether either secretory IgA or 
'secretor piece' was present since this would be supportive evidence 
for secretion.
It was also intended to raise an antiserum to BCF. This would 
be useful not only for studies of the protein content, but also to 
see whether any BCF proteins were localised in cells, particularly 
'pink' cells, of the mammary tissue using the technique of 
immunofluorescence. For this purpose histological as well as cytological 
material would be needed.
The cells found in breast cyst aspirates would be carefully 
examined to obtain information on the normal content. This would be 
correlated with other parameters to see whether any relationships 
could be found.
In order to undertake these exercises it would be necessary to 
ensure a high quality of sample material (samples sent for cytology 
can take a day to arrive). It was therefore considered desirable 
to attend at least one breast clinic in order to receive the fluids 
as they were aspirated. This would give the added bonus of allowing 
a complete patient history to be taken with perhaps some information 
not normally requested, if the consultant was willing. This bank of 
data might prove useful and would give some insight into the clinical 
aspects of cystic disease of the breast.
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1 SPECIMEN COLLECTION
1.1 BREAST CYST FLUID
Samples of breast cyst fluid (BCF) were obtained from hospitals 
in both the St. Helier and the Croydon Groups. They are sent to the 
laboratory for cytological examination. Over 180 samples were also 
collected from the Breast Clinic at Mayday Hospital (Croydon). This 
ensured fresh specimens (others can take over 24 hours to reach the 
laboratory) and a detailed record of the patient's history.
Any case of a lump in the breast suspected of being a cyst was 
treated by the consultant surgeon as follows. The adjacent skin was 
cleaned by swabbing with surgical spirit. Whilst immobilising the 
lump with the left hand, a needle fitted to a 20 ml hypodermic syringe 
was pushed into the lump. The syringeplunger was slowly withdrawn, 
the left hand still holding the lump. The aspiration was continued 
until no more fluid was obtained and the lump had disappeared. This 
sometimes required the syringe to be changed during the procedure.
If the lump did not completely disappear this was regarded - after 
checking there was no closely adjacent, but unconnected, cyst - as 
suspicious. The fluid obtained was placed into sterile Universal 
bottles for transport to the laboratory. A 10 ml sample of blood 
was also taken and placed into a sterile Universal bottle. Details 
of the patient's history were taken and recorded on the form shown in 
Fig. 5.
On returning to the laboratory, the colour and volume of each 
BCF was recorded on a form (shown in Fig. 6), and the fluids centrifuged 
at 1,000 x jj for 5 minutes to sediment cells and other matter. The 
supernatant was poured off the deposit, from which slides were prepared 
for cytological examination. The fluid was placed into 4 plastic tubes,
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PATIENT INFORMATION NUMBER
FORENAME(S):
BURGEON: G.P;
( Age: ) MARITAL STATUS*. S M U D
AGES Oldest:
Youngest:
If Post YEARS SINCE:
SURNAME:
HOSPITAL REG. No:
DATE OF BIRTH:
PARITY Liveborn:
Stillborn/Miec:
MENOPAUSE Pre Peri Post
BREAST FEEDING Number of times:
Durotion:
Time since lost lactation:
CONTRACEPTIVE HORMONES Now From:
Previously To:
OTHER MEDICINES:
FAMILY HISTORY OF BREAST DISEASE Ca:
Cystic:
Others:
ETHNIC GROUP: Caucasian Negro Indian Jewish Oriental Muslim
CLINICAL INFORMATION 
DIAGNOSIS:
DURATION:
SITE:
PREVIOUS CYSTS NOT ASPIRATED:
NUMBER OF CYSTS PREVIOUSLY ASPIRATED: 
DATE OF LAST ASPIRATION:
THIS CYST PREVIOUSLY ASPIRATED:
OTHER BREAST ABNORMALITIESI 
OTHER CLINICAL ABNORMALITIES:
BREAST SURGERY: .
GENERAL CLINICAL FINDINGS:
Dote(s):
Date(s):
Fig. 5 Form used for recording details of patient history.
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LABORATORY RESULTS
Fig.
BLOOD GROUP: 
BLOOD COUNT: BBC Polys
1/BC Lymphs
Plots Monos
HAEMOGLOBIN:
ESR:
U T Total Protein:
Albumin:
IONS etc, No: Cl:
K: 002:
Glucose:
Eos
Bob
Bilirubin: 
Aik. Fhos:
Ureo:
Fe:
OTHERS:
CYST FLUID
VOLUME ASPIRATED: 
COLOUR: Light
Medium 
Pole
BLOODSTAINED
ml.
Green 
Brovra 
Yellow 
Due to aspiration?
Milky 
Med. Milky 
SI. Milky
Form used for recording details of BCF samples
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with 1 ml in each/ and any remainder stored in bulk. The tubes 
were kept in a deep freeze at -20°C. The time from collection to 
freezing was never more than 3 hours. For investigation of the 
particulate fraction the specimens were not frozen but stored at 
4°C and used rapidly.
1.2 SERUM
The clotted blood samples were centrifuged at 2,000 x £  for 
10 minutes and the serum carefully removed with a Pasteur pipette 
and divided equally amongst four plastic tubes. It was stored at 
-20°C.
From patients who volunteered to provide urine specimens, a 
20 ml sample of blood was taken. The serum obtained from this was 
sent for steroid estimations, except for 2 ml which was retained and 
stored as usual.
1.3 URINE
Twenty-four hour urine specimens were obtained from breast 
cyst patients and controls for the estimation of steroids. Patients 
were asked if they would cooperate and the procedure, and the reason 
for collecting specimens, explained. None refused to help, and only 
one defaulted. They were given an instruction sheet. (Fig. 7) and 
a Winchester bottle, together with four standard forms for Chemical 
Pathology at Mayday Hospital. The samples were collected on a day 
of their choosing (usually Sunday/Monday) and the bottle returned 
within six hours to Mayday Hospital, together with one of the forms 
on which they noted details of menstruation and the date of specimen 
collection. Another three samples were taken, at weekly intervals, 
in order to cover one menstrual cycle.
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INSTRUCTIONS FOR COLLECTING 24 HOUR URINE SPECIMENS,
All the urine you pass during the 24 hour period must 
be collected in the bottle provided.
A convenient way of doing this is as follows
When you get up in the morning go to the toilet as usual.
Then for the rest of that day and the following night, collect
all the urine you pass into the bottle provided. Next morning 
get up at the same time and collect all the first specimen of 
urine into the bottle. This completes the collection and the 
bottle and contents should be taken during the morning to
Fig. 7 Instruction sheet issued to patients who volunteered 
to provide 24-hour urine specimens.
At the Chemical Pathology laboratory each specimen was mixed 
well, the total volume noted on the form, and a 100 ml aliquot stored 
in the deep freeze, the remainder being discarded. This aliquot was 
stored frozen and later sent for estimation of steriods.
1.4 TISSUE SAMPLES
Breast tissue was obtained from biopsy or mastectomy specimens. 
The whole specimen was transported, unfixed, from the operating theatre 
to the Histopathology Department, immediately after its removal. Any 
cystic areas were excised, and either frozen with liquid carbon dioxide 
or else fixed in formalin or buffered glutaraldehyde (for light and 
electron microscopy, respectively).
The formalinised tissue, in sizes up to 1 x 1 x 0.5 cm, was fixed 
for 24 hours, and then dehydrated and impregnated with wax in a 
Histokinette automatic processor. After embedding in wax, the blocks 
were trimmed and sections cut, usually 5 ym thick.
For electron microscopy the tissue was cut into pieces 1 mm 
square in buffered glutaraldehyde, transferred to fresh fixative for 
one hour, washed twice in buffer for 30 minutes, post-fixed in 1% 
osmium tetroxide for one hour and finally washed as before. Following 
dehydration the tissue was embedded in araldite.
Blocks or sections of breast and other tissues were also 
obtained retrospectively from the Histopathology Department, if 
unavailable in fresh form.
For frozen sections the tissue was cut into pieces about 
0.5 cm square and up to 0.5 cm thick. They were placed on a small 
amount of embedding compound (O.C.T., by Lab-Tek Products, obtained 
from Raymond A. Lamb, London) on a microtome chuck, and then
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surrounded with the same material. After fitting into a freezing 
apparatus, the inside of the metal chuck was blasted with liquid 
carbon dioxide, initially in short bursts, until the specimen was 
frozen. The chuck was then placed in a cryostat microtome and 
sections cut, 5 ym thick. These were picked up on cleaned glass 
microscope slides.
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2 ELECTROPHORETIC METHODS 
The methods of electrophoresis used were cellulose acetate, 
polyacrylamide gel and polyacrylamide gel incorporating sodium dodecyl 
sulphate (SDS gel).
2.1 CELLULOSE ACETATE
Strips of Cellogel (Chemetron, Milan, obtained from Whatman Ltd.) 
15 cm by 6 cm were soaked in 0.04 M sodium barbitone buffer, pH 8.6, 
for at least ten minutes. The Cellogel was placed so as to allow 
electrophoresis along the short axis, on wicks of Whatman 3MM paper 
soaked in the barbitone buffer, in a Shandon electrophoresis tank 
modified to take the short strips. A further layer of buffer-soaked 
3MM paper was laid on top of the wicks, thus holding the strip securely. 
Samples were applied to the cathodic side of the centre of the strip, 
using a Cellogel applicator, with one application (1.5 yl) for serum, 
two (3 yl) for B.C.F. The electrophoresis with 0.04 M sodium barbitone 
buffer was run at 100 V for about 35 minutes, progress being monitored 
by adding bromophenol blue, which binds to albumin, to the serum sample 
on each strip.
The strip was then carefully removed, using forceps, and floated 
on the staining solution for ten minutes, agitating intermittently.
For demonstrating proteins the stain used was 0.5% Amido Black in a 
mixture of methanol, water and glacial acetic acid (9:9:2). The 
excess stain was removed by passing the strip -through successive baths 
of a mixture of methanol, water and glacial acetic acid (19:19:1) until 
the background was clear.
Following destaining the strips were either cleared or whitened. 
Clearing was achieved by rinsing in fresh methanol for 30 seconds,
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placing in the clearing solution (a mixture of methanol, glacial
acetic acid and glycerol, 85:14:1) for one minute, then laying face
down onto a clean glass sheet and, after removing excess solution,
heating at 70°C for 5 minutes. After cooling, the transparent strip
was peeled from the glass plate. Whitening was performed by fixing
the strips in 40% aqueous formaldehyde for one minute, immersing in
7% aqueous glycerol for three minutes and heating face up on a glass 
oplate at 80 C for about five minutes.
2.1.1. PAS staining
The periodic acid-Schiff technique was used to demonstrate 
carbohydrate material. For cellulose acetate strips the method 
used was largely that of Smith (1968).
Following electrophoresis, the proteins were fixed by immersing 
the strip in a mixture of methanol, water and glacial acetic acid 
(9:9:2) for ten minutes. After oxidation for ten minutes in 0.02M 
sodium acetate containing 0.5% periodic acid, the strip was rinsed 
in 10 mM hydrochloric acid and placed in a bath containing 10% 
potassium iodide in 2.5 mM hydrochloric acid, freshly prepared.
The resultant brown coloration was just removed by adding saturated 
sodium thiosulphate solution, and the strip agitated in the bath 
until it was colourless. After rinsing again in 10 mM HC1, the strip 
was placed into Schiff’s reagent for 30 minutes and then washed in 
three changes of 0.05 M nitric acid, fifteen minutes each.
2.2 ACRYLAMIDE GEL
A variety of systems was used with this technique, in both 
disc and slab form, in order to attempt better resolution of BCF 
proteins than was obtained by cellulose acetate electrophoresis.
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2.2.1 Disc
Initially the method of Davis (1964) was used, but this was 
found to be very long and tedious, requiring three different gels of 
different constitution. Therefore the method of Clarke (1964) was 
adopted, which he claims to suffer little loss of resolution compared 
with that of Davis, and is certainly much faster and easier.
Gels were prepared from the following solutions:
(a) Acrylamide 30 g; N,N*-methylene bisaerylamide, 1.0 g; 
water 123 ml.
(b) N jN jN ’jN 1- tetramethyethylenediamine (TEMED) 0.28 ml; water 
to 100 ml.
(c) Glycine, 29 g; tris-hydroxymethylamino methane (TRIS),
6.0 g; water, 980 ml.
(d) Ammonium persulphate, 0.14 g; water to 100 ml.
(e) Glycine, 29 g; TRIS, 6.0 g; 1 M hydrochloric acid, 5.0 ml; 
water 975 ml.
Gels were cast in precision-bore, glass tubes of internal 
diameter 5 mm, fitted at the base with a plastic cap, and marked 
with a scratch 6 cm from the base. A mixture consisting of 6 ml(a),
3 ml(b), 3 ml(c) was prepared in a vacuum flask which was then 
stoppered, after adding a few glass granules, and connected to a 
water pump and de-aerated for 2 minutes. To this was added 12 ml 
freshly prepared solution (d), also de-aerated, and after mixing, 
pipetted into tubes up to the scratch mark. After filling all the 
tubes - usually 10 to 12 - the monomer solution was overlayered with 
water, using a hypodermic syringe barrel with a fine needle attached.
The water was allowed to run down the side of the tube to avoid
mixing into the monomer solution. The tubes were left for polymerisation
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to occur, and after one hour the overlayering water shaken out, the 
caps carefully removed and the best eight gels selected (by their 
regular length and flat surface) and the tubes fitted into the upper 
electrophoresis chamber. The lower chamber was filled with about 
250 ml of a 1*. 10 dilution of solution (e) , the electrode and upper 
tank holding the gels fitted, and the upper chamber filled with the 
same buffer.
Samples were prepared in 5% sucrose solution, containing 
0.05% bromophenol blue, such that 0.1 ml would contain approximately 
300 yg of protein. By means of a pipette 0.1 ml of the solution 
was carefully layered on top of the gel to form a layer between it and 
the buffer.
When all eight samples had been applied, the electrode was 
fitted to the upper chamber, and both electrodes connected to the power 
supply, with the lower tank as anode. Electrophoresis was continued 
with a current of about 30 mA until the bromophenol blue "tracking 
ring" had reached about 1 cm from the bottom of the gel. This usually 
took about 40 minutes.
The gels were removed from the tubes by "rimming out". An 
hypodermic needle, attached to a 20 ml syringe filled with water, was 
gently slid between the gel and the tube. By slowly forcing water 
from the syringe, whilst rotating the tube and pushing the needle 
further in, the adhesion of gel to tube was broken and the gel slipped 
out. The gels were then placed into large test-tubes and 20 ml of 
stain added. Various stains were used. Initially 0.1% amido black 
in 7% aqueous acetic acid was used. However, it was felt that 
since many BCF proteins are glycoproteins, a stronger fixative and 
more sensitive dye might be better. A solution of 0.1% Coomassie Blue
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in 20% aqueous methanol containing 10% trichloracetic acid was 
therefore tried, with and without heating at 60°C. Both stains were 
applied for at least one hour.
Following staining the gels were destained electrophoretically 
after a preliminary rinse for one hour in two changes of 3% acetic 
acid (amido black), or 5% acetic acid in 10% methanol (Coomassie blue).
The gels were placed into 7.5 mm bore glass tubes, the bottom ends 
of which contained about 1 cm of 7^% polyacrylamide gel. To prevent 
convection during electrophoresis a viscous solution of 7% polyacrylamide 
without cross-linking agent (N,N'-methylenebisacrylamide) was added to 
just cover the gels. The tanks were filled with the destaining 
solution used for the preliminary rinse and a current of 300 mA applied 
until all the excess dye had migrated into the lower buffer-tank (anode). 
The gels were removed and stored in plastic, capped tubes in 3% acetic 
acid.
PAS staining was performed by Clarke’s method (1967). The 
gels were immersed in 1% periodic acid in 3% acetic acid for one hour, 
and washed in several changes of water over a period of one hour.
They were then placed in Schiff reagent for one hour, washed several 
times in 1% aqueous sodium metabisulphite, and stored in the same solution.
2.2.2 Flat bed
The apparatus for this was constructed according to a design of 
Akroyd (1968) and consisted basically of two flat sheets of glass 
23 x 7.5 cm, onto each of the narrow ends of one being glued a spacer 
strip of 2 mm thick glass 7.5 x 1.0 cm. Thus with the plain glass 
sheet resting on the spacer strips a long, narrow glass cell is formed, 
open at top and bottom (i.e. long) edges.
The plates were cleaned carefully in detergent and a very thin
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smear of grease placed on each spacer strip. The plain strip was 
placed on top and held in place using bulldog clips over the spacer 
edges. The bottom was sealed using a strip of autoclave tape, which 
was continued up each side of the cell. Monomer solution was pipetted 
into the cell, which was held vertical using a burette clamp and stand 
on a level surface, to 1 cm from the top. After overlayering with 
water, the gel was left to polymerise, and after 30 minutes the water
shaken out and the autoclave tape removed.
Spacers consisting of 5 mm lengths of 2.5 mm O.D. silicon 
rubber tubing were inserted vertically into the top of the cell at 
about 8 mm intervals, and pushed down to touch the gel surface.
The cell was placed into one of two identical buffer tanks, constructed 
of 6 mm Perspex, with internal dimensions 24 x 4.5 cm and 3 cm high.
By adjusting the position of the bulldog clips attached to the sides 
of the cell so that they rested on the sides of the tank, the cell
could be maintained level and above the floor of the tank. The top
of the cell was then filled with distilled water, and samples, mixed 
with an equal volume of 10% sucrose containing a few drops of 
bromophenol blue solution, layered onto the gel in the compartments 
between the spacers. For BCF 50 yl was applied, for serum 10 yl.
Buffer was then added to the tanks, and the upper tank placed 
behind the cell so that the top of the buffer was about 1 cm above 
the top of the cell. A wick, consisting 0f three layers of 3 MM 
chromatography paper (20 x 10 cm) soaked in buffer and sandwiched 
between thin polythene sheets, was then placed into the top of the 
cell with the other end in the upper buffer tank. Platinum 
electrodes in the tanks were connected to the power supply and a current 
of 20 mA passed for 10 minutes until the proteins had entered the
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gel. The wick was taken out and.the spacers removed with a bent 
dissecting needle. The wick was replaced to 1 mm above the gel and 
electrophoresis recommenced at a current depending on the buffer 
system. On completion of electrophoresis the cell was removed, 
the bulldog clips taken off and the plain glass plate slid off.
The slab was removed and stained as for gel rods. Destaining was 
performed by diffusion, washing the gel in several changes of 
destaining solution. If PAS staining was to be performed it was 
found useful to place duplicate samples in each half of the gel.
After electrophoresis the gel could be cut and one half stained for 
proteins, the other by PAS.
A variety of gel and buffer systems were tried with this system, 
mostly those given by Akroyd (1968). These include Ornstein’s 
discontinuous buffer (TRIS-HC1 in the gel, TRIS-glycine in the tank), 
Poulik’s discontinuous buffer (TRIS-citrate in the gel, borate in 
the tank), and a continuous TRIS-EDTA-borate buffer, as well as 
Clarke's (1964) system. These were generally used with l\% 
acrylamide gels, but a discontinuous gel was also tried. For the 
latter, gels 2 cm high were successively cast in the cell of 15%,
10% and finally 5% acrylamide, using Ornstein's discontinuous 
buffer system.
2.3 SDS GEL
This method was originally used to attempt better resolution 
of BCF proteins. The sodium dodecyl sulphate (sodium lauryl 
sulphate, SDS) prevents re-aggregation of protein molecules after 
chemically breaking any disulphide bonds which link them using 
2-mercaptoethanol or dithiothreitol (Cleland’s reagent). Initially
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the disc method was used, but the flat gel technique was found to
be better as it allowed easier comparison of results for different
samples, and more samples per run. In each case the simplified
method of Clarke (1964) was used for gel and buffer, but incorporating
0.2% SDS in both. It was also found to be necessary to incorporate
SDS in the water overlay used in casting the gel to prevent it mixing
with the monomer solution.
For preparing the samples a longer procedure was necessary.
To 1 ml of a 10 mM Tris-HCl buffer pH 8.0, containing 1 mM EDTA, 1%
SDS, 1% dithiothreitol and 10% glycerol was added 0.5 ml BCF. After
incubating at 60°C for 15 minutes, 10 yl of the solution was layered
onto the gel in the usual way.
After electrophoresis, the gels were stained in a 1% solution
of Coomassie Blue, in 25% aqueous isopropanol containing 10% glacial
oacetic acid and 10% trichloroacetic acid, at 60 C for one hour.
The gels were then destained in 10% trichloroacetic acid solution 
in 10% aqueous methanol.
2.4 MOLECULAR WEIGHT DETERMINATIONS BY SDS GEL
The SDS method was also used to determine molecular weights 
of the protein sub-units of BCF. The method used was basically 
that of Weber et al. (1972). The following solutions were prepared.
(a) Dialysis buffer: 0.01 M sodium phosphate (since 
potassium precipitates SDS) buffer, pH 7.0, containing 
0.1% SDS and 0.1% 2-mercaptoethanol.
(b) Treatment buffer: 0.01 M sodium phosphate buffer, 
pH 7.0, containing 1% SDS and 1% 2-mercaptoethanol.
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(c) Gel buffer (pH 7.2): 8.82 g podium dihydrogen orthophosphate 
dihydrate, 20.4 g di-sodium hydrogen orthophosphate,
2.0 g SDS, distilled water to 1 litre.
(d) Acrylamide solution: 22 g acrylamide, 0.6 g N,N’-methylene 
bisacrylamide, distilled water to 100 ml.
(e) Ammonium persulphate solution: 15 mg/ml freshly prepared. 
(This was later changed to 10 mg/ml to increase gelling 
time).
Gels were prepared by mixing 15 ml gel buffer, 13.5 ml acrylamide 
solution and adding 45 yl TEMED. After deaerating, 1,5 ml ammonium . 
persulphate solution was added and the solution pipetted into tubes with 
an internal diameter of 7.5 mm, and 8.5 cm long (Shandon destaining 
tubes) to a height of 7.0 cm. The monomer solution was carefully 
overlayered with 1% SDS in distilled water and the tubes left for 
1 hour for the gel to form. This gave a 10% acrylamide gel. A 
7.5% gel was also used and was prepared in the same way but using 
acrylamide solution (d) diluted 3:4 with water instead of full strength.
After gelation, the overlay was shaken from the tubes and 
their caps removed. The tubes were fitted into the Shandon apparatus, 
but using the destaining tank, as previously described. The tank 
buffer used was gel buffer (c) diluted 1 + 2  with distilled water. 
Samples were layered onto the gels and a current of 80 mA passed 
for 4§ hours by which time the bromophenol blue ’’tracking ring” was 
about 1 cm from the bottom of the gels. The gels were "rimmed out" 
of the tubes, as before, cut off at the centre of the 'tracking ring", 
and placed in 20 ml stain each for 2 hours. The stain used was 
0.25% PAGE Blue 83 (a dye similar to Coomassie Blue, from BDH) in a 
mixture of methanol, water and glacial acetic acid (5:5:1). The
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gels were destained first overnight in the dye solvent used for 
staining■, and then electrophoretically in a mixture of water, methanol 
and glacial acetic acid (35:3:2). It was found that although the 
gels were originally cast in the larger, destaining tubes (not the 
usual running tubes) they could stili be fitted back into these tubes 
for destaining since they had shrunk somewhat due to partial dehydration 
in the stain. Following destaining the gels were stored in water in 
capped plastic tubes. With transillumination the distance migrated 
by each band was measured and calculated as mobility (percentage of 
total length of the gel, i.e. distance travelled by the bromophenol 
blue tracking ring) to allow for differences between gels.
Samples were prepared for electrophoresis by adding 0.1 ml of
BCF to 1 ml treatment buffer (b) at 100°C and incubating at that
temperature for 2 minutes. Gel loads were prepared by adding 300 yl
of this solution to 4 drops of glycerol, 300 yl of dialysis buffer
(a), 20 yl of 2-mercaptoethanol, and 20 yl of saturated aqueous 
bromophenol blue solution. After thoroughly mixing this solution 
100 yl was applied to the gels.
The standards used were BDH molecular weight markers (a series 
of oligomers of protein cross-linked with diethylpyrocarbonate).
These were prepared for electrophoresis by adding 1 ml of treatment 
buffer to one vial of marker (2 mg), heating at 100°C for 2 minutes 
and then continuing as for samples. A standard curve was prepared 
by plotting molecular weight against mobility on semi-log paper 
(molecular weight on the log scale). The molecular weight of the 
proteins in the bands of the sample gels was obtained from their 
mobility using this graph.
Initial trials of the method were conducted using two additional
68
sample preparation methods on the same specimens. Firstly heating
to 100°C was omitted to see if enzymic proteolysis, which should be
prevented by heating, was occurring. Secondly the period of heating
was extended to 5 minutes to check whether non-enzymatic hydrolysis
was occurring during the heat treatment. Also, since glycoproteins
are reported to give variable results with this technique (Webber
et al., 1972) depending on the gel porosity, identical samples were
run on both 7.5% and 10% gels, together with standards.
Some gels were stained for carbohydrate using the PAS technique
of Glossman and Neville (1971). Eight gels (four duplicates) were
washed overnight suspended in 2 litres of a stirred solution of 40%
aqueous methanol containing 7% acetic acid, and then washed in a
fresh solution for a further eight hours. One of the duplicates
was oxidised in 1% periodic acid in 7% acetic acid in the dark at
room temperature for one hour, and all were then washed for 24 hours
in 7% acetic acid, changing the solution twice. They were then
o
incubated in Schiff’s reagent for one hour in the dark at 4 C, and 
finally washed in four changes of 1% sodium metabisulphite acidified 
with a few drops of HC1 and stored in the same solution in capped 
plastic tubes. The tests (treated with periodic acid) and controls 
(untreated) were compared.
2.5 ISO-ELECTRIC FOCUSSING
This was performed in thin-layer polyacrylamide gel to attempt 
better resolution of BCF proteins.
A pH gradient is formed in the gel by ampholytes in an electric 
field, which also causes the proteins to migrate to their iso-electric 
point, where their nett charge is zero and they thus stop. The
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apparatus used was the LKB 2117 Multiphor. It consists of a gel 
casting chamber, a tank with a lid containing two long platinum 
electrodes, a cooling plate, and a high-output power pack. The gel 
chamber is two thin glass plates, separated by a rubber gasket running 
around the periphery, clamped together by small bulldog clips.
The gasket is cut at one corner to allow partial removal for introduction 
of monomer solution.
The gel was prepared from the following solutions.
(a) Acrylamide, 29.1 g; made to 100 ml with distilled water.
(b) N,N’-methylene bisacrylamide, 0.9 g; made to 100 ml with 
distilled water.
(c) Ammonium persulphate, 1.0 g; made up to 100 ml with 
distilled water. This was prepared fresh each time.
The glass plates were thoroughly washed using detergent, rinsed 
in distilled water and then ethanol (IMS) and allowed to dry. The 
gasket was then fitted and the plates clamped. In a vacuum flask 
were mixed 10 ml of (a), 10 ml of (b), 7.5 g of sucrose dissolved in
36.4 ml of water, and 2.8 ml of ampholytes (Ampholine, LKB) pH range
3.5 to 10. Following aspiration for two minutes to remove air from 
the solution, 0.8 ml of (0) was added and mixed and the solution 
carefully (to avoid bubbles) poured into the gel casting chamber.
This was held vertical and with the filling point raised above the 
rest of the chamber. When the chamber was full the small end of 
gasket was replaced to seal the chamber, and the last clamp applied.
After about one hour the clamps were removed and the chamber stored 
at 4°C for 15 minutes. This procedure allowed the glass plates 
to be separated 'more easily, leaving the gel on one plate. The 
gasket was peeled off, and the plate placed on the cooling surface
of the tank, which was wetted to ensure good thermal contact. The 
cooling plate was connected to a tap, and cold water circulated at 
a rate which was indicated by the in-line flow meter as being sufficient. 
Twenty samples were applied, on strips of Whatman 3MM paper 5 x 10 mm. 
Each strip was wetted with 10 yl of sample and then laid on the gel 
midway between the electrodes. Two long, narrow strips of thick 
paper, which had been quickly dipped into electrode solution, were 
laid on the gel, one at each end, such that after fitting the tank 
lid the electrodes rested upon them. The electrode solutions were 
1 M sodium hydroxide for the cathode and 1 M phosphoric acid for the 
anode.
After fitting the lid, and connecting the electrodes to the 
power pack, a voltage of 200 was passed for five minutes, and then 
increased in stages every ten minutes to a maximum of 1,000 V. After 
a total time of 2.5 hours the current was switched off, the tank lid 
and electrode strips removed, and the gel and plate immersed in the 
stain bath and placed in an incubator at 60°C. The staining solution, 
used for one gel only, was 0.4 g Coomassie Blue dissolved in 120 ml 
methanol and added to 250 ml water, followed, after mixing, by 12 g 
sulphosalicylic acid and 40 g trichloracetic acid. After staining 
the gel was removed from the bath, using the plate (from which it 
had now detached) as a support, and placed in the destaining solution, 
a mixture of water, IMS and glacial acetic acid (65:25:8). This 
solution was changed at hourly intervals until the gel background was 
as clear as possible. The gels were photographed, and then placed 
onto sheets of wetted 3MM paper and dried.
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3 COLUMN CHROMATOGRAPHY 
Attempts were made to separate BCF proteins using both gel- 
permeation and ion-exchange chromatographic techniques. The results 
were compared with those for milk and serum controls.
3.1 GEL-PERMEATION CHROMATOGRAPHY
This was performed principally on columns of Sephadex G-200 
cross-linked dextran gel (Pharmacia Fine Chemicals). The method was 
also used for de-salting samples to be applied to ion-exchange columns, 
with Sephadex G-25.
The dried gel was swollen in the eluant to be used for 
chromatography. For protein separations 0.1M tris-HCl buffer, pH 8.0, 
containing 0.2M sodium chloride, was used. About 5 g of Sephadex 
G-200 were weighed into a 500 ml conical flask, 250 ml of buffer added 
and the flask gently shaken. The flask was then heated on a boiling 
water bath for 5 hours, occasionally mixing the contents by swirling. 
After cooling to room temperature, pouring into a 250 ml measuring 
cylinder and allowing the gel to settle, the volume of buffer above 
the gel was adjusted to about one-third of the gel volume.
The column was prepared in a glass tube, 2.5 cm in diameter and 
45 cm long, fitted with adjustable end-pieces (Whatman). The tube 
was clamped vertically, with the lower end-piece fitted, and buffer 
injected from a syringe connected to the outlet tube, so as to cover 
the bed-support and exclude air. The outlet tube was clamped and the 
gel slurry gently stirred and then poured in, down a glass stirring- 
rod, to fill the glass tube. As the gel settled the upper end piece 
was slowly fitted and pushed down until the inlet tube was filled with 
buffer, then clamped. The inlet tube was connected to a four-way
72
valve and the outlet tube to a flow-cell (1 cm path length, 0.1 ml 
capacity, Helima) in an SP500 spectrophotometer (Unicam) and thence 
to a fraction collector (Medical and Biological Instrumentation Ltd.)
The layout is illustrated in Fig. 8. Eluant was supplied from a 
reservoir connected to a peristaltic pump (Watson-Marlow Ltd.) with 
its outlet running to the four-way valve.
The pump was started and the flow rate measured by collecting 
eluant for a timed period. The flow rate was gradually increased to that 
to be used in the experiment, usually about 40 ml/hour. The gel bed 
was allowed to pack under these conditions and then the end pieces moved 
to contact the bed and form a completely enclosed column. During this 
process the outlet tube was clamped and the four-way valve turned to 
allow the excess buffer from the column to run to waste.
The sample, 1 to 2 ml, was applied in one of two ways. The 
first simply involved removing the delivery tube from the eluant 
reservoir and pumping the required volume of sample onto the column.
The second method, which avoided running the sample through a long 
delivery tube and thereby reduced ’’tailing”, was to fit an hypodermic 
syringe barrel into the top position of the four-way valve, clamp the 
tube between the valve and the column and then turn the valve to 
connect syringe and waste. An excess of sample was poured into the 
syringe barrel and allowed to begin to run into the waste tube, 
whereupon the valve was switched back to connect syringe and column.
This procedure avoided the admission of air into the tubing. The 
outlet tubing at the fraction collector was then raised to be level 
with the base of the syringe, and the clamp on the inlet tubing 
removed. The sample was thus allowed to run onto the column under 
a very low pressure-head. When the required volume had been applied
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Fig.8 Diagramatic layout of apparatus for column chromatography.
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the valve was turned to reconnect the pump to the column, the outlet 
tube returned to the fraction collector, and the pump re-started.
The effluent from the column was collected in fractions on a 
volume basis, usually 100 drops. The absorbance of the effluent 
was measured at 280 nm and recorded using a chart recorder (Vitatron 
Ltd). The latter was also connected to the fraction collector to 
allow a reference scale of the fraction number also to be recorded on 
the chart.
Before running samples the packing of the column was checked, 
and the void volume estimated, by running 4 ml of a 0.3% solution of 
Blue Dextran (Pharmacia).
3.1.1 Analysis of fractions
Following completion of the run, the fractions constituting 
each peak on the absorbance chart were pooled and each pool was 
concentrated by ultrafiltration. This was performed in an Amicon 
cell fitted with a UM2 (molecular weight cut-off = 1000) membrane, 
until the volume of the retentate had been reduced to that of the 
original sample.
The concentrated pools were then tested by immunoelectrophoresis, 
and those from two samples were assayed for cholesterol. In one run 
the fractions were tested, before pooling and concentrating, for the 
presence of carbohydrate. This was done by adding to 1 ml of each 
fraction, 0.6 ml of 0.2% carbazole in concentrated sulphuric acid. 
Carbohydrate material gives a purplish colour.
3.1.2 Desalting for ion-excharige chromatography
The samples of BCF were initially desalted using gel chromatography 
on Sephadex G-25 fine grade, this grade having been shown to exclude 
the proteins of BCF. Six grams of dry gel was swollen in 50 ml of
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the buffer to.be used for the ion-exchange separation and heated on 
a boiling water-bath for one hour. The suspension was cooled to room 
temperature and the column prepared, as above, in the 1.5 cm diameter 
tube, and set up as in Fig. 8. The void volume of the column was 
estimated using Blue Dextran (Pharmacia), and the elution volume of 
salts found by running solutions of coloured salts, potassium dichromate 
and cupric sulphate. This was with a view to minimizing re-introduction 
of salts into the protein-containing run-off.
The column was then washed with three bed volumes of buffer 
and the sample, 1.0 ml of BCF, was applied to the column using a syringe, 
as before. The excluded protein was collected in one fraction, 
monitoring by means of the absorbance pattern of the effluent at 280 nm. 
This desalted fraction was then subjected to ion-exchange chromatography 
without prior concentration, its volume being about 5 ml.
3.2 ION-EXCHANGE CHROMATOGRAPHY
The resin used was QAE Sephadex A-25 (anion exchanger, Pharmacia) 
in 0.1 M tris-HCl buffer, pH 7.2. This type of ion-exchanger was used 
in preference to the cellulose type because it was found to be easier 
to pack and simpler to prepare. The prepared Sephadex bed was also 
less prone to compression during equilibration. A 1.5 x 20 cm tube 
was used to prepare the 12 cm column. To 300 ml of buffer was added 
15 g of resin which was left to swell for one hour, stirring occasionally. 
The supernatant was poured off the settled gel and replaced by fresh 
buffer. The pH of the supernatant was measured before it was discarded. 
The washing was repeated at ten minute intervals until the resin had 
almost equilibriated with the buffer. This was shown by the pH of 
the supernatant becoming close to that of the fresh buffer.
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The column was then prepared, as before, and set up as in Fig. 8. 
Buffer was pumped through the.column at a rate of 15 ml/hour, until the 
pH of the effluent was 7.2 (i.e. the same as the buffer). The desalted 
sample was then applied by pumping onto the column.
The buffer reservoir was then changed for a gradient mixer.
This was a "home-made" device, consisting of two 200 ml plastic beakers 
with a small plastic pipe cemented into the base of each and connected 
by a short length of silicon-rubber tubing. A paper clip was found 
to be satisfactory as a tube-clamp. An outlet tube was cemented into 
the base of one beaker and this was attached to the tube leading to 
the pump. This beaker was also fitted with a motor-driven stirrer.
To the stirred beaker was added 150 ml of 0.1M tris buffer pH 7.2, to 
the other 150 ml of the same buffer containing 1 M sodium chloride.
The beakers were placed on a levelled surface, the clip removed from 
the connecting-tube, and the stirrer started. Thus a linear gradient 
from 0 to 1 M sodium chloride was produced as the eluant was pumped 
onto the column. The linearity of the gradient produced by the mixer 
was checked by using it to prepare a gradient of Bromophenol blue in 
the tris buffer. This was pumped directly into the flow-cell in the 
SP500 and the absorbance of the solution, at 580 nm, continuously 
monitored by recording on the chart recorder.
Fractions were collected at the rate of one every ten minutes, 
and the column washed through, after the gradient, with the buffered 
1 M sodium chloride solution, until no more material absorbing at 
280 nm was eluted. As before the fractions were pooled to correspond 
to peaks on the output absorbance chart, and concentrated by 
ultrafiltration.
The gel was removed from the tube for re-equilibration with
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buffer before making another run. , This is much quicker than washing 
the column in situ, and also easier since the resin contracts considerably 
during the run.
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4 IMMUNOLOGICAL METHODS
4.1 PRODUCTION OF ANTTSERUM
Antiserum to BCF proteins was raised in two rabbits. Two
pools, each of 10 BCF, were prepared. The fluids for each pool
were all of "Pure" type, and selected on the basis of the original
volume aspirated. One pool was of fluids from cysts greater than
5 ml, the other cysts less than 5 ml. The pools were concentrated
four-fold in an Amicon ultra filtration cell fitted with a UM2 membrane
(Molecular weight cut off'= 1,000).
The concentrated fluids were mixed with Freund's Complete
Adjuvant (1 + 3) and injected subcutaneously into two sites, one pool
to each rabbit. After one week the animals were re-injected with
the same material.
Fortnightly test bleeds were made, the blood allowed to clot,
spun down, and the serum removed and stored at -20°C. The titre of
each bleed for each rabbit was estimated by rocket immunoelectrophoresis,
and maximum titre was obtained 6 months after the original injection.
The animals were given booster doses of antigen only, and bled out one
month later when the titre had risen again.
4.1.1. Absorption of antiserum
The antiserum was found to contain antibodies to serum proteins
and these were removed by absorption with freeze-dried plasma. To 1 ml
of antiserum in each of 6 plastic tubes was added 10,20,50,75,100 and
200 mg of freeze-dried plasma. The tubes were capped, and the contents
gently mixed and left at room temperature for 2 hours and then overnight 
o
at 4 C. They were then spun in a centrifuge at 2,000 X  g for 20 minutes 
and the precipitates discarded. The lowest concentration of freeze- 
dried plasma to abolish all reaction of the antiserum with human serum
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in immunodiffusion experiments was found to be 100 mg/ml. This was 
the Concentration used to absorb the antiserum.
It was later discovered that a milk-protein antibody was also 
present in anti-(BCF) and this was absorbed out by adding an equal 
volume of a pool of five human skimmed-milk samples to the serum- 
absorbed anti-(BCF).
4.1.2 Purification of immunoglobulins from antiserum
In order to remove unwanted proteins from the absorbed antiserum, 
the immunoglobulins were precipitated by salting out. To 10 ml of 
antiserum was added 40 ml of water, and 12.5 g of ammonium sulphate. 
After mixing to dissolve the salt, the solution was left overnight at 
room temperature and then centrifuged at 4,000 x j; for 30 minutes.
The supernatant was discarded and the precipitate washed twice with 
10 ml of 1.75 M ammonium sulphate, and then redissolved in 10 ml 
distilled water and transferred to an Amicon model 52 ultrafiltration - 
cell fitted with an XM 100A membrane (molecular weight cut off = 
100,000). The cell was connected to- a reservoir which contained the 
dialysing fluid and, by maintaining a constant pressure in the system, 
a volume of the fluid was admitted equal to that of filtrate leaving 
the cell. Thus the effect is the same as dialysis but much faster.
The following solutions were passed through the cell, in each 
case until 50 ml of filtrate were collected: distilled water;
0.05 M sodium acetate, 0.021 M acetic acid, pH 5.0; distilled water; 
and the acetate buffer. The solution was then removed from the cell, 
centrifuged, and passed through a 14 cm high column of DEAE-sephadex 
A-50, equilibriated with the acetate buffer used for dialysis, in a
1.5 cm diameter chromatography column. The column was eluted with 
25 ml of acetate buffer, the eluate collected and returned to the
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washed ultrafiltration cell and dialysed, as before, by passing through 
100 ml of 0.1 M sodium chloride containing 0.05% sodium azide. Finally 
the volume of the solution was reduced by ultrafiltration to 10 ml, and 
the resultant purified immunoglobulin solution stored at -20°C.
4.2. PREPARATION OF AGAROSE GELS
Agarose gels were prepared by a standard technique for all 
immunological procedures requiring them. To 500 ml of distilled water, 
rapidly stirred in a conical flask by means of a magnetic stirrer, was 
added 10 g agarose (Meath). The agarose was dissolved by heating 
the flask in a boiling water bath, stirring occasionally. When the 
solution had cleared, 0.5 g sodium azide was added. After mixing, 
the solution was poured into clean, glass Universal bottles, in 
aliquots of about 20 ml. The bottles were capped, left to cool, 
and then stored at 4°C. To prepare gels, as many bottles of 2% 
agarose as were needed were heated in a boiling water bath until the 
agarose had melted. Meanwhile double-strength stock buffer was 
pipetted into glass universals, or test tubes for small volumes, 
using half the volume of the gel to be prepared. Using a hot 
pipette an equal volume of molten agarose was added, the container 
capped and inverted gently to mix the contents, and the solution 
poured carefully onto the glass plate. These were of various sizes 
and were cleaned before use in hot Decon, rinsed in distilled water 
and dried. Before pouring the gel they were placed on a levelling 
table (Shandon). For 10 x 10 cm plates 18 ml gel was used; for 
8 x 8  cm, 12 ml; for 3.7 x 7.5 cm, 5 ml; and 2.6 x 7.5 cm (microscope 
slides), 3.5 ml.
When the gels had set and cooled they were placed in plastic
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boxes lined with damp filter paper, and cooled to 4°C for one hour 
before cutting wells.
This preparation method had several advantages. Firstly, it 
was not necessary to store several different buffered agarose solutions. 
Secondly, a new buffer could be prepared and used quickly. Thirdly, 
a large bulk of agarose could be stored.
4.3 OUCHTERLONY IMMUNODIFFUSION
Samples of BCF, human milk, colostrum, and serum were examined
by this procedure using various antisera. These were antisera to
human IgG, IgA, IgM, whole serum proteins, albumin, milk, lactoferrin, 
and BCF.
For immunodiffusion, glass plates size 10 x 10 cm were most 
frequently used, with 1% agarose gel in 0.15 M phosphate buffer pH 7.6, 
or 0.05 M tris buffer pH 7.6 containing 0.8% NaCl. Wells were made
using a cutter (Wellcome Reagents Ltd), connected to a water-operated
vacuum pump in order to remove the unwanted gel. The holes produced 
were 2 mm in diameter. The usual pattern of wells was an hexagonal 
array around a central well.
Both test samples and antisera were put up, at least initially, 
in a series of dilutions to ensure that optimum concentrations of 
antigen and antibody were subsequently used. Generally, two-fold 
serial dilutions up to 1:16 were made. This procedure also helped 
in revealing minor components which would otherwise have been missed 
if only dilutions appropriate to major constituents had been used.
The plates were then placed in a damp cupboard at room temperature 
and examined periodically until full.development was attained. This 
usually occurred within 48 hours, and the plates were never incubated
.82
for more than 72 hours.
4.3.1 Washing and Staining
Excess unreacted protein was removed from the gel by one of 
two methods; washing or pressing. The washing method has two main 
disadvantages. It is very slow, and the gels are liable to detach 
from the plates during the process. The latter problem necessitates 
careful handling of the free-floating gel, and damage usually results. 
Although a dried coating of agarose on the plates used for preparing 
the gels ensures good adherence, it was not used here since it also 
makes difficult the cutting of clean wells and troughs.
The gels were washed in 0.8% saline, containing 0.1% sodium 
azide, for 3 days, changing the solution twice daily. They were then 
washed in distilled water for about two hours and dried under a hot- 
air blower after covering with a filter paper moistened with distilled 
water.
The pressing method is much faster than washing. The gels were 
flooded with distilled water to fill all the wells (to prevent their 
splitting) and a wet filter paper laid over the top ensuring no bubbles 
were trapped beneath. A pad, 1 cm thick, consisting of squares of 
absorbent paper slightly larger than the plate, was placed on top and 
weighted with a thick glass sheet. After 30 minutes the weight and 
pad were removed, the filter paper wetted and then carefully peeled 
off the now-flattened gel. The majority of the unreacted protein is 
thus removed in the absorbent paper pad. The gel was then washed in 
0.8% saline for two hours, rinsed in distilled water for 15 minutes 
and re-pressed, as above, for 30 minutes. The gel, with the filter 
paper still attached, was then placed under a hot-air blower and dried., 
After drying, the filter paper was wetted with distilled water
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and peeled off the plate. The gels were then stained, either in the 
amido black as used for cellulose acetate strips, or else in a mixture 
of methanol, water and glacial acetic acid (9:9:2) containing 0.5% 
Coomassie Blue. For the latter method destaining was performed in a 
mixture of water, methanol and glacial acetic acid (9:5:2).
4.4 RADIAL IMMUNODIFFUSION
This technique was used for the estimation of immunoglobulins 
(IgG and IgA) in BCF. The agarose was prepared as previously described, 
using 0.15 M phosphate buffer pH 7.6 containing 0.05% sodium azide.
The mixture, in universal bottles containing 12 ml aliquots, was 
equilibrated in a water bath at 47°C. To each bottle was added 0.2 ml 
of antiserum (Wellcome) to IgG or IgA, the gel carefully mixed and 
quickly poured into a 9 cm Petri dish on a levelling table. After 
cooling the gel, wells 3 mm in diameter were cut, using the vacuum- 
operated cutter, guided by a perspex template (Wellcome). The wells 
were examined and any which were not clean-sided and undamaged were 
marked and not used. The samples were applied, undiluted, using 
fine pipettes prepared by pulling out Pasteur pipettes. The wells 
were quickly filled, level to the brim. This method is as accurate 
as using a measured quantity of sample, and avoids splashing, and 
theoretically corrects for any variations in thickness of the gel. 
Standards were prepared from four dilutions of an assayed control 
serum (Behringwerke AG), and were put up in duplicate.
After replacing the lids on the Petri dishes, they were placed 
in a damp-cupboard at room temperature for approximately 50 hours to 
allow completion of reaction. They were then removed and the diameter 
of each precipitate ring estimated, using a caliper gauge, taking
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the mean of two measurements at 90°. A standard curve.was prepared 
by plotting the square of ring diameter for the standards against 
concentration. From this the values of the Unknowns were derived by 
interpolation.
4.5 IMMUNOELECTROPHORESIS
This technique was used extensively for the examination of BCF 
proteins using antisera to whole human serum, human milk, immunoglobulins, 
lactoferrin, and BCF.
Two principal methods were used, macro and micro. The former 
was performed on 10 x 10 cm slides, the latter on microscope slides,
7.5 x 2.6 cm. For both methods, the agarose was prepared as before, 
using 0.04 M barbitone-sodium barbitone buffer pH 8.6. The macro­
method was preferred for ease of examining the precipitation pattern, 
but the micro-version was more economical in consumption of antiserum.
For the macro-method, three wells, 3 mm in diameter, were cut as 
shown in Fig. 9(a). Samples were placed into the wells using calibrated 
capillary tubes; the volume being determined by pilot experiments and 
depending upon the antiserum. In general, 5 yl serum and 15 yl BCF 
were used. A serum control was usually used, and placed in the central 
well. The electrophoresis was performed either in a Shandon or an 
MBI tank. The latter, being larger, could accommodate four plates.
The buffer used was the same as the gel buffer, and wicks were 2 layers 
of Whatman 3MM paper. These were moistened in buffer and laid on 
the ends of the plates, to cover about 7 mm, and a current of 75 mA per 
plate passed for about 2 hours. The plates were then removed from the 
tank and 2 mm wide slots for the antiserum cut as shown in Fig. 9(a).
For this purpose a gel cutter designed for the micro-method (Shandon)
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(a)
(b)
Fig. 9 Immunoelectrophoresis plates. Patterns of wells and slots 
used for the macro-method (a), and micro-method (b).
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was used. The agarose gel was removed from the slots using a Pasteur 
pipette attached to a vacuum pump, and the slots filled with antiserum.
The gels were placed in a damp-cupboard at room temperature and 
examined periodically until reaction was judged complete. This usually 
took 48 to 72 hours. Excess, unreacted protein was removed by washing 
or pressing (see above). The latter was found to be preferable, since 
if the gels were detached from the plates the slots made them very 
fragile. The gels were dried and stained as described previously for 
immunodiffusion.
For the micro-method,the technique was basically the same. The 
slides were loaded into a perspex tray (Shandon) and both wells and 
slots cut using a special cutter (Shandon). This apparatus allows 
either of the patterns in Fig. 9(b) to be used, the wells being 1 mm in 
diameter; the slots variable, but 1 mm was used. The agarose plug 
was removed to form the well which was then filled with sample using, 
generally, a 1:3 dilution of serum and undiluted BCF.
The tray was placed in a Shandon electrophoresis tank and wicks 
consisting of two layers of Whatmann 3MM paper laid so as to cover 
4 mm of each end of the gels. Following electrophoresis, at 17 mA 
per slide for approximately 2 hours, the slide tray was removed from 
the tank and the agar gel removed from the slots (cut before electrophoresis) . 
Hie slots were filled with antiserum, which was diluted up to 1:8 (depending 
on the type of antiserum) with gel buffer. Diffusion occurred more 
rapidly with the small slides and was complete in 48 hours. The gels 
were washed, or pressed, dried and stained as before.
4.6 CROSSED (LAURELL) IMMUNOELECTROPHORESIS
This technique, together with several modifications, was used
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mainly with antiserum to BCF. One such modification was the placing 
of a gel strip containing serum proteins between the running gel and 
the antiserum gel. Thus, when the second-dimension electrophoresis 
was rim, the large antigen excess of serum proteins prevented precipitation 
by any homologous antibodies in the antiserum. In effect, this is 
absorption in situ
For this method 8 x 8 cm plates were usually used, but 3.7 x
7.5 cm were later used to conserve antiserum. The technique was 
similar for both sizes. The plates were poured in the usual way, 
using the same buffer as for immunoelectrophoresis (0.04 M barbitone, 
pH 8.6). Wells were then cut using the 3 mm vacuum-operated cutter, 
as shown in Fig. 10(a). After adding sample, the plates were placed 
in the Shandon or MBI tank, containing the same buffer as in the gels. 
After fitting wicks consisting of 2 layers of Whatman 3MM paper, a 
current of 60 mA per plate (large) or 20 mA per plate (small) was 
passed for about 2 hours. For BCF and milk 5 yl of sample were used 
(3 yl for small plates); for serum the same volume was used after 
diluting 1:2.5. When the sample was not serum, a well was often 
cut higher up the plate and filled with serum containing bromophenol 
blue. The dye binds to serum albumin, and thus allows the 
electrophoretic separation to be monitored during the run. On 
completion of the electrophoresis, the position attained by the bound 
dye was marked on the back of the plate in order to provide a reference 
point.
The gels were removed from the tank and cut as shown in Fig. 10(a), 
using an old microtome knife. The large portion of the gel was 
discarded (including the serum control, as above, if included) and 
the empty part of the plate wiped with a tissue. To 8.8 ml of gel,
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O
(b)
0 O
Fig. 10 Patterns used for Crossed Immunoelectrophoresis plates, with
(b) and without (a) antigen strips.
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at 74°C was added 0.2 ml of antiserum and, after mixing, the solution 
poured onto the plate. For small plates 0.1 ml of antiserum in 
3.9 ml of gel was used. Care was taken to ensure it did not run over 
the top of the gel containing the electrophoresed sample. When the 
gel had set the plate was returned to the tank and, after replacing 
the wicks, the second dimension run at 5 mA per plate (2 mA for small 
plates) for 16 hours, overnight. The plates were then removed from 
the tank and the gels washed, pressed, and stained, as before.
As mentioned above, some modifications were also used. The 
main one was incorporation of a gel strip containing excess of antigens, 
to remove homologous antibodies in the antiserum, which would otherwise 
interfere. This was accomplished after removing the unwanted gel 
following the first-dimension electrophoresis. A brass bar of 2 cm 
square cross-section and 12 cm long, with flat polished surfaces, was 
placed across the plate 1 cm (2.2 cm for small plates) from the cut
edge of the remaining gel (dotted line Fig. 10(b)). To 1 ml of gel
o o
at 47 C, 0.5 ml of antigen solution (serum or milk), also at 47 C,
was added, mixed, and poured onto the plate between the gel and the
brass bar. When the gel had set, the bar was removed and the meniscus
at the bar end cut off. For the small plates the end 1.2 cm of gel
was cut off to leave an antigen-gel strip of 1 cm. After wiping
the plate the antiserum-gel was poured on the remaining blank portion
using 0.2 ml of antiserum in 7.3 ml of agarose gel for large plates,
0.1 ml in 3.2 ml of gel for small plates. The second dimension was
then run as before.
Another modification used was to run two antigen samples on 
the same plate. For this purpose, another sample well was cut in 
front of the usual one (dotted in Fig. 10(a)). The extra antigen was
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placed in this well, left to diffuse into the gel for about 5 minutes, 
and the now-empty well filled with agarose. This is to allow uninterrupted 
electrophoresis of the sample in the more cathodic well. The remainder 
of the procedure was completed in the usual way. By comparing two 
plates, identical in all respects except the extra antigen on one, 
the identity of components between the two may be established. The 
method was used here for comparison of BCF with milk. A variation, 
also used, is to cut a well below the line of, and subsequent to, the 
first dimension electrophoresis, in an appropriate position along 
the plate, and place the other antigen therein. Thus this antigen 
is only electrophoresed in the second dimension, and the technique 
is used to establish identity of a peak occurring in a known position.
It was used here with purified lactoferrin as antigen.
4.7 REVERSED ROCKET IMMUNOELECTROPHORESIS
This technique was used for the estimation of antibody titre 
in antiserum to BCF. The method is that of Axelsen and Svendsen (1973).
By using a buffer of pH 4.9 for electrophoresis, the BCF antigens have
zero or slow cathodic mobility, whereas the antibodies in the antiserum 
have a high cathodic mobility. By electrophoresing antibody into a 
gel containing antigens, "rockets” are obtained with peak height 
proportional to titre.
The gels were prepared, as before, using 0.1 M sodium acetate-
acetic acid buffer, pH 4.9.To 12 ml of gel at 47°C was added 0.1 ml of
BCF (from a pool of equal volumes of 10 fluids) and after mixing
poured onto an 8 x 8 cm plate. After cooling the gel, wells 2.5 mm
in diameter were cut at 0.5 cm centres along a line 1 cm from the
edge of the plate, and this was placed in the electrophoresis tank
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with the wells at the anode. Wicks of 3MM paper soaked in tank buffer 
(gel buffer diluted 1:2 with water) were fitted and 15 volts applied 
to the gel. The wells were filled with antiserum samples (diluted 
1:5), and after one hour the voltage across the gel was measured and 
reset to 15, and electrophoresis continued overnight.
The gels were pressed, dried, and stained as before, and the 
peak heights measured.
4.8 IMMUNOHISTOCHEMISTRY
Two types of labelled antiserum were used for this technique: 
a fluorescein-isothiocyanate (FITC) conjugate and a peroxidase 
conjugate. The former was used initially, but the latter was found 
to have several distinct advantages. Firstly, the peroxidase technique 
permits of the use of formaldehyde-fixed, paraffin-wax-embedded tissue 
providing formaldehyde does not affect the antigenicity of the material 
being examined. Such tissue can also be used for immunofluorescence 
but extensive washing of the sections is required to remove interfering 
autofluorescence generated by the fixation. This is time-consuming 
and sections are often ruined during the process. Extensive washing 
is not required when using peroxidase conjugates.
Secondly, the staining with immunofluorescent techniques is 
not permanent, whereas the peroxidase reaction product is. Therefore, 
if the latter technique is used it is possible to review the results 
at a later date.
Thirdly, the use of a special microscope is not necessary with 
the peroxidase method. The slides are also much easier to look at, 
and clearer.
Fourthly,the easy use of sections from routine histological
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blocks enables retrospective studies, especially of rare material, 
to be made by the peroxidase method.
It was found during this study that even frozen sections of 
breast tissue contained considerable amounts of autofluorescent material 
which often masked the specific staining reaction. This also weighted 
the decision in favour of the peroxidase method.
4.8.1 Immunofluorescence
The method was performed on both frozen sections and wax-embedded 
material. The techniques for both were essentially the same, but the 
wax sections required pre-washing.
Frozen sections were fixed in methanol at 4°C for two minutes.
Wax sections were warmed to 60°C, placed in xylene for 10 minutes and 
intermittently agitated, and then rinsed in two successive baths of 
absolute alcohol and finally in water. The sections were then washed 
in very gently agitated PBS (phosphate-buffered saline; 0.2 M phosphate 
buffer, pH 7.2, containing 0.8% w/v sodium chloride and 0.05% sodium 
azide) for 4 days, changing the PBS twice daily.
The frozen sections were washed briefly in PBS, and the following 
operations were identical for both types of section. The double-layer, 
or ’’sandwich" method was generally used.
The slides, excluding the area covered by tissue, were wiped dry 
and placed in the lid of a plastic box lined with moistened filter 
paper (to prevent drying out). Appropriately diluted rabbit antiserum 
was placed onto the sections, and incubated with the box closed, at 
room temperature for 30 minutes. The slides were carefully rinsed with 
PBS and then washed in the same buffer for 30 minutes, changing once. 
After drying the slides and replacing them in the box, diluted (usually 
1:32) FITC-conjugated antiserum to rabbit immunoglobulins (Wellcome) was
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placed on the sections. After incubating for a further 30'minutes> 
the slides were rinsed and washed, as before, for 60 minutes. For 
the single-layer method, only one application of antiserum was made. 
This was a labelled antiserum against the appropriate tissue component.
The slides were mounted in a mixture of glycerol and PBS (9:1) 
and examined without delay in a fluorescence microscope, using a dark- 
field condenser, with FITC3, BG12 and BG3 excitation filters, and a 
K500 barrier filter. The light source was a mercury lamp.
The tissues used with this technique were fresh cystic and 
"normal” breast, and wax-embedded cystic breast. The antisera used 
were anti-(BCF), and anti-(human IgG) and anti-(human IgA) which were 
both FITC conjugates used by the single-layer technique. Controls, 
omitting the first antiserum, and also substituting non-immune rabbit 
serum, were run with each batch of tests.
4.8.2 Peroxidase
The method used was that of Burns (1975). Formalin-fixed, 
wax-embedded sections were used generally, but initially the results 
were compared with those using frozen sections post-fixed in methanol, 
and glutaraldehyde-fixed, wax-embedded material. The techniques 
were the same in all cases except that de-waxing was not employed for 
frozen sections.
The sections (5 ym thick) were warmed to 60°C and placed into 
xylene for 10 minutes. They were then washed twice in absolute 
alcohol for 5 minutes and transferred to 0.5% hydrogen peroxi*de in 
methanol for 15 minutes, to block endogenous peroxidase. The slides 
were then rinsed in tap water and washed for 15 minutes in TBS (Tris- 
buffered saline; 1 M Tris-HCl buffer, pH 7.6, diluted 1:10 with 0.8% 
saline). The area around the section was carefully dried and the
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slides placed in the lid of a plastic box lined with moistened filter 
paper. Great care was taken to ensure that at no point did the sections 
dry out.
The sections were then covered with goat serum, diluted 1:5 
with TBS, the box covered, and left for 10 minutes. The serum was 
drained off and the appropriately diluted (in TBS) rabbit antiserum 
added to the slides, which were left in the damp-box for a further 
30 minutes. The sections were then rinsed in TBS, and washed in 
stirred TBS for 30 minutes, changing twice. The slides were then 
removed, wiped dry as before, and returned to the damp box. The 
sections were covered with a 1:25 dilution of peroxidase-conjugated, 
goat antiserum to rabbit immunoglobulins (Miles) and left for 30 
minutes. They were then rinsed, and washed in stirred TBS for 30 
minutes, changing twice.
The sections were then reacted to demonstrate peroxidase.
The reagent used was 5 mg of 3,3f-diaminobenzidine tetrahydrochloride 
in 10 ml of TBS containing 5 yl of hydrogen peroxide, prepared freshly. 
Five drops were placed on each slide and left for exactly five minutes. 
They were then rinsed with TBS, washed in running tap water for 15 
minutes and finally rinsed in distilled water. The sections were 
counterstained by immersing the slides in haematoxylin for about 
15 seconds, rinsing in distilled water, differentiating in 1% acid 
alcohol and blueing in running tap water for 15 minutes. The sections 
were dehydrated by agitating in 3 sequential baths of alcohol (IMS) 
followed by 2 of xylene, and mounted in DPX.
Various tissue substrates were examined by this method, principally 
with anti-(BCF) absorbed with serum and milk. These were cystic, normal, 
and carcinomatous breast; vermiform appendix; skin from male axillae,
95
and female axillae, nose, breast, and vulva; papillomata; ceruminal 
adenoma; hidradenoma; apocrine gland cystadenoma; kidney; cervix; 
rectum; stomach; and colon. Many were from specimens obtained at 
sergical operation for carcinoma.
As mentioned, the antiserum generally used was anti-(BCF), 
diluted 1:250. However, others were used, including antisera to whole 
human serum, and human milk. The direct, one-step method was employed 
with peroxidase-conjugated antisera to human IgG and IgA (Mercia 
Brocades) on cystic breast tissue.
Controls were included in each batch of tests. The most 
frequently used negative control was anti-(BCF) absorbed with BCF.
With runs using anti-(BCF), a positive control (cystic breast or 
axillary skin section) was included. Other controls used were as 
follows.
(a) Omission of primary antiserum in the two-stage technique,
to ensure there was no non-specific binding of the conjugate.
(b) Omission of all antisera, to check for endogenous peroxidase 
in the section.
(c) Initial incubation with sheep anti-(whole human serum) 
before the serum-absorbed anti-(BCF), to ensure that no 
antibodies to serum proteins were remaining in the anti-(BCF).
(d) Blocking after the reaction with rabbit antiserum, by 
using sheep anti-(rabbit immunoglobulins), before incubation 
with peroxidase-conjugate, to check for non-specific binding.
4C8.3 Treatment of sections with trypsin
Experiments were made with the use of trypsin to determine whether 
additional sites of reaction with anti-(BCF) were revealed. After 
de-waxing and blocking endogenous peroxidase, the sections were placed
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into a 0.1% solution of trypsin in 0.1% calcium chloride (adjusted to 
pH 7.8 with 0.1 M sodium hydroxide) at 37°C. Sections were removed 
after 5,' 10, 15 and 30 minutes, rinsed, and placed for 5 minutes in a 
0.1% solution of trypsin inhibitor. After washing in TBS for 15 
minutes they were reacted by the peroxidase technique, as usual.
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5 CHEMICAL ANALYSIS
501 TOTAL PROTEIN
A modification of the method of Lowry (1951) was used to 
estimate protein. Assays were performed in duplicate in clean glass 
tubes.
To 0.1 ml of sample, diluted so as to contain up to 1Q0 yg of 
protein, was added 0.1 ml of water and 1.6 ml of 0.66 M sodium hydroxide 
solution. The tubes were incubated in a water-bath at 37°C for 30 
minutes, to ensure dissolution of any solid proteins, and then cooled 
to room temperature. After cooling, 1.6 ml of buffer (8.4 g of 
sodium bicarbonate and 2.5 g of sodium hydroxide in 100 ml of water) 
was added from a repeating syringe (Zippette), to ensure thorough and 
rapid mixing, followed by 0.6 ml of copper tartrate solution (0.1% 
cuprous sulphate solution containing 0.2% sodium tartrate, freshly 
prepared), also from a Zippette. The use of such devices to ensure 
rapid mixing had been shown to be essential in pilot experiments 
whilst setting up the method.
The tubes were left for 15 minutes at room temperature and 
then 1.2 ml freshly-diluted Folin-Ciocalteu reagent was added, again 
forcefully. The Folin reagent was diluted with water to make it I N  
in acid. This dilution was determined by titrating each new batch 
of stock reagent against 1 M sodium hydroxide, with phenolphthalein 
as indicator, and was usually 1 volume reagent plus 2 of water.
After standing for 30 minutes, the absorbance of the solutions 
at 750 nm was read against a reagent blank prepared by substituting 
water for sample. Standards were prepared from bovine serum albuminf 
using 10,20,50,75, and 100 yg per tube. The protein content of each 
sample was- estimated from the standard curve.
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502 CHOLESTEROL
The method of assay was a modification by Ness et al. (1964) of 
the Liebermann-Burchard reaction. This method is unsuitable for 
fractions from density gradients, since it was found that the reagent 
charred the sucrose used to prepare the gradient. The resultant carbon 
interfered with spectrophotometry. Therefore, an extraction procedure, 
essentially as used by Keenan et al. (1970), was adopted as an initial 
step for such samples. Free cholesterol was estimated after digitonin 
precipitation of the lipid extract.
The reagent was prepared by mixing 150 ml of glacial acetic acid 
and 300 ml of acetic anhydride in a 1 litre conical flask. The flask
was placed in a sink full of cold water and the contents swirled to mix,
whilst slowly adding 50 ml of concentrated sulphuric acid. After 
adding, and dissolving, 10 g anhydrous sodium sulphate the solution was 
transferred to a glass bottle and stored at 4°C.
For the direct method, 0.2 ml of sample was pipetted into a
clean glass tube, and 5 ml of ice-cold reagent added forcefully, to
ensure rapid mixing. Samples containing high levels of cholesterol 
(e.g. BCF) were either diluted 1:2 with water, or only 0.1 ml was 
used. The tubes were incubated at 15°C to 16°C for exactly fifteen 
minutes. The absorbance of the solution was then read at 625 nm 
against a reagent blank prepared by substituting water for sample. 
Standards were prepared from assayed control sera and a solution of 
cholesterol (Biochemical standard, BDH) in chloroform.
For the extraction method, 0.1 or 0.2 ml of sample (as before) 
was pipetted into a clean glass tube having a ground neck into which 
a ground glass stopper could be fitted. Water was added to give a 
total volume of 0.5 ml, followed by 1.85 ml of a mixture of methanol
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and chloroform (2:1). The tubes were stoppered, shaken intermittently 
for 1 hour, and then centrifuged to remove any precipitated protein.
The supernatant was poured off into a fresh stoppered tube, 0.65 ml of 
chloroform and 0.6 ml of water added and the mixture shaken vigorously. 
The tubes were centrifuged to separate the two phases,and the lower 
chloroform layer removed to a glass test tube using a Pasteur pipette. 
The tubes were placed in a water bath at 30°C and evaporated to dryness 
under a stream of nitrogen. The residue was re-dissolved in 0.2 ml 
of chloroform and treated as above, adding 5 ml of reagent. Standards 
were prepared from a 1 mg/ml solution of cholesterol in chloroform, 
and the values for the samples estimated from the standard curve.
5 „2.1 Free and esterified cholesterol
To estimate free and esterified cholesterol the samples were 
first extracted as above and the dried lipid extract re-dissolved in 
1 ml of a mixture of acetone and 95% ethanol (1:1). To this was 
added 1 ml of a 1% solution of digitonin in 50% aqueous ethanol, the 
tubes mixed and left at room temperature for 10 minutes before 
centrifuging at 1500 x j* for 5 minutes. The supernatant was discarded 
and the tubes left upside-down for 5 minutes to drain the precipitate, 
which was then washed by adding 4 ml of cold acetone, vortex mixing, 
and centrifuging as before. After draining the precipitate for 5 
minutes, 0.2 ml of chloroform was added and cholesterol assayed as 
above. This gave the value for free cholesterol, and esterified 
cholesterol was'found by subtracting this from the total value.
5o3 PHOSPHOLIPIDS
Total phospholipids in BCF were estimated by the method of 
Baumann (1924). This involves an extraction of lipid followed by
100
estimation of phosphate in the extract after digestion to release inorganic 
phosphate.
To a sample of 1 ml of BCF, in a 25 ml volumetric flask, was 
added about 15 ml of a mixture of ethanol (IMS) and diethyl ether (3:1).
The flask was placed over a boiling water-bath until the solvent boiled, 
and after cooling, the level in this flask was made up to the mark with 
ethanol-ether. The flask was shaken and the contents filtered, 
retaining the extract filtrate.
Into pyrex tubes, 20 mm in diameter and calibrated at 12.5 ml, 
was pipetted 10 ml of filtrate; two glass beads were added and the tubes 
placed in a boiling water bath until the solvent had evaporated.
Similar tubes were set up containing 1 ml of 30% sulphuric acid, as 
blank, and 0.5, 1.0, and 1.5 ml phosphate standard solution (containing 
40 yg of phosphorous per ml, prepared from dried analytical grade 
potassium dihydrogen phosphate). A glass bead was added to each tube, 
and 1.0 ml of 30% sulphuric acid to the unknowns and the standards.
The digestion was performed by heating the tube over a Bunsen 
burner in a fume-cupboard until white fumes appeared. After cooling 
the tube for 30 seconds in a rack, 3 drops of 30% hydrogen peroxide 
were added so as to fall straight into the digest. The tube was then 
reheated,and digestion continued for two minutes after fumes appeared.
The tube was again cooled for 30 seconds and, if the solution was not 
colourless, 3 more drops of peroxide added, and this process repeated 
until the solution was clear and colourless. The number of drops of 
peroxide used was noted and the maximum number used in any batch of 
assays was added to all tubes in the batch, including standards and 
blanks.
After digestion, all the tubes were cooled and made up to the
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12.5 ml mark with water, and mixed. Duplicate 2 ml aliquots were then 
pipetted into clean glass tubes and assayed for phosphate. To each 
tube was added 1.5 ml of 0.6% ammonium molybdate solution in 5% PCA, 
followed by 0.5 ml of freshly prepared 0.5% ascorbic acid solution.
The tubes were mixed and incubated at room temperature for 30 minutes, 
when the absorbances of the solutions at 720 nra were read against the 
blank. Phosphate levels for the unknowns were calculated from the 
standard graph, and from these the amount of phospholipid (as lipid 
phosphorous) in the samples was derived.
50 4 NUCLEIC ACIDS
Both DNA and RNA were estimated by the method of Schneider 
(1945), which involves a total extraction of both polynucleotides 
followed by differential colour reactions to estimate ribose and 
deoxyribose.
To 1 ml of BCF in a 15 ml stoppered centrifuge tube, maintained
oat 0 C in an ice-bath, was added 1 ml of water and 10 ml of 5% PCA, 
both ice-cold. The tubes were vortex-mixed and stood at 0°C for 
3 minutes, and then spun in a refrigerated centrifuge at 0°C to 
produce an acid-insoluble precipitate. The supernatant was discarded 
and the pellet resuspended in 10 ml of ice-cold 2% PCA, using a glass 
rod, and then recentrifuged. The supernatant was again rejected and 
this washing procedure repeated twice more.
The washed pellet was then finely suspended in 3 ml of 5% PCA 
and extracted at 80°C for 20 minutes, mixing occasionally. After 
cooling and centrifuging, the resultant pellet was extracted, as 
before, with a further 3 ml of 5% PCA, and then centrifuged. The 
two supernatants were combined and used for estimation of DNA and RNA.
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Standards were prepared from purified DNA and ENA. Both were 
obtained from Sigma; the DNA was Type I, the RNA was Type IV. About 
6 mg of each was accurately weighed out, dissolved in 5 ml of 5% PCA 
and heated to 80°C for 20 minutes. To 1 ml of this stock solution 
was added 9 ml of 5% PCA to produce the working standard. A further 
1 ml of stock solution was digested by heating with 0.5 ml of concentrated 
PCA to hydrolyse the nucleic acids. The phosphate released was then 
estimated, after diluting the solution to 10 ml, on 2 ml aliquots. This 
was done to allow estimation of the purity of the standards. The 
standards were carried through the same extraction procedure as the 
samples.
For DNA estimation, 1.2 ml of extract was pipetted into each of 
two clean glass tubes. To this was added 2.4 ml of 1.5% diphenylamine 
(analytical reagent grade, recrystallised from ethanol^ freshly prepared 
in glacial acetic acid containing 1.5% concentrated sulphuric acid.
The solutions were mixed and stored in the dark at room temperature for 
two days, and the absorbances read at 600 nm. Blanks were prepared, 
substituting 5% PCA for sample, and standards using from 0.1 to 1.0 ml 
(equivalent to approximately 10-100 yg of DNA)of the DNA working solution. 
The specificity of the procedure was checked by running a 100 yg RNA 
standard in parallel.
For RNA estimations 2.0 ml of extract was used, adding 2 ml of 
0.5% orcinol (recrystallised twice from benzene) freshly prepared in 
concentrated hydrochloric acid containing 0.007% cupric chloride 
(dihydrate). After mixing, the tubes were heated in a boiling water-
i
bath for 30 minutes, cooled, and the absorbance of the solutions read 
at 665 nm. Standards were prepared using 0.1 to 1.0 ml RNA working 
standard solution (equivalent to approximately 10 to 100 yg RNA), and
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blanks substituting 5% PCA for sample. A 100 yg DNA standard was 
run in parallel.
5„5 LACTOSE
The presence of lactose in BCF was tested for, using Fearon's
methylamine test (Henry, 1964).
To 0.2 to 1.0 ml of sample, made up to 5 ml with distilled water,
was added 1 ml of 0.2% aqueous methylamine hydrochloride solution,
followed by 0.2 ml of 10% aqueous sodium hydroxide solution. The
o
tubes were vortex-mixed, capped, and placed in a water-bath at 56 C 
for 30 minutes. Standards were prepared from 1% lactose solution, 
making each tube up to 5 ml with distilled water to give 0, 0.01, 0.05,
0.1, 0.3, 0.5 and 1% lactose solutions, and run as above. Positive
controls were prepared using 0.1 to 0.4 ml of milk.
The tubes were all examined for the characteristic red colour 
produced by lactose, and the degree or absence of colour noted.
Tubes with no colour were allowed to stand for 30 minutes at room 
temperature, and then re-examined.
5<>6 URIC ACID
Uric acid in BCF was estimated using an enzyme method obtained in 
kit form from BDH. The uric acid is converted by uricase to allantoin.
The decrease in absorbance of the solution at 293 nm is used to estimate
the amount of uric acid destroyed. The method was used mainly to
assay samples which had levels above the range covered by the AutoAnalyzer.
To 0.2 ml of sample (or less, made up to 0.2 ml with distilled
water, if high levels of uric acid were present) was added 2.8 ml of 
glycine buffer containing uricase. A control was prepared for each
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specimen in the same way, but using the same glycine buffer without 
uricase. A standard was prepared using 0.2 ml of standard uric acid 
solution (0.1 mg/100 ml) and 2.8 ml of buffered uricase, a standard 
control substituting buffer for uricase, and a uricase blank from 
0.2 ml of water and 2.8 ml of buffered uricase. The tubes were all 
incubated at 37°C in a water-bath for 30 minutes, and then the protein 
precipitated by adding 1.0 ml of 15% aqueous TCA solution.
The tubes were placed in a boiling water bath for 60 seconds, 
removed and cooled in cold tap-water, and centrifuged for 15 minutes. 
The supernatant was poured off and its absorbance measured at 293 nm,
in a 1 cm cuvette, reading the samples and standard against the uricase
blank, the sample controls and standard control against distilled
water. The absorbance of the samples was subtracted from that of
the sample controls, and the standard from the standard control and 
the ratio of the two used to calculate the uric acid concentration.
50 7 AUTOANALYZER
A series of fresh BCFs were run through the Technicon SMA 
12/60 AutoAnalyzer, in the Biochemistry Department at St. Helier 
Hospital. For this, 2.7 ml of BCF were required. The machine 
assays twelve variables; total protein, albumin, calcium, inorganic 
phosphate, cholesterol, urea, uric acid, creatinine, bilirubin, 
alkaline phosphatase, glutamate-pyruvate transaminase (SGPT), and 
glutamate-oxalacetate transaminase (SG0T).
508 INORGANIC IONS
Sodium and potassium levels of BCF were estimated by flame 
photometry, and calcium was assayed by the SMA 12/60 AutoAnalyzer 
(Technicon).
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Standard solutions of potassium and sodium were prepared from 
0.1 M potassium chloride and 1 M sodium chloride respectively. By 
pipetting 3,4,5,6, and 7 ml of the potassium chloride solution, and 
12,13,14,15 and 16 ml of the sodium chloride solution, into 100 ml 
volumetric flasks and making up with distilled water, standards 
containing 3,4,5,6 and 7 meq/1 of potassium and 120,130,140,150 and 
160 meq/1 of sodium were produced. Two dilutions of samples and 
standards were prepared, 1:50 for potassium and 1:1000 for sodium.
The flame photometer was connected to the gas and air supplies, 
the gas turned on and lit, and then the air turned on. A beaker of 
distilled water was placed in the sampling position,and after five 
minutes the burner was checked to ensure the gas control was correctly 
adjusted. The potassium filter was inserted into the light path, and 
the galvanometer unclamped and the instrument switched on. The 
"Sensitivity” control was turned down and then the galvanometer was 
zeroed using the "Set Zero" control. The distilled water in the 
sampling position was changed for the highest potassium standard and 
the sensitivity adjusted until the galvanometer was set to 100. The 
zero and 100 were then re-adjusted with distilled water and high 
standard. The remaining standards and the samples were then run, 
periodically checking the zero with distilled water. Any samples 
falling out of the standard range were re-diluted accordingly to 
bring them within range.
The same procedure was repeated for the sodium estimations, 
using the appropriate filter and zeroing with distilled water and 
setting the highest standard to 100 on the galvanometer. On completion 
of the experiment the instrument was flushed through with distilled 
water until the galvanometer reading returned to zero, then the gas
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turned off, followed after one jninute by the air supply. The results 
were interpolated from the standard curves,' allowance being made for 
any variation from the normal dilution.
5c9 CARCINO-EMBRYONIC ANTIGEN (CEA)
A series of twenty BCF samples were assayed for CEA. A 
radioimmunnoassay method was used for the determinations, on 1 ml, 
randomly-selected samples, and kindly performed by Professor Munro 
Neville's Department at the Chester Beatty Research Institute, Fulham.
5©10 HORMONAL STEROIDS
Assay of testosterone, 5a-dihydrotestosterone, 5-androstenedione, 
and 173-oestradiol, was performed on BCF, and oestrogens and progesterone 
on sera and 24-hour urines from breast cyst patients and age-matched 
controls. Several sera from cyst patients were also assayed for prolactin. 
The estimations were made, using high-pressure liquid chromatography and 
radioimmunoassay, by Mr. D. Fry at West Park Hospital, Epsom, Surrey.
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6 ENZYME ASSAYS *
60 1 PHOSPHATE ASSAYS - VALIDATION
Preliminary work had shown that the estimation of phosphate, as 
liberated in the assay of phosphate-releasing enzymes in BCF, suffered 
a major problem. The proteins of BCF are very difficult to precipitate 
with acid, and addition of sufficient acid made the phosphate assay 
unreliable or even impossible. A series of experiments was therefore 
set up to determine optimum conditions for assay with the system being 
used. These experiments were in two sets; firstly to determine optimum 
acid concentrations for phosphate assay, and secondly to find a suitable 
method for precipitation of proteins and particles in BCF.
The standard method being used for phosphate assay was to add
1.5 ml of 0.6% ammonium molybdate in 5% PCA to 2 ml of acidified solution 
containing the phosphate to be estimated, followed by 0.5 ml of freshly 
prepared 0.2% ascorbic acid solution. In order to determine the optimum 
acid concentration in the phosphate solution a series of tubes were set 
up containing 6 yg of phosphate standard in 0,1,2,3,4,5,10 and 15% TCA, 
and PCA. The reagents were added, as above, and the absorbances read 
at 720 nm after 30 minutes, and again after a further 30 minutes. Three 
of the solutions and a blank were left overnight and their absorbances 
measured automatically at 30 minute intervals. This gave the optimum 
concentrations of TCA or PCA required to yield maximal colour development, 
and the time curve of same. A standard curve was then prepared, using 
these optima and standard phosphate solutions, in order to check linearity.
Protein precipitation proved more troublesome. Three precipitants 
were used: TCA, PCA, and trimethylammonium bromide (CAB). To tubes 
containing 0.1 ml BCF was added water, followed by 20% acid or CAB, to 
give concentrations of 1,2,3,4,5 and 10% precipitant in a total volume
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*
Many of the enzymes were assayed for use as markers of cell membranes 
and were selected with consideration of the pitfalls inherent in 
such use.(Hinton & Reid, 1976).
of 3 ml. The tubes were vortex-mixed and centrifuged at 2000 x jj for 
10 minutes, and the degree of precipitation estimated. This was done 
by eye, judging the degree of turbidity of the supernatant and the 
amount of precipitate at the bottom of the tube. Thus the optimum 
concentration range of each precipitant was found. The supernatant 
from these tubes was used in phosphate assay as above. However, since 
the optimum concentrations of precipitants were found to vary with 
different BCF specimens, and further precipitation occurred on adding 
molybdate reagent, it was decided to look for other methods.
Such methods tried included filtration through Millipore filters 
of small pore size, addition of methanol and ethanol to the precipitant 
in concentrations up to 20%, and mixtures of TCA and PCA, rather than 
the individual acids.
Eventually it was found that heating the centrifuged, acidified 
solution caused further precipitate to appear in the supernatant. Tubes 
containing 0.1 ml of BCF in 2.9 ml of 4% TCA were heated to 60,80 and 
100°C for 0.5, 1,2,3,5 and 10 minutes, rapidly cooled in iced water and 
centrifuged as before. The supernatants were assayed for phosphate 
as above.
From these results it was found that using optimum conditions 
of acid and heat the proteins and particles could be removed from 
incubation mixtures containing BCF. The subsequent reaction for 
phosphate was found to give a linear response. For some substrates 
which are hydrolysed by hot acid,the alternative of freezing was 
found to be effective in aiding complete precipitation. The method 
was first tested with the 5'-nucleotidase assay (see below) the chosen 
substrate for which is stable in hot acid.
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6„ 2 PHOSPHATASE ENZYME ASSAYS
When more than one such enzyme was to be assayed, particularly 
with fractions from density-gradient centrifugal separations, only one 
set of blanks was prepared. This saved valuable material. The same 
volume of sample was therefore used for all assays and the set of 
blanks, which consist of sample made up with water to the volume of 
the incubation mixtures. These were then precipitated and assayed 
for phosphate in the same manner as the assay solutions. Thus, by 
running a reagent blank in parallel for each enzyme estimation, the 
phosphate released by the enzyme was found by subtracting from the test 
absorbance those due to the appropriate sample and reagent blanks.
Two reagent blanks were usually used; one heat-treated or frozen as 
for the assay tubes, the other untreated. Thus any effect of such 
treatment could be observed.
For one density-gradient centrifuge run,the assay of phosphate 
was performed on a Technicon AutoAnalyzer at the Wolfson Bioanalytical 
Centre, at the University of Surrey. The machine was set up to use 
the same ammonium molybdate assay method as was used manually.
6„ 3 51-NUCLEOTIDASE
This enzyme was assayed by two methods. Initially a kit 
version (BDH) of the method of Persijn and van der Slik (1968) was 
used. This specific and highly sensitive assay is based on the 
estimation of ammonia produced by an excess of adenosine deaminase 
from the adenosine released by the test enzyme from adenosine-5’- 
monophosphate (AMP). Non-specific action of alkaline phosphatase is 
selectively inhibited by phenyl disodium orthophosphate. Unfortunately 
the method was found not to work with samples containing sucrose, and
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therefore the phosphate-assay approach was used with density-gradient 
centrifuge-separated material.
6 c3.1 Persijn and van der Slik method
Into each of two tubes was pipetted 0.1 ml of sample, and into
one of each pair (test) was added 1 ml of substrate reagent (barbitone
buffer, containing magnesium, adenosine deaminase and AMP), into the
other (test blank), 1 ml of the buffered adenosine deaminase. A
substrate blank was prepared using 1 ml of substrate reagent and 0.1 ml
of water, and a standard and standard blank using 1 ml of buffered
adenosine deaminase solution containing 0.1 ml of 3.7 mM adenosine,
and 0.1 ml of water, respectively. The tubes were all capped and 
oincubated at 37 C for 60 minutes. Reaction was stopped by addition 
of the two, freshly diluted, colour reagents. The first was a 
1:5 dilution of concentrated phenol reagent (50 g of phenol and 
0.25 g of sodium nitroprusside made up to 1 litre with distilled 
water), containing EDTA to prevent precipitation of magnesium salts.
The second was a 1:5 dilution of concentrated alkaline hypochlorite 
reagent (25 g of sodium hydroxide in 250 ml of water, with 72 ml of 
1 M sodium hypochlorite in 0.1 M sodium hydroxide, made up to 1 litre 
with water). The phenol reagent (5 ml) was added first, followed 
by 5 ml of hypochlorite as quickly as possible, both forcefully.
The tubes were left in the water bath at 37°C for a further 30 minutes t 
and then their absorbances at 625 nm measured, reading the tests 
against their corresponding test blank, and the substrate blank and 
standard against the standard blank. The enzyme activity was 
calculated from the absorbance of the test solution after subtracting 
that of the substrate blank.
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6„ 3.2 Method entailing phosphate assay
Into each of two clean glass tubes was pipetted 0.4 ml of tris 
buffer pH 7.7, containing 12.5 mM magnesium chloride and 25 mM sodium 
tartrate (to inhibit acid phosphatase), followed by 0.3 ml of water
o
and 0.2 ml of sample. The tubes were placed in a water bath at 37 C 
and 0.1 ml of 0.05 M AMP solution added and vortex mixed. A substrate 
blank was prepared, substituting water for sample, and a series of 
test blanks omitting substrate. As mentioned previously, only one 
set of test blanks was prepared if several phosphate-releasing enzymes 
were being assayed together. After incubating at 37°C for 60 minutes 
the reaction was stopped by forcefully adding 1.5 ml of 5% TCA. The 
tubes were placed in a boiling water-bath for one minute and rapidly 
cooled in ice-water. After centrifuging for 5 minutes, the entire 
supernatant was carefully poured off and assayed for phosphate as 
described previously.
6©3.3. Validation of assay
As mentioned previously the validation of this assay was combined 
with that of the phosphate assay. The aim was also to discover the 
longest permissible incubation time, in order to increase the sensitivity 
of the assay.
Three BCFs and one serum were used for the experiment,\yhich 
was run twice on different days. As a check on comparability of the 
two assay methods, the samples were also checked by the Persijn and 
van der Slik method in the usual way.
Into a clean glass tube was pipetted 6 volumes of the reagents 
and samples given above. Immediately after adding the AMP solution, 
and vortex mixing, 1 ml of the reaction mixture was pipetted into a 
tube containing 1.5 ml of 5% aqueous TCA. This was used as the
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zero-time blank. The tubes were incubated at 37 C and further
1.0 ml aliquots removed into TCA at 30 minute intervals up to 2 hours.
The tubes were then heated in a boiling water bath for one minute,
cooled, centrifuged and the entire supernatant used for phosphate
assay as before. Two reagent blanks were also run, substituting
o
water for sample, and one heated to 100 C with the other tubes to 
check the stability of AMP in hot acid. All the assay tubes were 
read against the unheated reagent blank. After subtracting the 
absorbance of the zero-time blank from the absorbances of the tests a 
velocity curve was plotted for each sample, and the results compared 
with those from the Persijn and van der Slik method.
6C 3.4 Stability of enzyme
The stability of the enzyme was also estimated,to check that 
losses on storage enforced by the density-gradient centrifugation 
were not too serious. Two BCF were used, one with high, the other 
with low, levels of the enzyme.
The two BCF were obtained on successive weeks and each was 
halved. One half was stored at -20°C, the other at 4°C. The assays 
were performed 8 and 15 days after collection for the first fluid,
1 and 8 days after collection for the second. Part of the sample 
stored at -20°C was frozen and thawed six times by placing the tube 
alternately in ice-salt mixture and cold tap-water. This was done 
to check stability on repeated freezing, and to see if any activation 
occurred. The assays were performed by the method of Persijn and 
van der Slik, this being the easier technique and correlating well 
with the other method.
6, 4 N a V  K*- DEPENDENT ADENOSINE TRIPHOSPHATASE
ATPase was estimated by assay of phosphate released from
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ATP substrate (Post & Sen, 1967). In this case the test-blanks were 
identical to the tests, but with the addition of ouabain. This inhibits 
the Na+ , K+-dependent enzyme and thus allows correction for non-specific 
hydrolysis of ATP, and hydrolysis by other ATPases.
Into tubes was pipetted 0.5 ml of buffer-substrate solution, 
consisting of 30 mM histidine buffer pH7.5 containing 3 mM magnesium 
chloride, 130 mM sodium chloride, 20 mM potassium chloride, and 3 mM 
ATP. The ATP was added freshly to the required volume of be.fore use.
An identical series of tubes was set up with 1 mM ouabain added to the 
buffer. After adding 0.3 ml of water and 0.2 ml of sample, and mixing, 
the tubes were incubated in a water-bath at 37°C for 60 minutes. The 
reaction was then stopped by adding 1.5 ml of ice-cold 5% TCA. The 
tubes were placed in a deep freeze until ready for phosphate assay, in 
order to assist protein precipitation. The heating method could not 
be used since ATP is hydrolysed under such conditions. On thawing, 
the tubes were centrifuged and the supernatant assayed for phosphate, 
as before.
6C 5 GLUCOSE-6-PHOSPHATASE
The method for this enzyme was that of Nordlie and Arion (1966), 
again estimating phosphate released. Since glucose-6-phosphate is 
also somewhat unstable in hot acid, freezing was used to assist protein 
precipitation.
Into tubes were pipetted 0.6 ml of 0.1 M cacodylate buffer 
pH 6.5, 0.2 ml of 0.15 M glucose-6-phosphate, 0.2 ml of water, and 
0.2 ml of sample. Blanks were prepared using 0.2 ml of sample and
1.0 ml of water, and a substrate blank substituting water for sample.
The tubes were vortex-mixed and incubated in a water-bath at 30°C
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for one hour. The reaction was stopped by adding 1.5 ml of ice-cold 
5% TCA. After freezing and thawing, the tubes were centrifuged, and 
the entire supernatant carefully decanted and assayed for phosphate, 
as before.
60 6 ACID PHOSPHATASE
Total acid phosphatase was estimated by the p-nitrophenol- 
releasing method of Bessey, Lowry and Brock (1946). The substrate^ 
4-nitrophenyl phosphate^ is hydrolysed to 4-nitrophenol, and this is 
converted to a yellow coloured complex on adding sodium hydroxide.
An assay set (BDH) containing pre-weighed' ingredients was used.
Into duplicate tubes was pipetted 1 ml of buffered 4-nitrophenyl 
phosphate, followed by 0.2 ml of sample. A sample blank was prepared 
by immediately adding 5.0 ml of 0.05 M sodium hydroxide solution to 
one of each pair of tubes, and one substrate blank for each batch, 
substituting water for sample. After mixing well and incubating in 
a water-bath at 37°C for 30 minutes, 5.0 ml of 0.05 M sodium hydroxide 
solution was added to the tests and substrate blank. The absorbances 
were then measured at 400 nm, reading against the substrate blank.
A calibration curve was prepared from a standard solution of 
100 mM 4-nitrophenol. Six tubes, in duplicate, containing 0.5, 1.0,
1.5, 2.5, 3.5 and 4.5 ml of standard solution were made up to 6.2 ml 
with 0.05 M sodium hydroxide solution and their absorbances measured 
at 400 nm against a distilled water blank. The calibration graph 
was drawn, plotting absorbance directly against enzyme activity of 
the sample; 1 ml of standard solution, made up to 6.2 ml, is equivalent 
here to 16.6 mlU/ml of sample.
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60 7 ALKALINE PHOSPHATASE
This was estimated by essentially the same technique as for
acid phosphatase, but using an alkaline buffer.
In duplicate tubes for each sample, 1.0 ml of glycine-magnesium
buffer containing 4-nitrophenyl disodium orthophosphate was pre-incubated
in a water-bath at 37°C for 5 minutes. To one of each duplicate pair
was added 10 ml of 0.2 M sodium hydroxide solution, and then 0.1 ml of
o
sample pipetted into each. After mixing and incubating at 37 C for 
30 minutes, 10 ml of 0.02 M sodium hydroxide was added to the tests, 
and the absorbances read at 400 nm against a substrate blank. The 
absorbances of the test blanks were subtracted from those of the 
corresponding tests, and activities interpolated from a calibration 
curve constructed as above, but making the standard solutions up to
11.1 ml with 0.02 M sodium hydroxide. In this case 1 ml of standard 
is equivalent to 33.3 mlU/ml of sample.
60 8 ALKALINE PHOSPHODIESTERASE
This enzyme was also estimated by a p-nitrophenol releasing 
method, but in this case the substrate was bis-(4-nitrophenyl) phosphate.
Into tubes was pipetted 1.0 ml of 0.25 M tris buffer, pH 8.8, 
containing 10 mM magnesium chloride, followed by 0.5 ml of distilled 
water, 0.3 ml of 10 mM bis-(4-nitrophenyl) phosphate, and finally 
0.2 ml of sample. Tissue blanks were prepared by adding 0.2 ml of 
sample to 1.8 ml water, and a substrate blank by substituting water 
for sample. The tubes were mixed and then incubated at 37°C for one 
hour. Reaction was stopped, and colour developed, by adding 2 ml 
of 1 M sodium hydroxide containing 0.15 M EDTA, and the absorbances 
measured at 400 nm against a water blank. The absorbances of the 
standard and appropriate test blanks were subtracted from those for
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the test, and the enzyme activity calculated from a standard curve 
prepared from 4-nitrophenol, as above„
60 9 ACID PHOSPHODIESTERASE
This was estimated by the same method as was used for alkaline 
phosphodiesterase, but substituting 0.3 M acetate buffer, pH 5.0, for 
the tris buffer, pH 8.8, and omitting EDTA from the sodium hydroxide 
solution used to stop the reaction. When the two enzymes were assayed
together,only one set of tissue blanks was prepared and used for both 
estimations.
6JL0 CATHEPSIN D
The method used to assay this enzyme was that of Barrett (1967). 
The substrate used is haemoglobin, from which the enzyme produces 
peptides that are soluble in TCA. These may be estimated by their 
absorbance at 280 nm.
The substrate was prepared from bovine haemoglobin. A 10% w/v 
solution in water was prepared, and dialysed in Visking tubing against 
3 changes of distilled water at 4°C, for 24 hours. The solution was 
then made up with distilled water to give a final concentration of 8%, 
and stored frozen in 5 ml aliquots.
To 0.2 ml of sample, in triplicate, the following reagents were 
added: 0.25 ml of 1 M formate buffer, pH 3.0, 0.3 ml of water, and
0.25 ml of 8% haemoglobin substrate. One of the triplicates was 
precipitated immediately by adding 5 ml of 5% TCA, the remaining tubes 
were incubated in a water-bath at 45°C for 2 hours. Two substrate 
blanks were prepared, substituting water for sample, and one 
precipitated immediately with TCA, the other incubated with the tests
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at 45°C. Following incubation, 5 ml of 5% TCA was added to each 
tube, and all the tubes heated in a boiling water-bath for 5 minutes, 
then centrifuged to remove precipitated protein. The supernatants 
were poured off and their absorbance measured at 280 nm. The tests 
were read against the incubated substrate blank,and the test blanks 
against the unincubated substrate blank.
The assay was performed mainly on whole BCF. A few rough 
separations of particle- and fluid-fractions were run to see whether 
the enzyme was localised in one or the other.
6 „ 10.1 Validation of assay
As with 5 ’-nucleotidase, great trouble was experienced initially
with this assay due to difficulty in precipitating all the BCF proteins.
The use of other precipitants was tried, with no success, and eventually
filtration was attempted. Millipore filters (0.22 ym pore size) were
used in a Swinnex filter. The supernatant from the assays was drawn
into a 10 ml hypodermic syringe, to which the filter was then attached,
and the fluid ejected through the filter into a clean tube. However,
this method although satisfactory was very time-consuming, and the
heating method used for 5'-nucleotidase was tried. Even with heating 
oat 100 C for 10 minutes, complete precipitation was not obtained.
Raising the concentration of TCA in the precipitant from 3% to 5% was 
tried and found to give protein precipitation after heating for five 
minutes at 100°C.
A series of experiments was then undertaken to determine the 
effects of raising acid concentration and heating. Using two BCF 
specimens, and setting up the assay medium as given above, eight 
tubes were run for each specimen. Two were precipitated immediately 
with 5 ml of 3% TCA, another two with 5 ml of 5% TCA, and the remainder
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incubated at 45°C for one hour. These were then also precipitated
with 3% and 5% TCA as for the blanks. The tubes to which 5% TCA had
been added were then heated in a boiling water-bath for 5 minutes and 
all the tubes centrifuged. The supernatants from the unheated tubes 
were filtered through a Millipore membrane. The absorbances were
read as before at 280 nm. Substrate blanks were prepared, substituting
water for sample, then half were incubated, half immediately precipitated. 
One for each pair was precipitated with 3% TCA, the other with 5% TCA 
and the former centrifuged and filtered, the latter heated to 100°C for 
5 minutes, cooled and centrifuged. Thus the effect of hot acid on 
the substrate could be determined.
A time-curve for the assay was then prepared. To 1.6 ml of
sample (a threefold concentrate of a pool of 3 BCFs) was added 2.0 ml
of 1 M formate buffer pH 3.0, 2.4 ml of water, and 2.0 ml of 8%
haemoglobin substrate, and after mixing, 1 ml of the fluid removed into
a tube containing 5 ml of 5% TCA solution. The tubes were incubated 
o
at 45 C and 1 ml aliquots removed into 5 ml of 5% TCA solution after 
30,60,90,120,180 and 240 minutes. The tubes were placed in a boiling 
water-bath for 5 minutes, cooled in ice-water, centrifuged, and the 
absorbance of the supernatants measured at 280 nm.
6 o10.2 Activation and stability of the enzyme
The stability of the enzyme was investigated to determine 
whether assays could be made on stored samples, and also whether storage 
at 4°C would allow continuing proteolysis of BCF constituents.
Experiments were also performed to see if the enzyme could be activated 
by freeze-thawing, as in the classical experiments on lysosomes by 
de Duve et al. (1955).
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The two BCF samples used were the same as those used for the 
experiments on stability and activation of 5’-nucleotidase. They were 
assayed following storage at 4°C and -20°C, after 1 and 8 days for one, 
and 8 and 15 days for the other. A part of the frozen specimen was 
freeze-thawed six times. The assays were performed as described above.
6 .11 SUCCINATE DEHYDROGENASE
This enzyme was assayed by the method of Pennington (1961). To 
0.3 ml of 0.3 M phosphate buffer, pH 7.4, containing 1.25 mg of INT (2- 
(p-iodophenyl)-3-(p-nitrophenyl)-5-phenyltetrazolium chloride) per ml, was 
added 0.3 ml of water, 0.2 ml of 0.3 M succinate (brought to pH 7.4 with 
potassium dihydrogen orthophosphate), and 0.2 ml of sample. Blanks were 
prepared for each specimen in the same way, but substituting 0.3 M 
malonate for succinate, and reagent blanks substituting water for sample. 
The tubes were incubated in a water-bath at 37°C for 30 minutes,and 
reaction then stopped by adding 1.5 ml of ice-cold 6% TCA solution, 
followed by 4 ml of ethyl acetate. The ethyl acetate layer was removed 
with a Pasteur pipette, and its absorbance measured at 490 nm in a 1 cm 
cuvette. After subtracting the absorbance of the blanks from the tests, 
the enzyme activity was calculated from the molar extinction coefficient 
of reduced INT (20.1 x 103).
6 .12 AMYLASE
The enzyme was assayed by the method of Somogyi (1938) as modified 
by Henry and Chiamori (1960). Starch is hydrolysed to glucose by amylase, 
and this is measured by the method of Folin and Wu (1920), as modified by 
Lauber and Mattice (1944) and Tonks (1952).
To 0.3 ml of sample was added 2.1 ml of 1% soluble starch solution
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in 0.1 M phosphate buffer pH 7.0, and the tubes incubated in a water- 
bath at 40°C for 30 minutes. Reaction was stopped by adding 1.5 ml 
of 0.33 M sulphuric acid and, after mixing, 0.5 ml of 10% sodium tungstate 
solution. The tubes were centrifuged, and the supernatant poured off 
and assayed for glucose. Controls were prepared by adding the precipitants 
immediately to duplicates of the reaction mixture.
For the glucose assay, a copper reagent was prepared by adding 
to 40 ml of distilled water, dissolving after each addition, 4 g of 
anhydrous sodium carbonate, 0.75 g of tartaric acid, and 0.45 g of 
cupric sulphate (pentahydrate). The solution was made up to 100 ml 
with water. Phosphomolybdic acid was prepared by mixing 7.0 g of 
molybdic acid, 1.0 g of sodium tungstate, 40 ml of 10% sodium hydroxide 
solution, and 400 ml of water. The solution was boiled for 20 minutes, 
cooled, diluted to 70 ml with water; 25 ml of orthophosphoric acid 
(85%) was added, and finally the solution made up to 100 ml with water.
To duplicate 0.5 ml aliquots of supernatant from the amylase 
reaction was added 0.5 ml of copper reagent, and the tubes placed in a 
boiling water-bath for 6 minutes. The tubes were removed from the 
water-bath, 0.5 ml of phosphomolybdic acid reagent added, and then 
reheated at 100°C for 2 minutes. After cooling and adding 3.5 ml of 
water, the absorbance of the solutions was measured at 420 nm. A 
reagent blank was prepared by substituting water for sample, and 
standards by running 0.1,0.2,0.3,0.4 and 0.5 ml of standard glucose 
solution (freshly prepared by diluting 1 ml of a 10 mg/ml stock 
solution of glucose, saturated with benzoic acid, to 100 ml), each 
made up to 0.5 ml with water.
6 .13 XANTHINE OXIDASE
This enzyme was assayed by the method of de Lamirande et al.(1958).
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Urate production by the enzyme is monitored by its absorbance at 293 nm.
To 0.2 ml of sample was added 0.6 ml of distilled water, 1.0 ml 
of 0.1 M phosphate buffer pH 7.5, and 0.3 ml of 2 mM potassium cyanide. 
After incubating in a water-bath at 37°C for 5 minutes, the solution was 
poured into a 1 cm cuvette which was then fitted into a heating-block 
in an SP500 spectrophotometer (Pye Unicam). Water at 37°C was 
circulated through the heating-block, from a water-bath. After adding
1.3 ml of 0.55 mM xanthine solution at 37°C, mixing, and equilibrating 
for 1 minute, the absorbance of the solution at 293 nm was measured, at
5 minute intervals for 1 hour, against a control consisting of 0.2 ml 
of sample in 3.2 ml of water. Standards were prepared from 0,0.1,0.2, 
0.3,0.4 and 0.5 ml of a 1 mM uric acid solution, made up to 3.4 ml with 
water, to cover the range corresponding to 0 to 41.7 mlU enzyme/ml of 
sample, for a one hour incubation.
6 .14 LACTOPEROXIDASE
This was assayed by measuring the oxidation of o-dianisidine 
(3,3’- dimethoxybenzidine dihydrochloride) by hydrogen peroxide, 
according to the method of Oram and Reiter (1966).
To 0.2 ml of sample was added 3.8 ml of 0.1 M sodium acetate 
buffer pH 5.7, and the tubes incubated at 37°C for 5 minutes. The 
solution was poured into a 1 cm cuvette, which was placed in a heating- 
block in an SP500 spectrophotometer, and 1.0ml of 0.04 mM o-dianisidine 
solution, containing ImM hydrogen peroxide, added. The solution was 
mixed, and the absorbance at 520 nm measured at 5 minute intervals for 
30 minutes, against a blank consisting of 0.2 ml of sample in 4.8 ml of 
water.
6.15 AUTOANALYZER
As mentioned previously, three enzymes were assayed on the Technicon
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SMA 12/60 AutoAnalyzer. These were alkaline phosphatase, SGOT and 
SGPT.
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7 CENTRIFUGATION METHODS 
In order to. separate out the particle-fraction of BCF,various 
methods of centrifugation were used. These were; high-speed 
centrifugation of whole BCF, flotation methods involving the use of 
materials to raise the density of the sample, and isopycnic density- 
gradient centrifugation.
7.1 HIGH-SPEED CENTRIFUGATION WITHOUT A GRADIENT
This technique was the first one used. initially, the purpose 
was to ’’clear*' the BCF samples, since this was not achieved by the low- 
speed centrifugation used to remove cells.
Samples were placed in 15 ml capacity polypropylene tubes (M.S.E. 
Ltd.) and pairs of tubes balanced by adding more sample to the lighter 
one. The tubes were capped and fitted into an M.S.E. 16 x 15 ml angle-
r
head rotor in an M.S.E. refrigerated centrifuge, then spun at 18000 r.p.m. 
(30,000 x g) for periods up to 4 hours, at 4°C.
It was found that if only small volumes were being centrifuged 
they could be placed in M.S.E. 5 ml capacity polycarbonate tubes.
These could then be gently inserted into the 15 ml tubes, which they 
fitted snugly. Following centrifugation,the smaller tubes were 
removed using a dissection needle with the tip bent over at right- 
angles. This method also had the advantage that any separation of 
particles could be seen easily through the clear polycarbonate tubes, 
but not the white, polypropylene type.
7.2 FLOTATION METHOD
This method was used to improve the separation of the particle- 
fraction of BCF. The density of the samples was raised by adding
sodium bromide.
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To 5 ml of BCF was added 2.0 g of sodium bromide, which was 
dissolved by gently mixing, to give a density of 1.3. The solution 
was transferred to a 15 ml capacity polycarbonate tube, and then 
carefully overlayered with 1 ml of sodium bromide solution,of density 
1.22,in 0.05 M tris buffer, pH 7.5. After balancing by adding overlay, 
the tubes were centrifuged in the angle-head rotor at 18,000 r.p.m. 
for 2 hours.
The particles formed a layer on the surface of the overlay, 
and were carefully removed, with the overlay, using a Pasteur pipette. 
This fraction and the clear fluid-fraction were each dialysed against 
0.01 M tris buffer, pH 7.5, in an Amicon ultrafiltration cell with a 
UM2 membrane (Amicon), and finally made up to 5 ml with the same buffer, 
before analysis.
7.3 DENSITY GRADIENT CENTRIFUGATION
This method was used to separate the particle-fraction in seven 
samples of BCF, and, as controls, two milk specimens and one plasma 
sample. Sucrose was adopted as a more satisfactory density-producing 
medium than sodium bromide, despite the viscosity of concentrated 
solutions.
7.3.1 Gradient Formation
Gradients were prepared from two solutions; 0.01 M tris-HCl 
buffer, pH 7.4, and 2 M sucrose in the same buffer solution. An 
M.S.E. gradient-mixer was used. This consists of two cylindrical 
vessels of identical dimensions, joined at the base by a narrow-bore 
tube fitted with a tap. One vessel is fitted with a three-way 
outlet tube at the base, and a motor-driven stirrer. With the tap 
off, to disconnect the vessels, 24 ml of buffer was poured into the 
unstirred vessel and the tap opened slightly to allow the solution
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to fill the connecting tube and exclude air from it. The tap was 
turned off, and the other vessel filled with 24 ml of the buffered 
2 M sucrose solution. The three outlet tubes were connected to three 
silicon tubes fitted into a peristaltic pump, and which led into three 
polycarbonate tubes (25 ml capacity, M.S.E. Ltd.), supported in a 
vessel containing crushed ice. The outlet tubes were arranged to 
touch the inside of the tops of the centrifuge tubes, and held there 
with adhesive tape. The stirrer was started, the tap opened, and 
the pump switched on. The gradient solution, becoming gradually 
less dense as light solution was mixed in in the gradient-former, 
was thus pumped into the centrifuge tubes, and ran down their sides, 
the progressively lighter fluid smoothly overlaying the more dense.
When all the solution had left the gradient-mixer, the apparatus was 
switched off.
7.3.2 Sample preparation and addition
The BCF samples used were six different specimens, centrifuged 
in two batches of three, and one large specimen, concentrated from
o
50 ml to 12 ml by ultrafiltration,using nitrogen at 75 p.s.i. (5.2 kgf/cm ), 
in an Amicon cell fitted with a UM2 membrane (molecular weight cut off = 
1000), and run in all three tubes of the centrifuge. The samples were 
all fresh, unfrozen, and were stored briefly at 4°C before centrifuging.
The large sample was maintained at below 4°C during ultrafiltration, 
by surrounding the cell with crushed ice. Two human skimmed milks 
and a plasma sample were also centrifuged by the same techniques used 
for BCF. The fresh milk samples were centrifuged at room temperature 
for 15 minutes at 2000 x j£, and then cooled to 4°C and the skimmed 
milk removed from under the solidified fat-layer. The plasma sample 
was a 10 ml blood sample obtained from a 45 year old woman (i.e. in
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the cystic disease age range) selected at random in the Haematology 
Outpatients Department at St. Helier Hospital. The blood was placed 
into a tube containing EDTA anticoagulant. After centrifuging, to 
sediment the cells, the plasma was removed using a siliconised Pasteur 
pipette. EDTA was chosen as it prevents oxidative changes to lipoproteins.
The three samples were brought to a density greater than that of 
the gradient by adding 4 ml of sample to 6 g of sucrose in a plastic 
tube, capping the tubes, and gently mixing by inversion on a rotator 
in the cold-room. When the sucrose had completely dissolved, the 
tubes were left standing upright until all air bubbles had risen.
The prepared samples were then layered under the gradients. This was 
achieved by aspirating an aliquot into a 5 ml hypodermic syringe, to 
which was then fitted a short blunted needle attached to a 10 cm 
length of narrow-bore, plastic tubing. A small amount of sample was 
expelled to fill the tube,which was then inserted through the gradient 
solution to the base of the centrifuge tube. Four ml of sample was 
gently forced from the syringe, taking great care to ensure that no 
air bubbles were released into the gradient, and the syringe tube then 
slowly withdrawn. When all three tubes had been charged with sample 
they were weighed, and the two of least weight made up to that of the 
greatest by carefully overlaying 0.01 M tris buffer, pH 7.4, onto the 
gradients.
7.3.3 Centrifugation and fractionation
The tubes containing the gradients were fitted into an M.S.E.
3 x 23 ml swing-out rotor which had been cooled to 4°C. The rotor
was then fitted into a Super Speed 65 ultracentrifuge (M.S.E.Ltd.) and
spun at 29,000 r.p.m. overnight. The temperature was maintained at 
o
4 C. The centrifuge was accelerated slowly, using manual control,
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up to 5000 rpm, in about 5 minutes. Thereafter it was allowed to 
accelerate freely. At the end of the run, usually 16 hours, the 
machine was switched off, and the rotor allowed to decelerate without 
using the brake.
The rotor was removed from the centrifuge, and the tubes were 
taken out of the buckets. The gradient was pumped out by upward 
displacement. The tube was placed in a stand and a perspex cap, 
fitted with a rubber gasket, screwed down to seal the mouth of the 
tube. The inside of the cap was ground to a conical shape and had a 
small, horizontal outlet tube running from near the top of this cone.
A hollow needle was fitted vertically through the centre of a vertical 
bolt in the apex of the cone. This needle was gently pushed to the 
base of the tube and the bolt tightened, compressing a small rubber 
ring fitted below it,which hermetically sealed the needle. The needle 
was joined at its upper end to a silicon-rubber tube connected to a 
syringe pump. The syringe, tube, and needle were all filled with 
aqueous 2.1 M sucrose, and care was taken to ensure that this contained 
no air bubbles. The pump was set to deliver 1 ml per minute, and 
then started. The dense sucrose solution underlaid the gradient and 
pushed it up the centrifuge tube and through the outlet tube. Here 
it was collected in fractions of 1 ml, in small plastic tubes, by 
moving the outlet tube from one container to the next at one minute 
intervals. For one set of three BCFs the absorbance of the effluent 
at 600 nm was monitored during displacement, using a Unicam SP500 
spectrophotometer fitted with a Hellma flow cell of 1 cm light path 
and 1 ml capacity.
7.3.4 Analysis Of fractions
The twenty or so fractions collected from each sample, and the
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remainder of that sample, were maintained at 4°C, and enzyme assays 
performed as soon as possible. The refractive index of each fraction 
was measured in an Abbe refractometer. Protein and cholesterol assays 
were made on all fractions from all samples. In addition 5'-nucleotidase 
was estimated in the BCF fractions. The refractive indices of the 
fractions from the large BCF sample were measured to check that they 
matched in corresponding fractions from the three tubes. Each set of 
three corresponding fractions was then pooled. The bulked fractions 
and starting material were assayed for protein, cholesterol, 5’-
•f* 4*
nucleotidase, Na -K -ATPase, acid and alkaline phosphodiesterases, 
glucose-6-phosphatase, and succinate dehydrogenase. Some of the 
particle-containing fractions were also examined in the electron 
microscope as negatively stained preparations.
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8 CYTOLOGY
Cells from BCF specimens and histological sections of cystic 
breast, were examined using light microscopy, after staining by a 
variety of methods.
8.1 CELLS FROM BCF
The cell deposit from centrifuged BCF (see ’’Specimen collection” , 
p. 52) was drained well, by inverting the centrifuge tube on absorbent 
paper for 3 minutes. Three air-dried and 3 wet-fixed smears were made 
on glass slides, using a small wire loop.
Air-dried smears were prepared first, by taking a small portion 
of the drained deposit on the loop and smearing this material down the 
long axis of the slide. A series of short strokes were then made with 
the loop, starting from the original streak, and running at right angles 
to it. The object was to produce a thin smear which dried rapidly.
When dried, two smears were fixed in methanol, one by briefly flaming, 
using a Bunsen burner.
Wet-fixed smears were prepared after re-inverting the tube 
containing the cell deposit, thus allowing the film of BCF on the walls 
of the tube to run back. The deposit was mixed with this fluid, 
using the loop, and one loopful of material streaked down the slide, 
which was then quickly transferred to fixative. Initially Schaudinn’s 
fixative had been used, but this was later substituted with IMS to 
avoid the dangers involved in using mercuric chloride. The fixed 
smears were stored in IMS before staining.
After preparing the slides, the remainder of the cell deposit 
was suspended in fixative (formol saline, IMS, glacial acetic acid, 
45:50:5) for the preparation of a filter slide. Fixation was continued 
for 20 minutes, and the suspension was then filtered through a Millipore
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membrane (type SM, 5 ym pore size), supported in a Millipore holder 
connected to a vacuum pump. The membrane was removed and clipped to 
a microscope slide, with the cells facing outwards.
This filter was stained by haematoxylin and eosin (HE), the wet- 
fixed smears by HE, Papanicolaou’s (Pap.) and Peris' methods; the air 
dried smears were stained by May-Griinwald-Giemsa (MGG), PAS, and Gram’s 
stain. The techniques used are given below.
8.2 HISTOLOGICAL SECTIONS
Sections of formalin-fixed, paraffin-wax-embedded tissue were
cut at 5ym, and stained by a variety of methods. Sections were initially
examined, using HE stain, to select tissue which contained'pink*cells
and microcysts. Such blocks were then used for preparing slides reacted
by special methods, and for immunohistochemistry. The special methods
used were PAS, diastase-PAS, Alcian Blue in solutions containing various
concentrations of magnesium chloride, phosphotungstic acid-haematoxylin,
Heidenhain's method, chrome alum-haematoxylin, Schmorl's technique,
Peris' method, and Turnbull's method.
Wax sections were first brought to water by dewaxing the slides, 
o
after heating to 60 C, in two 10-minute changes of xylene, agitating 
intermittently, followed by two changes of IMS, and then one bath each 
of 90, 70 and 50% aqueous IMS, and finally water.
Frozen sections were fixed by placing the slides either in formol 
saline or methanol.
8.3 STAINING METHODS
8.3.1 Haematoxylin and eosin
The stain was used for wet-fixed and filter preparations of BCF
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cells, and histological sections.
1) Place in Harris’ Haematoxylin (Ortho Chemicals Ltd), 5 minutes
(filters, 3 minutes).
2) Rinse in deionised water.
3) Differentiate in acid alcohol (1% HC1 in 70% aqueous IMS),
10 to 15 seconds.
4) Rinse, and blue in tap-water, 15 minutes (filters, 30 minutes)
5) Rinse in IMS.
6) Stain in 1% alcoholic eosin, 30 seconds (filters, 15 seconds)
7) Rinse in three changes of IMS.
8) Clear in two changes of xylene (for filters, 30 minutes in
second bath).
9) Mount in DPX.
For filter preparations of BCF cells, the membranes were 
unclipped from the slides, the bare edges trimmed away using a razor 
blade, and, after blotting off excess xylene, the membrane mounted 
between thin layers of DPX beneath a coverslip.
8.3.2 May-Griinwald-Giemsa
The stains were prepared from stock solutions (Raymond A. Lamb), 
diluting the May-Griinwald stain 1:2.5, and the Giemsa 1:5, with Sorensen’s 
buffer, pH 6.8. Air-dried smears, fixed in methanol, were used.
1) Place in May-Griinwald stain, 10 minutes.
2) Rinse in deionised water.
3) Place in Giemsa stain, 30 minutes.
4) Rinse in tap-water.
5) Place in Sorensen's buffer, pH 6.8, 15 minutes.
6) Dry in air, mount in DPX.
8.3.3 Gram’s Stain
Air-dried, flame-fixed smears were used.
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1) Place in Lillie’s Crystal Violet, 1 minute.
2) Wash off under tap.
3) Place in Lugol’s Iodine, 1 minute.
4) Wash off under tap.
5) Decolourise by running acetone over the slide.
6) Wash off under tap.
7) Counterstain with Safranin, 30 seconds.
8) Wash off under tap.
9) Air dry, and mount in DPX.
8.3.4 Papanicolaou’s stain
Wet-fixed smears were used, and the staining performed in a 
Shandon automatic stainer. The staining solutions were purchased in 
bulk from Ortho Chemicals Ltd. The slides were continuously agitated 
in the following solutions.
1) 66 O.P. IMS, 30 seconds (66 overproof alcohol is an
approximately 95% aqueous solution).
2) Distilled water, 90 seconds.
3) Haematoxylin, 5 minutes.
4) Distilled water, 2 x 90 seconds.
5) Acid alcohol, 1 minute.
6) 66 O.P. IMS, 2 x 1  minute.
7) Ammoniacal alcohol, 1 minute.
8) 66 O.P. IMS, 3 x 1  minute.
9) Orange G., 90 seconds.
10) 66 O.P. IMS, 3 x 1  minute.
11) EA50, 90 seconds.
12) 66 O.P. IMS, 2 minutes.
13) Absolute IMS, 3 x 1  minute.
14) Xylene, 3 x 90 seconds.
The slides were left in xylene before mounting in DPX.
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8.3.5 PAS stain
Smears were air-dried, methanol-fixed.
1) Place in 1% aqueous periodic acid, 5 minutes.
2) Wash in tap water and rinse in deionised water.
3) Place in Schiff reagent (Raymond A. Lamb), 15 minutes.
4) Rinse in deionised water.
5) Wash in tap water, 10 minutes.
6) Counterstain in Harris' Haematoxylin, 2 minutes.
7) Blue in tap water, 15 minutes.
8) Dehydrate, clear, and mount in DPX.
8.3.6 Diastase - PAS
Saliva was used as the source of diastase. It was obtained 
by rinsing the mouth out thoroughly with distilled water, and then 
spitting into a clean glass tube. The saliva was well mixed with an 
equal volume of distilled water.
1) Rinse in distilled water.
2) Treat with saliva solution, 30 minutes.
3) Wash well in running tap water.
4) Stain by PAS, as above, together with an untreated
control of identical material.
8.3.7 Peris' Prussian blue stain (for smears)
Wet-fixed smears were used. (The method for sections is given 
below.) The reagent was prepared by mixing equal parts of 2% potassium 
ferrocyanide and 2% hydrochloric acid.
1) Rinse well in deionised water.
2) Place in freshly prepared reagent, 30 minutes.
3) Wash well in tap water.
4) Counterstain in Safranin, 15 seconds.
5) Wash off in tap water.
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6) Dehydrate, clear, and mount in DPX.
8.3.8 Alcian Blue stain
This stain was used with various electrolyte concentrations by 
the method of Scott and Dorling (1965). They report that this allows 
differentiation of types of acid muco-substances.
A stock solution of 250 mg of Alcian Blue in 500 ml of distilled 
water was prepared. To 50 ml aliquots was added sufficient magnesium 
chloride to produce 0.06, 0.3, 0.5, 0.7 and 0.9 M solutions.
1) Stain serial sections in the various Alcian Blue solutions,
overnight.
2) Y/ash in tap water.
3) Counterstain in neutral red, 3 minutes.
4) Wash in tap water.
5) Dehydrate, clear, and mount in DPX.
8.3.9 Phosphotungstic acid haematoxylin (PTAH)
The PTAH solution was prepared by dissolving 0.5 g of haematin
in 100 ml of water, and 5 g of phosphotungstic acid in 400 ml of water.
The two solutions were mixed and stored overnight in an airtight bottle. 
Post-chromate solution was prepared by mixing 12 ml of 10% hydrochloric 
acid in IMS and 36 ml of 3% aqueous potassium dichromate. Acidified 
potassium permanganate was produced by mixing 50 ml of 0.5% aqueous 
potassium permanganate and 2.5 ml of 3% sulphuric acid.
1) Place solution in post-chromate solution, 30 minutes.
2) Wash in tap water.
3) Treat with acid permanganate solution, 1 minute.
4) Wash in tap water.
5) Differentiate in 2.5% aqueous ferric ammonium sulphate.
The slide was dipped into the solution, rinsed with tap
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water, and examined microscopically. This process was 
repeated until mitochondria were visible.
6) Wash in running tap water, 10 minutes.
7) Dehydrate, clear, and mount in DPX.
8.3.10 Schmorl's Method
This stain (Schmorl, 1934) was used to detect lipofuscin in
sections. Ferrous iron interferes with the reaction, but controls to
detect this (Turnbull's method) were also prepared. The sections were 
examined microscopically after staining for 30 seconds, to observe the 
reaction, and staining terminated when judged to be adequate, in order 
to prevent background staining.
The staining solution was freshly prepared by mixing 37.5 ml of 
1% aqueous ferric chloride, 5 ml of 1% aqueous potassium ferricyanide, 
and 7.5 ml of distilled water.
1) Immerse sections in staining solution until reaction is
judged satisfactory. This took about 2 minutes.
2) Rinse in tap water.
3) Place in 1% acetic acid, 2 minutes.
4) Wash well in tap water.
5) Counterstain in Neutral Red, 2 minutes.
6) Wash in tap water.
7) Dehydrate, clear, and mount in DPX.
8.3.11 Chrome Alum Haematoxylin
This method (Pearse, 1954, after Gomori) was used to detect 
lipofuscins. The stain was prepared by mixing 50 ml each of 1% 
aqueous haematoxylin and 3% chrome alum, then adding 2 ml of 5%
potassium dichromate and 1 ml of 5% sulphuric acid, and storing for
3 days.
1) Place sections in 0.5% potassium permanganate solution
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in 0.15% aqueous sulphuric acid, 2 minutes.
2) Bleach in 1% aqueous oxalic acid solution, 1 minute.
3) Wash in tap water.
4) Stain in chrome alum haematoxylin, 10 minutes.
5) Differentiate in 1% alcoholic hydrochloric acid.
6) Counterstain in 1% aqueous eosin, 5 minutes.
7) Wash in running tap water.
8) Dehydrate rapidly, clear, and mount in DPX.
8.3.12 Peris1 Method (for Sections)
This technique (Peris, 1867) demonstrates ferric iron, usually 
found in the form of haemosiderin.
1) Rinse in distilled water.
2) Place in 1% potassium ferrocyanide in 1% hydrochloric acid
(both analytical grade reagents), 20 minutes.
3) Rinse in distilled water.
4) Counterstain in 1% Neutral Red, 1 minute.
5) Rinse in tap water.
6) Dehydrate, clear, and mount in DPX.
8.3.13 Turnbull’s Method
This technique demonstrates ferrous iron, and was used principally 
as a control for the tissues stained by Schmorl’s method.
1) Rinse in distilled water.
2) Place in 10% potassium ferricyanide solution in 1%
aqueous hydrochloric acid (analytical grade reagents, 
freshly prepared), 15 minutes.
3) Transfer to 1% aqueous hydrochloric acid, 15 minutes.
4) Rinse in distilled water.
5) Counterstain in 1% Neutral Red, 1 minute.
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6) Dehydrate, clear, and mount in DPX.
8.4 TRANSMISSION ELECTRON MICROSCOPY
Both whole tissue, and cells from BCF, were examined by transmission 
electron microscopy; the particles in BCF were examined using negative 
staining techniques. Scanning electron microscopy was employed to reveal 
the internal structure of small cysts.
8.4.1 Fixation
Small pieces of cystic breast tissue were prepared by cutting
into 1 mm cubes; cells were obtained by centrifuging BCF, as described
previously. Both were pre-fixed in 3% glutaraldehyde, and post-fixed 
in 1% osmium tetroxide.
Glutaraldehyde buffer was prepared by mixing 12 ml of a stock 
solution of 25% glutaraldehyde and 88 ml of 0.1 M cacodylate-HCl buffer, 
pH 7.2. Osmium tetroxide solution was prepared by adding 0.5 g of the 
salt to 50 ml of the same buffer.
' The cells were fixed in glutaraldehyde for 30 minutes at 4°C,
and then centrifuged. The fixative was poured off, and the cells washed
in cacodylate buffer for 30 minutes. Following a rinse in the same 
buffer, they were post-fixed for 2 hours in osmium tetroxide at 4°C, 
and rinsed in cacodylate buffer.
Tissue specimens were treated in the same way, except that 
centrifugation was unnecessary, the solutions being merely poured off.
Also, fixation times were increased to 90 minutes in glutaraldehyde, 
and 7 hours in osmium tetroxide.
8.4.2 Embedding
The tissues and cells were firstly dehydrated by washing in 
the following solutions.
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(a) 50% aqueous alcohol (IMS), 10 minutes.
(b) 70% " ” 15 minutes.
(c) 90% " ” 15 minutes.
(d) Absolute alcohol, 30 minutes.
(e) Absolute alcohol, 30 minutes.
They were then embedded in EMix resin (Emscope Laboratories Ltd) , 
an Araldite medium, of unspecified type, supplied in pre-measured 
quantities for mixing.
The procedure for clearing and embedding the dehydrated specimens 
was as follows.
(a) Propylene oxide, alcohol (1:3), 15 minutes.
(b) " " " (1:1)
(c) " " " (3:1)
(d) Absolute propylene oxide, 15 minutes.
(e) ” ” ». .»
(f) Specimen transferred to a small glass bottle, and a small
amount of fresh propylene oxide added, followed by an 
equal volume of resin. The vessel was capped and
placed on a rotator for 30 minutes, at 37°C in an
incubator.
(g) The propylene oxide-resin mixture was removed and replaced
by resin alone. The vessels were replaced on the
rotator, uncapped, for 60 minutes, at 37°C.
(h) The specimens and resin were poured into plastic moulds,
topped up with more resin, and polymerised overnight 
at 60°C.
8.4.3. Sectioning
Sections of the blocks were made on a Huxley ultramicrotome 
(Cambridge Instruments Ltd), using glass knives produced in the LKB
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knife-maker.
Blocks were cut free from the mould and fitted into the microtome 
chuck. They were trimmed - around, and down to, the specimen - with 
a razor blade, to produce a small cutting face with the top and bottom 
edges parallel. A knife was selected, and a trough formed, using 
fabric sticking-plaster (Elastoplast), in front of the cutting edge, 
and the knife fitted to the microtome. The trough was filled with 
filtered double-distilled water. The knife was then advanced until 
it was almost touching the block face, and the motor drive started.
Sections were first cut at 2 ym thickness, using manual advance, 
until the wholeblock face was being cut, and then at 0.5 ym. Unwanted 
sections were removed from the water's surface with a small artist’s 
brush, and the water in the trough topped-up as necessary. Two or 
three 0.5 ym sections were picked up on the brush, and transferred 
thus to a drop of water on a glass, microscope slide. The slide was
left on a hot-plate at 70°C until dry, and a drop of 1% toluidine blue 
in 1% borax solution placed on the sections. When the stain began to 
steam, the slide was washed under the tap, dried, and examined with a 
light microscope. By this means the specimen was checked to ensure 
it was the type required before cutting thin sections. If not so, 
another block was selected, or else the block trimmed further into the 
tissue.
Thin sections were then cut using the automatic feed system of 
the microtome. The sections varied in colour when illuminated 
obliquely, due to interference phenomena, depending on their thickness. 
Only pale gold or silver sections (120 - 60nm) were selected for use, 
the others discarded after removing them from the trough, with a brush. 
The sections to be used were mounted on copper grids (usually 300 mesh).
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The grid, held with fine forceps, was pushed below the water in the 
trough, the sections (usually about three) positioned near it using 
a mounted eye-lash, and the grid withdrawn obliquely with the sections 
adhering. The grid was dried by touching onto filter paper, and stored 
in a special box.
8.4.4 Staining
The sections were stained, generally with alcoholic uranyl 
acetate and aqueous lead citrate, in batches. Double-distilled and 
filtered water was used for preparing stains and wash baths. All 
stain solutions were filtered immediately before use through Whatman 
No.50 filter paper, and the uranyl acetate was prepared freshly.
Alcoholic uranyl acetate solution was prepared by adding 1.5 g 
of uranyl acetate to 50 ml of IMS and shaking until dissolved. Reynolds' (1963) 
lead citrate solution was prepared as a stock solution and stored at 
room temperature. To a mixture of 13.3 g of lead citrate and 17.6 g 
of sodium citrate (dihydrate) in a 500 ml volumetric flask, was added 
300 ml of water. After shaking the flask intermittently for 30 minutes,
80 ml of 1 M sodium hydroxide solution was added, mixed, and the flask 
filled to the mark with water.
The staining was performed in grid holders made from perforated,
plastic, block moulds, in which grids were transferred from one solution
to the next. These were stored in 5% acetic acid, and washed twice 
in water before use. The stains were placed in small, capped, plastic 
pots. The staining routine was as follows.
(a) The grid-holder was placed in water and one grid placed
in each bucket, ensuring that they sank.
(b) Wash in 70% aqueous IMS.
(c) Incubate in 3% alcoholic uranyl acetate at 37°C for
60 minutes.
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(d) Rinse in 70% aqueous IMS.
(e) Rinse in three changes of water.
(f) Stain in Reynolds' lead citrate for 5 minutes.
(g) Wash in two changes of 0.02 M NaOH solution.
(h) Rinse in two changes of water.
(i) Remove grids, dry by touching on filter paper, and store
in grid-boxes.
8.4.5 Carbohydrate stain
For the demonstration of carbohydrate material in the electron 
microscope a variation of the PAS technique was used. The method was 
that of Vye and Fischman (1971), entailing staining by periodic acid- 
thiosemicarbazide-silver protein, which is a modification of the method 
of Thiery (1967).
Sections were cut from blocks prepared as before, but with 
tissue fixed for 12 hours in buffered glutaraldehyde, and for only one 
hour in osmium tetroxide. The method was only used for breast tissue, 
not BCF cells. The sections were mounted on gold grids since copper 
reacts with the stain. The method used was as follows.
(a) Oxidise in 1% periodic acid for 30 minutes.
(b) Rinse in double-distilled water.
(c) Incubate in a 1% solution of thiosemicarbazide in 25%
acetic acid for 60 minutes.
(d) Rinse in double-distilled water.
(e) Incubate in 1% aqueous silver protein (EMscope Laboratories
Ltd.) at room temperature for 30 minutes, in the dark.
The reagent was prepared fresh and filtered through
Whatman No.50 filter paper, also in the dark.
(f) Wash for 60 seconds in running double-distilled water,
dry, and store in grid-box.
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Serial sections of the same block were used as controls, stained
as above but,with one,omitting the periodic acid incubation and, with a
second, omitting the silver protein reagent. These indicate any non­
specific binding of silver protein, or any staining already in the 
section, respectively.
8.4.6 Negative stain
This technique was used for examination of the particles of BCF. 
Two stains - sodium tungstate and ammonium molybdate, both as 1% aqueous 
solutions - were used, and the samples were placed on collodion-coated 
grids.
The coated grids were prepared by the following method.
(a) A Petri dish containing a wire basket was filled with
double-distilled water.
(b) Two drops of 2% collodion in amyl acetate were placed
on the water surface from a height of 3 inches. After
about 30 seconds the film produced had dried, and it
was removed with forceps. This procedure cleans the 
the surface of the water.
(c) About twenty copper grids (100 mesh) were placed on the
basket under the cleaned water.
(d) A collodion film was made and dried on the water, as in
(b), and the basket lifted out of the dish and placed 
on filter paper to dry.
(e) The film was cut by running a dissecting needle round
each grid,and the grids then removed from the wire 
basket, using fine forceps, and transferred to a clean 
Petri dish for storage.
The samples, either whole BCF or fractions obtained from
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density-gradient centrifugation, were carefully placed onto coated 
grids and after 30 seconds washed off with stain solution. Another 
method used was to mix equal parts of the sample and stain, and apply 
a drop to the grid. In both cases the grids were left for 60 seconds, 
and any remaining moisture removed with filter paper. The dried grids 
were stored in a grid-box.
8.4.7 Examination and photography
The grids were examined in a Phillips EM100B electron microscope. 
The machine was pumped down according to the manufacturer's instructions. 
A grid was placed into the holder which was then inserted into the 
microscope. The high tension, lenses, and filament current were turned 
on, the sections found on the grid using low magnification, and the 
specimen examined at appropriate magnification.
Photographs were taken on imperforate 35 mm Kodak Fine Grain 
Safety Positive film. Exposure was estimated by eye; the usual practice 
was to turn down the filament until the screen was barely illuminated, 
and then open the camera shutter for 5 seconds. The magnification was 
noted by the position of the coarse control and the reading of a meter 
connected to the fine control. From this the actual magnification could 
be determined from a calibration table prepared by measuring photographs, 
made in the microscope, of a replica grid of known dimensions.
The film was developed in Ilford Contrast FF developer (diluted 
1:20 with water) at 20°C for 5 minutes. Development was stopped with 
a 1% acetic acid stop-bath, and the film fixed in Ilford IF23 fixer 
(diluted 1:3 with water, then 5% Ilford Acid Hardener added). After 
washing in running tap water for 30 minutes, the film was rinsed in 
distilled water and hung up to dry. "When printing, the magnification 
of the print was also noted; which for the sake of convenience was
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restricted to 6x, except for special purposes.
8.5 SCANNING ELECTRON MICROSCOPY
Two cysts excised from a mastectomy specimen, and about 4 mm in 
diameter, were carefully cut across to expose the interior, and placed 
into cacodylate-buffered 3% glutaraldehyde for 3 hours. After rinsing 
in cacodylate buffer they were placed in small, screw-capped bottles 
and posted to Dr. M. Johnson at the University of North Wales (Aberystwyth).
Preparations of the particle fraction were also made for scanning 
electron-microscopy. Samples of particles from a density gradient 
separation were pooled to give a total volume of 1 ml, and fixed by 
adding 10 ml of buffered glutaraldehyde solution. A Millipore filter
(type GSWP, 0.22 ym pore size, 25 mm in diameter) was fitted into an
Amicon ultrafiltration cell, the fixed particle solution added, and the 
cell pressurised to 10 p.s.i. (0.7 kgf/cm2) with nitrogen. When the 
liquid level had barely reached the filter, the pressure was slowly 
released, the filter removed and placed in a screw capped glass vial 
containing cacodylate buffer, and posted with the other specimen.
In Dr. Johnson's laboratory the specimens were dehydrated and 
dried as follows.
(a) 30% aqueous ethanol, 15 minutes.
(b) 50% aqueous ethanol "
(c) 70% aqueous ethanol "
(d) 100% ethanol "
(e) Flurosol, ethanol (1:3), 10 minutes.
(f) " " (1:1)
(g) " " (3:1)
(h) absolute Flurosol, 15 minutes.
The specimens were then dried in a E3000 critical point drying 
apparatus and mounted onto stubs using Kodaflat. After coating with 
gold-palladium in a diode sputtering unit, they were examined in a 
Cambridge scanning electron microscope, and photographs taken on 35 mm 
Ilford FP4 film.
8.6 MICROBIOLOGY
In order to establish the sterility of BCF, and exclude the 
presence of any infection, attempts were made to culture organisms from 
BCF. A series of 20 BCFs was carefully collected aseptically.
Following aspiration of the fluid, the syringe needle was removed and 
the contents of the syringe gently expelled into a sterilised, Universal 
bottle. The cap of the bottle was only removed enough to allow access 
to the syringe, and was rapidly replaced afterwards.
On returning to the laboratory the fluids were each streaked 
onto four plates; two blood agar, one McConkey, and one Sabouraud plate 
(for yeasts). One of the blood agar plates was incubated anaerobically, 
the others aerobically, at 37°C. They were examined after 16, 24, and 
48 hours.
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9 PHOTOGRAPHIC METHODS
9.1 PHOTOGRAPHY
Monochrome photographs were produced using Ilford PAN F film at 
the normal rating of 50 ASA. Light micrographs were taken in a Leitz 
photo-microscope fitted with Leitz flat-field objectives. Slides and 
microscope lenses were carefully cleaned, and the microscope adjusted 
by the Kohler method. Exposure was automatic, being estimated by the 
built-in, integrating, exposure meter.
Photographs of electrophoresis strips and immunoelectrophoresis 
plates were taken using a Nikon F camera, fitted with a Photomic exposure 
meter (Nikon). The lens used was a 50 mm, f3.5 Macro-Nikkor (Nikon), 
with an extension ring for close-up work. The specimens were trans­
illuminated using a Shandon daylight lamp on which was rested a sheet 
of opal glass, to act as a diffuser. The specimen was placed on this 
and photographed from above, with the camera fitted to a Nikon copying 
stand. Exposure was estimated using the built-in exposure meter.
Three exposures were made, one at the indicated value and one at one 
stop above, another one stop below. For lightly stained subjects, an 
appropriate filter was used to increase contrast.
Photography in the electron microscope has already been described 
(see "Electron Microscopy", above).
9.2 PROCESSING
The films were developed in a Patterson tank, using ID11 developer 
(Ilford). The solution was brought to 20°C, and poured into the tank.
The film was agitated continuously for the first 20 seconds of development, 
and thereafter by twice inverting the tank every minute. After 6^ 
minutes, the developer was poured out and fixer (Ilford IF23, diluted
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1:3 with water and then adding 1 ml of Ilford Liquid Acid Hardener for 
each 20 ml), also at 20°C, rapidly poured in. The film was agitated 
continuously for 1 minute, then the tank lid was removed, and the time 
taken for undeveloped emulsion to clear was noted. Fixation was
continued for twice this clearing time, and the film then washed in 
running tap water at approximately 20°C for 30 minutes. After rinsing 
twice in distilled water, and once in distilled water with a drop of 
liquid detergent added, the film was hung up to dry. When dry, it was 
cut up into six-frame lengths and stored in glassine envelopes.
9.3 PRINTING
Prints were made on Ilford YRP glossy paper of a suitable hardness, 
usually grade 2 (normal), using a Durst enlarger (model 606), fitted 
with a Durst Companar, 75 mm, f4.5 lens. The prints were developed and 
stabilised in an Ilford automatic processor (type 1502) with IA11 
activator and IS21 stabiliser. Satisfactory prints were then fixed 
(The stabiliser allows the prints to be examined in artificial light,
but the results are not permanent) for 5 minutes in Ilford IF23 fixer
(diluted 1:6 with water and adding 5% v/v Ilford Liquid Acid Hardener).
For prints requiring extra permanence, a further 5 minutes in a fresh 
bath of fixer was given.
The fixed prints were washed in running tap water for one hour, 
and then dried and glazed using a rotary glazer.
Some prints were also made on other types of paper and developed
in Ilford PQ Universal developer (diluted 1:10 with water) for 2 minutes. 
Fixation and washing were carried out as before.
Colour photography was carried out using Kodak Vericolour II, 
Professional, Type S negative film. This was mainly used for photo-
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micrography using the Leitz photomicroscope, with a hlue filter to 
correct the colour temperature of the light from the tungsten filament. 
In the camera the film was exposed in daylight, and rated at 100 ASA. 
Developing and printing were carried out by a commercial laboratory. 
Some colour prints were prepared on reversal-type paper, from colour 
slides. This was also carried out by a commercial laboratory.
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R E S U L T S  
 0O 0------
1 PATIENT AND CYST DATA
1.1 PATIENT DATA
1.1.3. Age
The ages of 1043 breast cyst patients from all hospitals in the 
area are shown graphically in Fig. 11. Those of the smaller sample of 
patients, from Mayday Hospital Breast Clinic, are shown graphically in 
Fig. 12, together with their menstrual status.
The great majority of the patients were of menopausal age, and 
the age distribution of the small sample, from which extensive data was 
obtained, is shown to be the same as that of the large group. In the 
younger patients, a history of recent lactation was a frequent finding.
1.1.2 Parity
The parity of the patients in the small group is shown in Fig. 13.
This shows that all parity groups up to 6 are represented, and suggests
that there is no major influence of this factor on breast cyst formation.
1.2 CYST PHYSICAL DATA
1.2.1 Volume
The volumes of BCF obtained at aspiration (presumably representing 
cyst volume), and their depth of colour, are shown in Fig. 14. The 
median volume was 2 to 4 ml, and the majority of cysts were smaller 
than 10 ml.
1.2.2 BCF colour
The colour of cyst fluid was found to be very variable, ranging
from a pale straw, through various shades of yellow, brown, and green,
to a very dark greenish-brown (see Fig. 15).
The fluids also had a characteristic "milkiness" which varied 
from a slight opacity to greater than that of human milk.
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showing their menstrual status.
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Fig. 13 Parity of patients of the Mayday Hospital series.
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Volume and colour of BCF samples from the Mayday Hospital series.
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Fig. 15 Appearance of breast cyst fluid. Note the range of
colour, and the characteristic "milkiness".
1 5 ^
1.2.3 Site
The quarters of the breasts in which cysts of the Mayday sample 
were located are shown diagramatically in Fig. 16. Of these cysts the 
majority (56.2%) were found in the left breast. In both breasts the 
commonest site was the upper outer quadrant, and over 80% of cysts were 
in the upper half of the breast.
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25.0% 56.3%
3.1% 15.6%
Left
Fig. 16 Site of breast cysts in patients of the Mayday Hospital series.
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2 CYTOLOGY
The cellular content of BCF was examined in order to gain
information about the types of cell present, and to relate such information
to the presence of other components in the fluid. Histological sections
of breast tissue were used to show the structure of ’pink’ cells, and to*
test their reaction to various cytochemical methods. The ultrastructure 
of ’pink' cells was observed, by electron microscopy, in order to see 
whether information on secretion by such cells could be obtained.
2.1 CELLS FROM BREAST CYST FLUID
The free cells in BCF are a mixed population, with various numbers 
of each type present in different fluids. They are sometimes rather 
degenerate in appearance, and usually accompanied by what appears to 
be fine granular debris, presumably of cellular origin.
2.1.1 Epithelial cells
The most frequently found type is the 'pink* cell (see page 30).
In cytological preparations these invariably appear.in groups or large 
clusters, and sometimes appear degenerate. The cells (see Fig. 17) 
have a central to polar nucleus, with evenly dispersed chromatin and a 
large nucleolus, and abundant granular cytoplasm. In large groups, 
the periphery shows the characteristic lobulated appearance also seen 
in histological sections of ’pink’ cells. The frequent finding of 
papillary formations suggests that this type of epithelium is proliferative 
in nature.
The degenerate ’pink’ cells are of similar appearance, but often 
smaller, with a pyknotic nucleus. They sometimes have an enlarged 
nucleus showing margination of chromatin, and a very prominent nucleolus. 
The cytoplasm is also often vacuolated.
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Fig. 17 The appearance of 'pink1 cells in a smear of the
cell deposit obtained by centrifuging BCF. The
’pink’ cells are on the left of the picture. M.G.G. stain. Cx4&0)
The ’pink’ cells contain PAS-positive granules (see Fig 18), and 
these are often concentrated at one side of the cytoplasm. If the 
cells are in large groups, this side is seen to be the apical end. The 
reaction with Peris’ stain was usually negative, but occasional very 
weak positives showed an overall reaction in the cytoplasm. A granular 
pattern was never seen.
Normal duct cells were sometimes seen. These were somewhat 
smaller than ’pink’ cells and had a smaller, denser nucleus, and much 
less cytoplasm.
2.1.2 Other cell-types
The other cell-type which was frequently found is the polymorphonuclear 
leucocyte. These were found to be present, in small numbers, in 60% 
of BCF specimens, in large numbers in 25%, and to be absent in 15%. In 
the fluids which had large numbers, other leucocytes were also present, 
including lymphocytes and plasma cells (see Fig. 19).
Erythrocytes were found in 40% of BCF specimens, usually in small 
numbers. They are presumably picked up by the aspirating needle as it 
travels through the breast tissue surrounding the cyst.
2.1.3 Relationship of cell type to BCF electrophoresis pattern
In a series of 227 BCFs, the presence of lymphocytes and plasma 
cells was correlated with the cellulose-acetate-electrophoretic pattern 
(See p.176). The results (see Table 2) show that there is a strong 
association between the presence of many leucocytes (including lymphocytes 
and plasma cells) in the fluid, and the serum-type electrophoretic 
pattern. The cytological patterns are illustrated in Fig. 19, the 
electrophoretic types in Fig. 32.
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Fig. 18 ’Pink’ cells stained by the PAS technique. Note the
strongly stained granules. (*4do)
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Fig. 19 (a) BCF cell smear, showing pattern with large numbers of
leucocytes, including lymphocytes. HE stain. (x4eo)
(b) BCF cell preparation, showing the pattern with very few 
leucocytes, and a clump of epithelial cells. Filter 
preparation, HE stain. ( * W )
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TABLE 2 Correlation of cellulose acetate electrophoretic
patterns and cell types in breast cyst fluid
Cytology Electrophoresis
Serum-type Pure-type 
Leucocytes (including 41 (18.1%) 28 (12.3%)
lymphocytes)
No leucocytes, or a few 15 (6.6%) 143 (63%)
polymorphs
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2.2 HISTOLOGICAL SECTIONS
2.2.1 Cystic .breast tissue
In histological sections, the cysts were found to be lined by ’pink’ 
epithelium (Fig. 20). The cells are generally in one layer, but 
papillae are often found projecting into the lumen. The cell shape 
varies with the intracystic pressure, but in microcysts the cells are 
moderate to tall columnar. In larger cysts, with higher pressure, the 
epithelium tends to become flattened. The epithelium rests on a 
basement membrane, with occasional myoepithelial cells.
Schmorl's stain gave only a slight over-all background reaction, 
showing absence of lipofuscin. This was borne out by the chrome-alum 
haematoxylin stain. Alcian blue staining varied with the salt 
concentration; the results are given in Table 3. They show that 'pink' 
cells contain only carboxylated or weakly sulphated mucins. The 
material in the cyst lumen showed traces of strongly sulphated mucins.
The connective tissue reacted at all electrolyte concentrations, and 
showed a trace of keratan sulphate.
Turnbull's reaction was negative in ’pink' cells, as was Peris' 
stain, showing the absence of ferrous and ferric iron.
2.2.2 Cytoplasmic granules
Granules which are PAS-positive were found in the histological 
sections of 'pink' cells (Fig. 21), as well as in the cytological 
preparations mentioned above. They are located mainly at the apical 
end of the cells. Staining was not abolished by prior incubation 
with diastase, and the granules are therefore not glycogen.
Mitochondria were demonstrated in 'pink' cells by the PTAH 
stain (Fig. 22). The same type of reaction was given by Haidenhain's 
method, although showing fewer granules.
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Fig. 20 Histological section of 'pink' cells lining a microcyst. The
Golgi complex may be seen as an understained area in the 
supranuclear region. (c.f. Fig. 24) HE stain. (x 315)
Fig. 21 Histological section of 'pink* cells lining a micro-cyst, stained 
by the PAS technique. The PAS-positive granules are seen to be 
at the apical end of the cells. (x 400).
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TABLE 3 Staining of Cystic breast sections by Alciari Blue at 
various concentrations of electrolyte
Electrolyte concentration
0.06 M 
0.3 M 
0.5 M 
0.7 M 
0.9 M
'Pink* cells
+++
Reaction
Lumen
material
Connective
Tissue
+++
++
+++
++
++
++
+++ strong reaction 
++ moderate "
+ weak "
- Negative "
Components stained at various electrolyte (MgCl ) concentrations
a
(Scott and Dorling, 1965) are as follows.
0.06 M 
0.3 M 
0.5 M 
0.7 M 
0.9 M
carboxylated and sulphated mucins, 
weakly and strongly sulphated mucins, 
strongly sulphated mucins, 
highly sulphated connective-tissue mucins, 
keratan sulphate only.
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Histological section of ’pink' cells lining a microcyst, stained 
by the PTAH method. (x 315).
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Histological section of axillary skin, showing secretory cells of 
an apocrine gland. The Golgi complex is seen as an understained 
area in the supranuclear region (c.f. Fig. 20). HE stain (x 315
2.2.3 Golgi complex
No staining methods were used to show positively this organelle. 
However, it is clearly seen in HE-stained sections (Fig. 20) as an 
understained area in the supranuclear region. It is also shown in the 
PTAH-stained sections by a reduction in density of mitochondria in the 
same area.
The organelle can also be seen in the skin apocrine gland cells 
(see Fig. 23), in the same position as that in 'pink' cells.
2.3 ELECTRON MICROSCOPY
2.3.1 ’Pink* cells
The ultrastructural appearance of 'pink' cells is shown in 
Fig. 24. They have many characteristics of a secretory cell, and 
strongly resemble apocrine skin gland cells, ultrastructurally (e.g. 
Ellis, 1967). The shape is variable, depending on the distension of 
the cyst, but is usually taller than its width. The nucleus is basally 
situated and has one or two nucleoli.
The apical surface is covered by microvilli, and below these are 
usually many small vesicles, not unlike those found in apocrine skin 
gland cells (Ellis, 1967).
Mitochondria are present in moderate to large numbers, and 
frequently have few, or altered, cristae. They are seen more clearly 
at higher power (Fig. 25). Endoplasmic reticulum, both rough and 
smooth, is present, and sometimes abundant.
The plasma membrane at the base of the cell is very invaginated, 
(see Fig. 26), presumably to give greater surface area for the intake 
of nutrients.
A well developed Golgi complex is seen in the supranuclear
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Fig. 24 Electron microscopic appearance of 'pink' cells. Microvilli,
mitochondria (M), endoplasmic reticulum (both rough and smooth) 
and Golgi complex (£p may be seen. The dense osmiophilic 
bodies in the supranuclear region in (a) are seen in an 
understained section (b) to contain small dense granules. 
Lipoprotein vesicles are also seen (arrowed) in (b). Fixed 
in glutaraldehyde and OsO^, stained uranyl acetate and lead 
citrate.
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Fig. 25 High power electron micrograph of a section of a 'pink' cell,
showing mitochondria surrounded by rough endoplasmic reticulum 
(arrow). The cristae of the mitochondria are sparse and 
somewhat deformed. Fixation and Stain as in legend to Fig. 24. 
(x 24,500).
Fig. 26 Electron micrograph of a section of ’pink’ cells, showing the 
invaginations of the basal plasma membrane. The epithelial 
basement membrane and nucleus of a myoepithelial cell are also 
visible. Fixation and Stain as in legend to Fig. 24. (x 15,000
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region (Fig. 24). It is of the same size, and in the same position, 
as the body seen using the light microscope, as mentioned above. Around 
this are a number of large osmiophilic bodies tfrhich, in an understained 
section, can be seen to contain small dense granules (Fig. 24). These 
probably correspond to the PAS-positive granules seen by light microscopy, 
and are identical to those in apocrine skin gland cells (Ellis, 1967).
It is possible that they are secretory granules, but their secretion 
has not been seen in any sections, and they may be altered mitochondria. 
The attempts to stain these granules by the electron-microscope equivalent 
of the PAS stain (the Periodic acid-thiosemicarbazide-silver proteinate 
reaction) were not very successful. Some reaction was obtained with the 
osmiophilic bodies, but there was insufficient contrast to prepare usable 
photographs. The controls were negative.
2.3.2 Particle-fraction of breast cyst fluid
The appearance of the particles separated by centrifugation 
(see "Centrifugation Methods" in Results) from a BCF sample is shown by 
the negative-stained preparation in Fig. 27. They have a very variable 
shape and size, but the average diameter is 0.2 ym. Their appearance 
suggests a membranous nature. Attempts were made to prepare sections 
of the material for electron microscopy, but they were not successful. 
However, a section of the material in the lumen of a cyst is shown in 
Fig. 28. It should be emphasised that this is the material from a 
microcyst, whereas the negative-stained preparation is of unsectioned 
material separated from an aspirated macrocyst fluid. However, the 
particles seen are of a similar appearance.
2.3.3 Scanning electron microscopy
The interior of a breast cyst, as revealed by scanning electron 
microscopy, is illustrated in Fig. 29; a high-power view of the
170
Fig. 27 Electron-microscopic appearance of the particle-fraction from
two BCF specimens, in negative-stained preparations. The particles 
have a variable shape and size, with an average diameter of 0.2 ym, 
and have a similar appearance in the two specimens. Negative stain
using sodium tungstate. (Both x 19,440).
Both preparations are of particles separated from whole BCF by sucrose 
density gradient centrifugation.
1*1
Fig. 28 Electron micrograph of a section of a microcyst which was excised
and fixed whole. The contents of the lumen of the cyst are shown, 
and they have a similar appearance to the particles in Fig. 27. 
Fixation and stain as in legend to Fig. 24. (x 19,400).
Fig. 29 Scanning electron micrograph of the interior of a bisected 
microcyst. Several papillae are seen inside the cyst. Fixed 
in glutaraldehyde and coated with gold-palladium.
epithelium is in FigJ 30. In Fig. 29, several papillae may be seen 
inside the cyst.
The microscopic appearance of the particles by this method is 
shown in Fig. 31. The exercise was not very successful, but some idea 
of particle shape is obtained.
2.4 MICROBIOLOGY
No growth was obtained on any of the plates which were inoculated 
with the 20 aseptically collected BCF specimens; this demonstrates that 
the fluids do not contain bacteria or yeasts. The possible presence of 
viruses was not investigated.
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Fig. 30 Higher power scanning electron micrograph of the cyst illustrated
in Fig. 29. The epithelial cells appear irregular in size, and 
have a rough surface presumably due to the microvilli. In (b) 
the epithelium is folded back, thus revealing the under-side and 
the stroma beneath. Preparation as in legend to Fig. 29.
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Fig. 31. Scanning electron micrograph of the particles of BCF. The
glutaraldehyde-fixed particles are on a Millipore filter- 
membrane, and coated with gold-palladium.
175
3 PROTEIN INVESTIGATIONS
The proteins of BCF were shown to be generally unlike those of 
serum and much of the work was concentrated upon them. A variety of 
methods was used to attempt to separate them; their identity was 
investigated by immunological techniques. The necessity to raise an 
antiserum to BCF became obvious after this work, in order to characterise 
the proteins, and to see whether any of them could be shown to occur 
in the epithelial cells lining breast cysts.
Estimations of molecular weight of the proteins were made by 
SDS-acrylamide-gel electrophoresis, since the method is simple and can 
be applied to mixtures of proteins.
3.1 ELECTROPHORESIS
3.1.1 Cellulose acetate
Typical examples of the results of cellulose acetate electrophoresis 
of BCF are illustrated in Fig. 32, together with serum and human milk 
controls. The patterns for BCF can be divided into two major groups.
These are designated "pure-type" and "serum type", and represented 
roughly 80% and 20% of BCFs, respectively. Pure-types had a long 
streak stretching from the application point up to, or beyond, the 
position of albumin in the serum control; no discrete bands, with the 
possible exception of albumin; and no cathodically migrating material 
(y-globulin). Serum-types were so classified on the basis of their 
possessing at least a trace of y-globulin. They ranged from those 
having a trace of y-globulin and perhaps one discrete, anodically 
migrating band, to those having a pattern identical to that of serum.
In this study, no attempt was made to subdivide the two patterns, since 
the number of such smaller groups would have been very large.
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Fig.
M Se
32. Cellulose acetate electrophoresis of BCF, human mature skimmed
milk, and serum. Identical specimens are stained to demonstrate 
protein (upper strip) and carbohydrate (by PAS, lower strip).
The electrophoretic pattern of pure-type BCF (P) is shown, 
together with a range of serum-type BCFs (S), and milk (M) and 
serum (Se). The anode is at the top end of each strip.
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Electrophoresis of patient’s serum revealed no abnormalities.
Use of a PAS stain following cellulose acetate electrophoresis, 
showed a strong reaction of pure-type BCF proteins (Fig. 32), indicating 
that much of the protein is glycoprotein.
Since poor resolution of the proteins in pure-type fluids was 
obtained using this method, other techniques, such as polyacrylamide- 
gel electrophoresis and isoelectric focussing were tried.
3.1.2 Acrylamide gel
No improvement in resolution of pure-type BCF proteins was 
obtained using this technique, and the use of various buffer systems 
and gel concentrations had no effect. The pattern obtained was very 
similar to that on cellulose acetate electrophoresis, with a long, 
weakly staining band stretching almost the full length of the gel.
The serum-type fluids again gave a pattern resembling that of 
serum. However, for some, the pattern had an appearance of being 
combined with that of pure-type fluids, suggesting that both pure-type 
and serum-type proteins were present.
3.1.3 SDS - gel
The incorporation of SDS into the gels and samples had a great 
influence on resolution of pure-type BCF proteins. The technique was 
used with both disc and flat-bed methods, and showed, in the pure-type 
fluids, at least four bands in disc gels, and up to ten in some flat­
bed runs. The presence of glycoprotein was again shown by PAS staining.
The technique was also used solubilise the particle-fraction of 
BCF and thus allow electrophoresis of its protein. The results were 
rather inconclusive, but seemed to show the presence of at least one 
protein not found in the fluid-fraction of BCF. Whether the other 
proteins were simply contaminants from the fluid fraction of BCF is 
not known.
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3.1.4 Molecular weight determinations
The results of the SDS gel electrophoresis of pure-type BCF, by 
the method of Weber (1972), in order to estimate protein molecular 
weights, are illustrated in Fig. 33. A number of results are also shown 
diagramatically in Fig. 34.
The majority of the sub-unit bands occurred in all pure-type 
fluid samples, but their relative concentrations were variable. There 
were four major bands, representing molecular weights of 16,000, 29,000, 
43,000 and 70,000. One of these always predominated (M.W. 29,000), the 
others appeared more variable. The molecular weights of all pure-type 
BCF proteins ranged from 15,000 to 100,000.
Omission of heating the sample at 100°C, in order to check for 
any enzymic hydrolysis, produced a pattern with fewer bands. This 
pattern was consistent, even if the samples were left for 24 hours before 
running, and it was concluded that the variation was due to incomplete 
reaction with SDS or mercaptoethanol, rather than enzymic breakdown of 
protein. The extension of sample heating produced no changes in the 
normal pattern.
The use of 7.5% gels, instead of the normal 10%, gave some 
variation in the calculated molecular weights, but for most bands this 
was no more than 10%.
The PAS staining method used for these gels showed several non- 
reacting components to be present. The major bands stained strongly, 
and, although some showed a very weak positive reaction in the controls, 
the presence of glycoproteins is demonstrated.
3.1.5 Isoelectric focussing
This gave by far the best resolution of BCF proteins. With 
pure-type fluids, from 14 to 23 components were demonstrated (Fig. 35),
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Fig. 33 SDS-polyacrylamide-gel electrophoresis of pure-type BCF specimens.
The anode is at the bottom of the photograph, and thus the molecular 
weight of the proteins decreases down the gel (see also Fig. 34).
ISo
LFig. 34 Diagram of pure-type BCF proteins and lactoferrin (L), separated by 
SDS-polyacrylamide-gel electrophoresis. The molecular weight scale 
(in thousands) is derived from the results for standards run 
coincidentally. The major BCF-protein bands are indicated by open 
arrows. Lactoferrin showed four trace contaminants; the main band 
is indicated by the solid arrow.
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Isoelectric focussing of BCF. Five pure-type fluids are shown, 
with two serum-type specimens on the right of the photograph.
The picture covers the range from pH 3 (at the top) to pH 6 
(at the bottom).
and over 50 were seen in serum-type fluids.
In the pure-type BCF, the proteins were all shown to have a low 
pi. The range was from pH 3 to pH 6 or less. In the serum-type fluids, 
the range covered almost the entire gel, from pH 3.5 to pH 10.
The technique was also used to analyse the fractions obtained 
from column chromatography of BCF and milk (see below).
3.2 COLUMN CHROMATOGRAPHY
A typical separation of Sephadex G-200, as shown by the effluent 
absorbance at 280 nm, of pure-type BCF is presented in Fig. 36, and of 
human skimmed-milk in Fig. 37.
The milk gave four well-separated peaks, the BCF samples gave 
three main peaks (1,3 and 5) with two minor ones (2 and 4). In both 
cases, peak 1 was the fraction excluded from the gel. Peaks 2,3 and 4 
in milk corresponded approximately with 3,4 and 5 in BCF.
The peaks were analysed, after concentration, for serum proteins, 
using immunoelectrophoresis. The milk had IgG and IgA in peak 1, a 
complete milk pattern, but with reduced immunoglobulins, in peak 2, a 
weak arc in the 3-globulin position in peak 3, and no serum protein in 
peak 4. The BCF samples had albumin in peak 3, and a 3-globulin arc 
in peak 1. Peaks 2, 4, and 5 had no serum protein.
The carbohydrate analysis showed all such material to be present 
in the excluded fraction (peak 1) of the BCF separations. This peak 
was also found to contain all the cholesterol of BCF. It contained 
most of the protein, and had a very milky appearance, due to the BCF
particle-fraction. The milk cholesterol was also mainly in peak 1,
but with a trace in peak 2.
The proteins in each peak from BCF and skimmed milk were also
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Fig. 36 Absorbance at 280 nm of the effluent from a chromatographic 
separation of pure-type BCF on a column of Sephadex G-200. 
Five peaks were obtained. (For details of the method, see 
"Column Chromatography" in Methods.)
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Fig. 37 Absorbance at 280 nm of the effluent from a chromatographic
separation of human skimmed milk on a column of Sephadex G-200. 
Four well-separated peaks were obtained. (For details of the 
method, see "Column Chromatography" in Methods.)
185
separated by isoelectric focussing. The results for the whole milk 
and peaks 1,2 and 3 are shown in Fig. 38, and for the whole BCF and 
peaks 1 to 4 in Fig. 39. The majority of the milk protein is seen to
be in peak 2, and that of BCF protein to be in peak 3. These peaks
were eluted at approximately corresponding volumes, suggesting the 
majority of BCF and milk proteins have molecular weights of a similar 
order of magnitude.
The proteins of BCF in peak 1, which contained all the 
carbohydrate material reacting with the carbazole reagent, were all of 
very low pi, with one exception. This is a protein seen around the 
centre of the gel, with a pi of about 6.8. Since the particle-fraction 
is in the gel-excluded peak (peak 1), this may be a protein which is
bound to, or forms a part of, the particles. Peaks 4 and 5 contain no
protein material demonstrable by isoelectric focussing, neither does 
peak 4 of milk. Presumably they represent either non-protein components 
of low molecular weight which absorb at 280 nm, or small peptides which 
cannot be fixed and are therefore leached from the gel during staining. 
This may be the same material that is found in BCF ultrafiltrates 
(see p. 195)
During the fractionation, the colour of the BCF was found to 
separate into two components. The dark-coloured fluids produced a 
brown and a green band, which appeared in peak 3 and 5 respectively.
With paler fluids, these components appeared in the same fractions, but
were brown and yellow in colour.
3.2.2 Ion-exchange
A typical elution pattern, again measured by absorbance at
280 nm, is shown in Fig. 40. Six, mostly poorly separated, peaks were
obtained. These were analysed by immunological methods using absorbed
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Fig. 38 Isoelectric focussing of a human skimmed milk specimen and the
fractions corresponding to the peaks obtained after it was 
separated by chromatography on a Sephadex G-200 column (see 
Fig. 37). Reading from left to right the specimens are: 
whole skimmed milk; fractions 1, 2, and 3.
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Fig. 39 Isoelectric focussing of 3 pure-type BCF and the fractions
obtained after it was separated on a Sephadex G-200 column 
(see Fig. 36). Reading from left to right the specimens 
are: whole BCF; fraction 1, 2 , 3 and 4.
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Fig. 40 Absorbance at 280 nm of the effluent from a chromatographic
separation, on a column of QAE Sephadex A-25 anion exchanger, of 
a pure-type BCF specimen (previously de-salted on Sephadex G-25). 
The molarity of sodium chloride in the buffer is shown at top.
Six mostly poorly separated peaks were obtained. The BCF-specifi 
proteins were in peak No. 2. (For details of the method, see 
"Ion-exchange Chromatography" in Methods.)
anti-(BCF). Both the BCF-specific proteins (see below, Section 3.3.5) 
were found in peak 2. Since the aim of the experiment was to separate 
the two proteins from each other, different conditions, such as using a 
shallower gradient and a different buffer pH, were tried. No improvement 
in separation was obtained.
The gradient-mixer used was found, when tested, to prepare 
reproducibly linear gradients of bromophenol blue.
3.3 IMMUNOLOGICAL TECHNIQUES
These techniques were used for the detection of specific proteins 
of serum and milk in BCF. The object was to see whether BCF resembled 
either of these fluids; this would then throw some light upon its source. 
The anti-(BCF) was also used to show the presence of milk and serum 
proteins in BCF, and to demonstrate the existence of BCF-specific proteins.
3.3.1 Serum proteins
The reaction obtained between BCF and anti-(whole human serum) in 
immunoelectrophoresis depended on the type of fluid. Pure-type BCF gave 
very little reaction, while serum-types gave more arcs, the number 
increasing the more the cellulose-acetate-electrophoretic pattern 
resembled that of serum.
The pure-types all gave one arc, in a position corresponding to 
that of albumin, although of a slightly higher electrophoretic mobility 
in many cases (Fig. 41). In many fluids, this arc was very indistinct' 
and tailed back towards the application well, occasionally reaching it.
In 30% of pure-type fluids, there was a small arc around the application 
well. In 10% there were one or two additional arcs in the 0&2 and 3 
regions.
Albumin was shown to be present in pure-type BCF, using anti-
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Fig. 41 Immunoelectrophoresis of BCF against antiserum to whole-human-
serum proteins. A pure-type BCF is on the left, a serum-type 
BCF on the right, and a control human serum in the centre. The 
serum-type fluid has a pattern similar to that of serum, but with 
fewer arcs; the pure-type fluid shows very little reaction with 
the antiserum.
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(human albumin) in immunodiffusion experiments. A reaction of complete 
identity was obtained with albumin of serum controls. Originally, 
attempts were made to demonstrate this identity in Immunoelectrophoresis 
using anti-(whole human serum), and allowing the BCF arc and that of a 
serum control to form close together. However fusion of the arcs, and 
a reaction of identity, were not obtained.
I
Serum-type fluids showed more reaction, with up to 12 arcs, 
including IgG, IgM, and IgA (Fig. 41). They never showed as many arcs 
as serum controls, and therefore had fewer proteins than serum. A most 
noticeable feature in some of these fluids was a tailing of the albumin 
arc, similar to that seen in pure-types but less marked. This almost 
seemed to be a mixture of pure-type pattern and serum.
The serum obtained from breast cyst patients of the Mayday sample 
showed no gross abnormalities in immunoelectrophoretic examination using 
anti-(whole human serum).
t
3.3.2 Immunoglobulins
Although cellulose acetate electrophoresis revealed no y-globulin 
in pure-type BCF, immunodiffusion of un-diluted fluid against suitably 
diluted specific antisera showed IgG and IgA to be present in low 
concentrations; IgM was not found.
The results of the assay of IgG and IgA are given in Table 4.
They show IgG to be low relative to serum values, but within the range 
for human milk, and IgA to be low relative to both serum and milk.
Only 30% of the fluids had levels of IgA greater than IgG. In 
milk and other secreted fluids IgA predominates. Also, neither secretory 
IgA nor secretor piece could be found in BCF, by immunodiffusion against 
specific antisera.
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TABLE 4 Intourioglobulin levels in pure-type BCFs and normal levels
in hnmart milk and serum
IgG IgA
BCF 10.5(10.8) 5.4(4.0)
♦Serum 720-1680 80-480
♦Milk 4-43 150-1735
Values are all mg/100 ml. Standard deviations in parentheses. 
♦Normal ranges for serum and milk from Documenta Geigy.
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3.3.3 Lactoferrin
The presence of lactoferin in BCF was shown by immunodiffusion 
against antiserum to human lactoferrin. The precipitate gave a reaction 
of identity with that of human milk controls. The concentration was 
roughly 20% of that in milk.
Confirmation of this observation was obtained by the presence of 
antibody to lactoferrin in the BCF antiserum. This was demonstrated by 
its reaction with purified lactoferrin in immunodiffusion, and Laurel1 
immunoelectrophoresis.
3.3.4 Milk proteins
Immunodiffusion of pure-type BCF against anti-(whole human milk) 
revealed several reacting proteins. These were shown to be, with one 
exception, due to low concentrations in pure-type BCF of serum proteins 
also present in milk. This was demonstrated using Laurell immuno­
electrophoresis with antiserum to milk and incorporating a serum strip.
The antigen excess of serum proteins removed all the peaks from the gel, 
except the one previously mentioned. By running purified lactoferrin in 
the same system, from a second well on the plate, two fused peaks were 
obtained giving a reaction of identity. Therefore the one non-serum 
protein was lactoferrin.
3.3.5 BCF-specific proteins
BCF was shown to contain at least two specific proteins relative 
to milk and serum. Despite the poor reaction of pure-type BCF with anti- 
(whole human serum), there was a sufficient quantity of serum proteins 
present to produce antibodies in the rabbits.
With anti-(BCF), the pure-type fluids showed the presence of 8 to 
10 proteins in immunodiffusion and immunoelectrophoresis. The'antiserum 
also reacted with human serum, and therefore some of the reacting proteins
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must be serum proteins. After absorption of the antiserum with 50 mg 
of freeze dried plasma per ml, no further reaction was obtained with 
serum in immunodiffusion. With BCF, the absorbed 'antiserum gave 3 zones 
of precipitation in immunodiffusion, and 3 arcs on immunoelectrophoresis.
The same effect was shown using Laurell immunoelectrophoresis.
With pure-type BCF against unabsorbed anti-(BCF), 7 peaks were obtained 
(Fig. 42). Introduction of a serum-containing strip, as before, 
effectively absorbing the antiserum in situ, reduced the number of peaks 
to 3. These peaks all had a similar electrophoretic mobility, close to 
that of albumin. Addition of human skimmed-milk to the serum-containing 
strip caused the smallest of the peaks to disappear (Fig. 42), showing 
it to be a milk protein. This peak was again identified as lactoferrin
(see section on "Milk Proteins", above), since it gave a reaction of
identity with purified lactoferrin electrophoresed coincidentally with 
BCF, from a separate well. The pure lactoferrin, milk, and BCF all 
gave one line of precipitate, with a reaction of identity, when 
diffused against absorbed anti-(BCF).
When the anti-(BCF) absorbed with freeze dried plasma was further 
absorbed with human skimmed-milk, only two lines of reaction were obtained 
against BCF. This, therefore, was the antiserum used for immuno- 
histochemical experiments.
3.3.6 Titre of antiserum to BCF
This was estimated by rocket electrophoresis, and was found to
reach a maximum after 6 months. Pool number one was found to yield 
the higher titre of both BCF and serum protein antibodies, and this one 
was therefore used for most experiments.
3.3.7 Ultrafiltrate of BCF
The filtrate produced during concentration of BCF, for various
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Fig. 42 (a) Laurell immunoelectrophoresis of pure-type BCF against
unabsorbed antiserum to BCF. Compare with Fig. 42 (b), 
overleaf.
1 9 6
Fig. 42 (b) Laurell immunoelectrophoresis of pure-type BCF against antiserum 
to BCF. A strip of gel, containing human milk and serum, was 
placed between the running and antiserum gels. This effectively 
absorbs out In situ any antibodies to milk and serum proteins, 
leaving the two peaks due to BCF-specific proteins (arrows).
The two reaction lines half-way up the antiserum gel are due to 
there being insufficient antigen in the strip to create an antigen 
excess, and thereby push them right off the plate.
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purposes, using a UM2 membrane, was found to contain materials absorbing 
strongly in the ultra-violet region. A typical absorption spectrum of 
a 1:100 dilution of the filtrate is shown in Fig. 43. The strength of 
this absorbance is thus shown to be high, since the original filtrate 
will contain only the BCF components with a molecular weight of less 
than 1000. The absorption at 280 nm is very strong, and is probably 
due to small peptides, or even amino acids. There is also a small 
peak at just above 290 nm, and this could be due to uric acid, which is 
often present in high levels in BCF, and has a peak of absorbtion at 
293 nm.
3.4 IMMUNOHISTOCHEMISTRY
Having shown the presence of two BCF-specific proteins, it was . 
necessary to attempt to discover whether they were present in the cells 
of the cyst epithelium. Such a location of specific protein would be 
strong evidence for secretion. The investigation was made using the
immunohistochemical technique. Tissues other than breast were used
as controls, with anti-(BCF); and other antisera were used on cyst 
sections to locate any milk or serum proteins, particularly immuno­
globulins . The latter was done to try to explain the virtual lack 
of immunoglobulin in pure-type BCF.
3.4.1 Breast cyst sections - anti-(BCF)
For anti-(BCF), absorbed with milk and plasma, the optimum 
dilution using the "sandwich” technique was found to be 1^ :250. This 
gave a strong specific reaction, but almost no non-specific background 
reaction. Immunofluorescence was initially used, but the peroxidase- 
conjugate technique gave better results. Brief formalin fixation 
did not affect the results, but one glutaraldehyde-fixed, wax-embedded
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Fig. 43 Ultraviolet-absorption spectrum of a 1:100 dilution of an
ultrafiltrate of pure-^type BCF. This represents the components 
of BCF not retained by an Amicon UM2 membrane (i.e. molecular 
weight less than 1000).
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specimen was found to have no reaction.
The antiserum was found to react with both the contents, and the 
epithelial cells, of cysts. Typical results are illustrated in Fig. 44. • 
The material in the cyst, and in some closely adjacent ducts (presumably 
connected to the cyst), was strongly positive, but there was no staining 
of nearby areas of normal glandular tissue.
Strong and characteristic reaction with the epithelial cells 
lining the cysts -'pink1cells - was obtained. Vacuoles in some cells 
had a rim of staining round their periphery; and the cell ’cap', and 
possibly plasma membrane, reacted strongly. There was no nuclear 
staining, but very strong reaction was obtained with a supra-nuclear 
body, which had a tortuous appearance and is suggested (with supportive 
evidence in the ’'Cytology" section in the Results) to be the Golgi 
complex (see also Fig. 20). The cytoplasm also had a weak overall 
stain which varied in intensity in different sections, and was sometimes 
stronger at the apical end of the cell. The same reactions were noted 
in ’pink' cells which were not lining cysts.
Of the controls, no reaction was obtained if the anti-(BCF) had 
been absorbed with BCF, if all or primary antiserum were omitted, or if 
the reaction with peroxidase conjugate were blocked with unlabelled 
sheep anti-(rabbit immunoglobulins). Initial incubation of sections 
with sheep anti-(whole human serum) had no effect on the subsequent 
reaction with the absorbed anti-(BCF), showing that no antibodies to 
serum proteins remained in the absorbed anti-(BCF).
Treatment of the sections with trypsin also had no effect on 
their reaction with absorbed anti-(BCF).
3.4.2 Breast Cyst sections - other antisera
With anti-(whole human serum) some weak reaction was obtained
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Fig. 44 'Pink* epithelium lining a breast microcyst, stained by the
immunohistochemical peroxidase technique using milk and plasma 
absorbed antiserum to BCF. This is seen to react with the cyst
contents (top) and with the ’pink’ cells. Note the strong
reaction with the cell 'cap1 and the Golgi complex (arrow), and
slight reaction of the apical cytoplasm. Stained by
diaminobenzidine (to demonstrate peroxidase) and haematoxylin.
201
with the material in the lumen of cysts and adjacent ducts, and stronger 
reaction with connective tissue and blood vessels. However, there was 
no staining of "pink” epithelial cells.
A very similar result was obtained with anti-(human milk), with 
the exception that there was weak, generalised staining of the cytoplasm 
of ’pink’ cells.
Antisera to IgQ and IgA also showed a weak overall reaction of 
the whole section, with stronger reaction in blood vessels. However, 
no immunoglobulin-producing cells were revealed around, or in, the 
cysts.
3.4.3 Axillary skin sections - anti-(BCF)
Axillary skin sections were examined for the presence of BCF- 
specific proteins. It was felt that this may help to resolve the 
problem of the similarity of apocrine gland cells and 'pink* cells which 
has often been shown structurally, but never functionally (see also p. 30).
In sections of both male and female axillary skin, absorbed anti- 
(BCF) is seen to react with the cells lining the apocrine glands, in an 
identical manner to 'pink* cells in the breast. No reaction is 
obtained with sebaceous glands or eccrine sweat glands.
Typical results are seen in Fig. 45. The anti-(BCF) reacts 
with the supra-nuclear body in the secretory cells of apocrine glands 
(i.e. Golgi complex, c.f. Fig. 23), and with the cell ’cap’, but not 
with the duct cells. There is also staining of the secreted material 
within the glands, and this can be traced up through the ducts and out 
onto the skin surface.
3.4.4 Other tissues - anti-(BCF)
The reaction of various tissues with absorbed anti-(BCF) is 
shown in detail in Table 5. Positive reaction is only obtained in 
cells which are, or are derived from, apocrine-type cells. In no
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Fig. 45 (a) Secretory cells of apocrine gland in a section of axillary
skin, reacted with anti-(BCF) using the peroxidase technique 
(as in legend to Fig. 44). Note the similarity of the reactio 
to that in ’pink* cells (Fig. 44). The material in the gland 
lumen also reacts, and can be traced through ducts (D) and out 
onto the skin surface, as seen in the low-power photograph of 
the same section (b). (a x 400; b x 40).
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TABLE 4 Reaction of various tissues with antiserum to BCF absorbed
with JUilk and plasma
Tissue
Vulval hidradenoma (1) 
Nodular hidradenoma (1) 
Ceruminal adenoma (2)
Apocrine gland cystadenoma
II f» II
Skin from nose 
Vulvectomy specimen
Cellular
(occasional
cells)
++ (apocrine 
gland)
Stomach -
Colon
Rectum -
Appendix
Kidney -
Cervix & Cervical brush biopsy
Secretion
++
Apocrine cells 
present t
- (slight
resemblance only)
+ (hair follicle, 
apocrine duct)
++ Strong reaction
+ Moderate reaction
- Weak or scattered reaction
t presence or absence of cells bearing 
a strong resemblance to ’’pink’1 or skin 
apocrine gland cells.
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case was the intracellular staining pattern the same as that found 
in 'pink* or skin apocrine gland cells. In the vulval hidradenoma, 
some cells had an appearance very like ’pink' cells, and showed staining 
of a supra-nuolear body. , The reaction was different from that in ’pink' 
cells, being more diffuse and granular.
Staining of ,secretion was more frequently found. In all cases 
this was presumably derived from apocrine-type glands.
3.4.5 Breast carcinoma - anti-(BCF)
Ten carcinomas of the breast were examined. Of these, six were 
negative, three were weakly positive, and one strongly positive. The 
strong positive was a so-called ’’sweat-gland", or apocrine, carcinoma.
The neoplastic areas in this specimen all showed a positive reaction, 
with some cells in each area being very strongly stained. The pattern, 
again, was unlike that of ’pink’ and skin apocrine gland cells, being 
granular, and evenly distributed throughout the cytoplasm.
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4 CHEMICAL ANALYSIS 
The objective of the chemical assays of BCF was threefold. 
Firstly, to establish some basic knowledge of the levels of various 
parameters in BCF. Secondly, to compare the chemical composition of 
BCF with that of milk and serum, and thus to see if it resembled either. 
Thirdly, to obtain evidence for., or against, BCF being a secretion of 
'pink' epithelium.
4.1 AUTOANALYZER PROFILE
Table 6 shows the assay results of 12 variables in 120 BCFs, 
assayed on the SMA 12/60 AutoAnalyzer. The samples were 98 pure-type 
(no discrete bands, or y-globulin, on cellulose acetate electrophoresis) 
and 22 serum-type (serum-like electrophoretic pattern) fluids (see also 
p.176). The mean, standard, deviation, and range of each constituent 
is given for each type, together with the normal ranges for human milk 
and serum. Of the twelve parameters, seven showed a statistically 
significant (p<0.05) difference between the pure- and serum-type fluids 
using the Paired t-Test. With two exceptions, the serum-type had 
levels of these seven parameters closer to, but not necessarily within, 
the normal serum range, than the levels in the pure-type. The 
exceptions are SGOT, which is within normal serum range in both types, 
and bilirubin, which is above the normal range in serum-types. It 
must be emphasised that these are comparisons of the means for each 
variable to a normal range. The range of values of most of these 
variables in BCF is very large.
Total protein values are low relative to serum, but comparable 
with milk, as are the levels of albumin, especially in the pure-type 
fluids.
Calcium is found in the serum-types to be generally within the
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normal serum range, whereas in pure-types the level is lower. Both 
types have very low calcium levels relative to milk. The same applies 
to inorganic phosphate.
Urea is low in both groups relative to serum, but within the 
range for milk; with creatinine the reverse is the case. For both 
types bilirubin is within normal serum range, although it is higher in 
the serum-types.
Alkaline phosphatase is high relative to serum in the pure-types, 
but within serum range for serum-types.
SGPT is at the lower end, and SGOT at the upper end, of normal 
serum range in both types.
Cholesterol and uric acid both had levels well above the serum 
range in most fluids - especially cholesterol, with levels up to 
1900 mg/dl.
4.1.1 Correlation of variables
Coefficients of correlation were calculated between all pairs 
from the 12 variables in each fluid, and these are shown in Table 7.
They are all correlation coefficients on a linear regression; various 
transformations (e.g. logarithmic) made no improvement to the results. 
Despite the low values of most of the coefficients, many are statistically 
significant, several at p<0.001.
The twelve variables were also compared with values assigned to 
each fluid from a visual assessment of its darkness of colour and degree 
of turbidity ("milkiness"). Attempts were made to measure the colour 
spectrophotometrically, but this was subject to interference due to the 
turbidity. This latter was measured in ten fluids using a nephelometer. 
Results were very variable and greatly increased if the fluid had been 
frozen and thawed (although this increase was remarkably constant at
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60 to 65% of the original value). Therefore the visual estimation, 
being in addition much easier, was used. The correlation coefficients 
are given in Table 8.
They show that as colour depth increases, BUN, water and bilirubin 
levels rise. Cholesterol is strongly and positively associated with 
"milkiness”, but all other variables are negatively related.
Serum from breast cyst patients was found to have no deviation 
of any of the 12 variables from their normal serum ranges. It was 
noticed that the levels of cholesterol tended to be at the upper end 
of the normal range.
4.2 TOTAL PROTEIN
The manual estimates of protein were found to agree well with 
those from the AutoAnalyzer. However, they were consistently 5 to 
10% higher, for serum as well as BCF, probably reflecting the difference 
in the two techniques used.
4.3 CHOLESTEROL
Cholesterol estimations also gave results which agreed well 
with those from the AutoAnalyzer for BCF and serum. In most cases, 
the BCF levels were above the range for the AutoAnalyzer, and the manual 
method was used for these fluids.
The cholesterol in BCF was found to be mainly in the particle- 
fraction (see Section on ’'Centrifugation” in Results). In some 
samples of BCF, small crystals were seen floating on the surface of the 
fluid. When examined by light microscopy, they had the characteristic 
form of cholesterol crystals (Documents Geigy), and are illustrated in 
Fig. 46.
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TABLE 8
Correlations of cyst fluid 12/60 results with colour and milkiness
Colour Milkiness
T.P. 0.252 -0.12
Albumin 0.19 -0.08
Calcium 0.20 3 0.02
Phosphate 0.04 -0.11
Cholesterol -0.15 0.491
BUN 0.331 -0.223
Urate 0.242 -0.19
Creatinine 0.12 -0.272
Bilirubin 0.242 -0.19
Alkaline Phosphatase 0.213 -0.371
SGPT 0.282 -0.451
SGOT -0.06 -0.12
Statistical significance 1 p< 0.001
2 "  0.01 
3 " 0.05
The remainder are not significant.
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Fig.
. . H-
46 Unstained smear of BCF, showing crystals with the
characteristic appearance of cholesterol crystals
2 1 2
4.4 TRIGLYCERIDES
No triglyceride was detectable in the twenty samples of BCF on 
which the estimation was performed. If the fluid was centrifuged, no 
fat layer was formed at the surface, as happens with milk.
4.5 PHOSPHOLIPIDS
The results of phospholipid estimations on BCF, and serum controls, 
are given in Table 9. The values for BCF were very variable, with a 
range from 4.0 to 16.1 mg P/dl.
Attempts were made to separate the phospholipids by the method 
of Parsons and Patton (1967), using two-dimensional thin-layer 
chromatography on silica gel HR. The results were not very good, giving 
only two phosphate-containing components, and the assay was abandoned.
4.6 NUCLEIC ACIDS
Neither DNA nor RNA were detected in the assay on BCF. Two 
series of assays were run, with ten fluids in each. That the method
was working adequately was shown by the results of the standards, and 
a control using homogenised leucocytes.
4.7 LACTOSE
Lactose was not detected in twenty samples of BCF. Human 
skimmed-milk was found to contain roughly 2.5 g/dl. The test was 
performed in order to determine whether any synthetic activity, 
comparable to that in milk production, was occurring in breast cysts.
4.8 URIC ACID
A manual method for the assay of uric acid was used to verify 
the AutoAnalyzer results and to obtain values for the levels in those
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TABLE 9 Phospholipid content of BCF and serum
Phospholipid (as mgP/dl)
BCF 7.20 (4.0)
Serum 10.25 (1.6)
Values are means, with standard deviation in parentheses
TABLE 10 Ion levels in BCF
Mean Standard deviation 
Sodium 95.0 (32.0)
Potassium 16.0 (14.2)
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BCF samples which were off-scale on the instrument.
The heating step modification to the method (see p.105) was 
validated using sera. It was found to have no effect on the results. 
In addition, two UM2 membrane ultrafiltrates of BCF were assayed, 
since they have the interfering proteins removed, and could therefore 
be assayed without the heating step. No effect on the results was 
observed in the heated specimens, and the levels found were very near 
to those in the corresponding BCF (without ultrafiltration) by the 
heating method.
The assay was therefore used to determine uric acid levels in 
those fluids which were off-scale in the AutoAnalyzer, and the results 
are amongst those in Table 3.
4.9 INORGANIC IONS
The mean, standard deviation, and range of values obtained for 
sodium and potassium levels in BCF are given in Table 10, together with 
the normal values for human milk, serum, and whole blood.
The values for potassium were frequently very high relative to 
serum and milk, and of the order of levels in whole blood. Sodium 
is low relative to serum, but generally higher than in milk. Neither 
ion could be correlated with other factors, but they are negatively 
related (p<0.01) to each other (correlation coefficient - -0.67).
The serum-type fluids tended to have potassium levels in the normal 
serum range, but still had low sodium.
The values for calcium are in Table 6.
4.10 CARCINO-EMBRYONIC ANTIGEN
The assay was made, following a report of the presence of
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CEA-like material in BCF (Fleisher et al., 1974), to confirm the 
finding in the BCF material used in this study.
The results of twenty assays on BCF are presented in Table 11. 
The levels are high in all the samples, compared with serum. Two
cysts, aspirated on different occasions from the same patient, 
showed similar values.
4.11 HORMONAL STEROIDS
The levels of four steroids assayed in BCF are shown in Table 12. 
They are mostly around the range found in serum, with two notable 
exceptions. These are both very high levels of 5 a-dihydrotestosterone 
and are from cysts of patients who both subsequently had mastectomies 
for carcinoma of the breast. Unfortunately, serum was not obtained 
in either case at the time of aspiration of the cysts, but a blood 
sample obtained 3 months post-operatively from one patient, showed no 
elevation of DHT.
The oestrogen and progesterone assays of serum and 24 hour 
urine samples were made in an attempt to check the frequently suggested 
hypothesis that hormonal irregularities were involved in the aetiology 
of cystic disease (see p. 28). They showed the same patterns in 
both the breast cyst patients and the controls. Both groups fell 
into the normal range of serum levels and excretion rates for women 
of the appropriate menstrual status.
The prolactin levels in BCF were very low, and in the sera 
were within the normal range.
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TABLE 11 Levels 6f dafcinoeiflbryOiiic antigen in BCF.
34
38
57
61*
79*
86
88
122
128
140
190
192
280
339
510
560
570
630
720 I If a normal distribution,
Mean = 254 j
I f
Population standard deviation = 228 ;
| ' I
Pooled plasma level = 12 )ig/ml
♦Same patient; the two were cysts aspirated on different occasions.
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TABLE 12 Steroid concentration in pure-type BCF specimens
5 Androstene- DcHydro- Testosterone Oestradiol
diode testosterone • ------------  -----------
0.81 178 -f 35
2.89 193 -f 94
1.10 90 86 57
0.83 106 116 13
0.69 123 83 19
1.26 332 386 25
0.64 259 146 7
1.03 82 89 46
3.76 158 239 26
1.79 130 162 10
0.40 1354 289 49
0.70 170 194 0
1680
* patient subsequently presented with carcinoma of the breast. 
+ no assay performed.
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5 ENZYME ASSAYS 
The objectives of the enzyme assays were two-fold. They were, 
firstly to obtain data on the levels of some enzymes in BCF, especially 
in relation to milk and blood serum, and secondly to use results of 
marker-enzyme assays in the examination of the particle-fraction of 
BCF (see "Centrifugation Methods", in Results).
In the estimations of phosphate-releasing enzymes, considerable 
problems were experienced in the assay of phosphate. A novel method 
of protein precipitation was developed in order to overcome the problem.
5.1 VALIDATION OF PHOSPHATE ASSAY
The maximum absorbance of a standard phosphate solution in the 
phosphate assay was found to be achieved with acid concentrations, in 
the solution to be assayed, of between 2 and 10% for TCA, and 1 and 
5% for PCA. Outside these ranges the colour production fell off
markedly, mostly with PCA above 5%. The absorbance increased
')
considerably if left for a further 30 minutes; on average by 65%
The time curve of absorbance, using optimum acid concentrations, 
showed that colour development continued beyond 60 minutes, but at a 
lower rate and reaching a maximum after 2.5 to 3 hours. Although a 
further rise in absorbance was found after 3 hours, this was matched 
by an increase in absorbance of the blank. With no acid in the 
solution to be assayed, the absorbance continued to rise rapidly 
beyond 3 hours. It was decided to continue to use the normal 30 
minutes incubation time for the assay, but to take extreme care to 
perform the absorbance measurement after exactly 30 minutes.
The best precipitation of BCF protein was found to be given by 
1 to 2% CAB, 4% TCA, or 1 to 3% PCA. However, the addition of assay
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reagents resulted in further protein precipitation. The precipitate 
also absorbed the blue-coloured reaction product and thus spoiled the 
assays. The CAB was also precipitated by the phosphate reagent, and 
was therefore discarded as a protein precipitant.
Further tests showed that different BCF samples had different 
optimum acid concentrations for protein precipitation. Mixtures of 
TCA and PCA were not effective; neither were ethanol or methanol, or 
a mixture of the two (1:1), in concentrations up to 20% with 4% TCA. 
Filtration was moderately effective, but time-consuming, expensive, 
and frustrating, since the Millipore filters were inclined to block 
halfway through a filtration.
Heating of the acidified solutions was found to be the answer. 
With 4% TCA, heating in a boiling water bath gave the best results.
The minimum time was 1 minute. When the solutions were cooled, 
centrifuged, and the supernatants assayed for phosphate, repeatable 
and accurate results were obtained.
5.2 5*-NUCLEOTIDASE .
The results obtained for the assays of 5'-nucleotidase are 
given in Table 13. A wide variation of levels was found in BCF.
The highest was 98.5 mlU/ml, the lowest 1.0 mlU/ml. Values for serum 
from the cyst patients were found to lie mostly in the upper region 
of the normal serum range of 3.5 to 11 mlU/ml, with a mean, from 
20 assays, of 9.5 mlU/ml (standard deviation, 1.2). The values 
for BCF did not correlate with other variables. The enzyme is a 
marker for plasma membrane, and was used as such in the studies of 
the particle-fraction of BCF (see "Centrifugation Methods", in 
Results).
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TABLE 13 5*-Nucleotidase levels in BCF and serum of cyst patients
Activity (mlU/ml)
Mean Standard deviation
BCF 27.6 29.5
Serum 9.5 1.2
TABLE 14
BCF 1
Validation of 5*-nucleotidase assay - effect of 
incubation time
Phosphate-assay Method
30 mins 60 mins 90 mins 120mins
4.8
4.6
4.7
4.5
4.1
4.1
3.7
3.8
Adenosine deaminase 
method (60 mins)
4.8
BCF 2 1.0 0.9 0.8 0.6 0.9
BCF 3 5.8
5.7
5.9
5.7
5.3
5.5
5.0
5.1
5.8
Serum 3.0
3.1
3.0
3.2
2.9
3.1
2.9
3.0
3.3
All values are mlU/ml, and each specimen (except BCF2) was 
assayed in duplicate on two occasions.
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The two enzyme assay methods were found to give excellent 
agreement of results. In solutions containing sucrose, the Persijn 
and van der Slik (1968) method failed to work. Tests, adding varying 
amount of sucrose to 1 ml of ammonia standard (2 ]il of conc. ammonia 
solution in 100 ml of water), followed by the colour reagents, showed 
sucrose to have no effect on colour development. Since 5*-nucleotidase 
is not complete inhibited by sucrose, the effect must be on adenosine 
deaminase.
5.2.1 5’-Nucleotidase assay - validation
The results of the assay validation experiment, using the 
phosphate-estimating method, are given in Table 14, together with 
values obtained by the adenosine deaminase method. After 60 minutes 
the activity of the enzyme fell, but at 30 and 60 minutes the same 
results for activity were obtained. It was noticed that the fall in 
activity was less marked with serum samples. The assay also gave 
good repeatability when re-run, and good agreement with the adenosine 
deaminase method. The heating step did not affect the substrate, as 
the heated and unheated reagent blanks both had the same absorbance.
5.2.2 Stability of 5*-nucleotidase
The levels of 5’-nucleotidase in 2 BCFs after storage for 8 or
15 days at 4°C and -20°C, and freeze-thawing, are given JLn Table 15.
These show that the enzyme is very stable when stored at 4°C, but 
slightly less so at -20°C. The freezing and thawing resulted in little 
loss of activity in both fluids tested.
5.3 ACID PHOSPHATASE
The activity of acid phosphatase in BCF is given in Table 16.
The assay results for the p-nitrophenol—releasing method are not very
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TABLE 15 Effect of time and method of storage on 5f-nucleotidase
in BCF
Storage 1 day 8 days 15 days
BCF 1 4°C 5.7 - 5.6
-20°C - 5.4
Freeze-thawed - 5.3
BCF 2 4°C 51.0 51.4
-20°C 45.9
Freeze-thawed 49.8
All activities are in mlU/ml
TABLE 16 Levels Of acid phosphatase in BCF and sera from
cyst patients
Mean Standard Deviation 
BCF 5.5 6.8
Serum 7.3 2.5
All activities are in mlU/ml
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revealing as to enzyme source, as discussed by Jacques . (1974), since 
several phosphatases will break down the substrate under acid conditions. 
The assay was therefore discontinued, but the results show generally 
low activity - mostly within the serum range - with occasional fluids 
having somewhat higher levels. The sera from cyst patients all had 
levels at the upper end of normal range.
5.4 ALKALINE PHOSPHATASE
The activity of this enzyme in BCF, estimated by AutoAnalyzer,
is given in Table 6. The results of the manual assay, using
p-nitrophenyl phosphate as substrate, gave good agreement with the
AutoAnalyzer results. The levels in sera from cyst patients were
within normal serum range.
5.5 CATHEPSIN D
This enzyme was assayed in order to determine whether lysosomal 
enzymes were present, and also to see if proteolysis could be occurring 
in BCF in vitro.
The enzyme was found to be present in BCF. Activity was 
measured as increase in absorbance obtained in one hour by 1 ml of 
sample. The levels in BCF were found to be low, with values from 
0.05 to 0.70 units for most fluids, one exception being a value of 
1.33 units.
5.5.1 Validation Of assay
The heating method (see p.118) was found to give identical 
results to that using Millipore filtration, and was therefore adopted 
for all assays. The heating method gave slightly lower absorbance 
values for all the solutions, but the differences between tests and
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blanks were unaffected.
The results of the time curve assay are given in Table 17. The 
reaction was found to be linear only up to one hour. For the three­
fold concentrated pool of 3 BCFs, the activity was 1.45 units.
5.5.2 Stability and activation Of cdthepSin D
The results for the assay of cathepsin D on BCF stored at 4°C 
or -20°C and for freeze-thawed BCF are given in Table 18. The activity 
was largely unaffected by storage up to two weeks at either 4°C or 
-20°C. Freeze-thawing had no activating effect on the enzyme activity, 
suggesting that it was not present in intact lysosomes in the fluid.
The process caused a slight reduction in activity, presumably due to 
denaturation of the enzyme. The apparent rise in activity of one 
sample over a period of one week is difficult to account for, but is 
probably experimental error rather than real.
5.6 AMYLASE
No activity of amylase was detected in twenty BCF samples.
The method was working, as shown by the activity which was obtained 
in saliva samples used as positive controls. This result contradicts 
the report of Bonser et aJ. (1961) that BCF is rich in amylase. The
assay was made in order to confirm this unsubstantiated claim.
5.7 XANTHINE OXIDASE
It seemed unlikely that the high levels of uric acid in BCF 
(see p. 208) could be derived from serum. However, if it was formed 
in the cyst, xanthine oxidase would be required; the fluid was therefore 
tested for the presence of the enzyme.
No activity was demonstrated in ten BCFs which were assayed for
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TABLE 17 Time curve for cathepsiil P assay
Time (mins) Absorbance Activity (AE/ml/hr)
TABLE
BCF 1
BCF 2
30 0.73 1.46
60 1.45 1.45
90 1.64 1.09
120 1.78 0.90
180 1.89 0.63
240 2.01 0.50
18 Effects of storage and freeze-thawing on activity
of cathepsin D 
1 day 8 days 15 days
stored 4°C - 0.49 0.94
stored -20°C - 0.55 0.94
freeze-thawed - 0.55 0.80
stored 4°C 1.33 1.33
stored -20°C 1.31 1.33
freeze-thawed 1.20 1.16
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xanthine oxidase, nor in two samples of human skimmed-milk.
5.8 LACTOPEROXIDASE
Again no activity of the enzyme was found in BCF. Some activity 
was found in controls (human skimmed-milk). The aim of making the 
assay was to compare BCF with milk, which is rich in the enzyme, and 
also to determine whether the anti-microbial system involving 
lactoperoxidase (Oram & Reiter, 1966), could be operating in breast 
cysts.
5.9 AUTOANALYZER
The results for the assay of alkaline phosphatase, SGOT, and 
SGPT, by the SMA 12/60 AutoAnalyzer, are given in Table 6 and on pages 
206 and 208).
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6 CENTRIFUGATION METHODS 
The centrifugal-separation studies were made in order to 
investigate the "milkiness" of BCF. The hypothesis that this may be 
due to membranes, derived from the ’pink’ cells lining the cyst, was 
tested by the assay of marker enzymes.
6.1 HIGH-SPEED CENTRIFUGATION
The method was used for many BCFs, to attempt to separate out 
the ’'milky" material (i.e. "particle-fraction). It was found to be 
rather unsuccessful with most specimens, but some had a partial 
separation yielding a clear layer (i.e. "fluid-fractipn") and a cloudy 
layer (not pure particles, but a particle-enriched fluid-fraction). 
These two fractions were assayed for cholesterol, which was found to be 
highly concentrated in the cloudy layer. Assays were then made for 
5’-nucleotidase and cathepsin D, to determine whether the cloudiness 
could be due to cell membranes, and whether lysosomes were present.
Three BCF samples which gave reasonable separations were used, 
and the assay results are given below. The cloudy fraction was at the 
top of 2 samples, and at the bottom in the other.
6.1.1 5 *-Nucleotidase
The results of the 5 ’-nucleotidase assay are in Table 19.
They show that in two of the BCFs, the enzyme was concentrated in the 
fraction containing the particles. In the third, the majority was 
in the fluid-fraction. The adenosine-deaminase method was used for
the assay.
6.1.2 Cathepsin D
The results (see Table 19) showed the activity to be associated 
with the particle-enriched fraction, with hone in the fluid fraction,
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TABT.F. 19 Analysis of particle-enriched fraction and clear fluid
obtained by centrifugal separation
5 ’-Nucleotidase Cathepsin D Cholesterol 
(mlU/ml) (AE/ml/hr) (mg/ml)
BCF sample 1
Particle-enriched (top) 17.6 0.67 4.62
Clear fluid (bottom) 2.1 0 1.38
BCF sample 2
Particle-enriched (top) 29.5 0.11 3.81
Clear fluid (bottom) 74.4 0 2.17
BCF sample 3
Particle-enriched (bottom) 221 0 4.20
Clear fluid (top) 4.7 0.38 1.16
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in two samples. The third sample gave exactly the opposite result.
6.1.3 Cholesterol
The majority of the cholesterol was also found to be associated 
with the particle-enriched fraction (see Table 19).
Since the particle-fraction was not completely separated from 
the clear fluid, results for this fraction also contain a contribution 
from the clear fluid.
6.2 FLOTATION METHOD
This technique was used to obtain a complete separation of the 
particle-fraction from the fluid-fraction. It was found that the 
sodium bromide inhibited 5'-nucleotidase completely, and also 
interfered with cholesterol assay. The fractions were therefore 
dialysed in an Amicon ultrafiltration cell, in the diafiltration mode, 
against 0.1M tris buffer, pH 8.0.
The particles in the BCF were found to float on top of the 
overlay solution, leaving the clear fluid-fraction beneath. The 
particles had a white or off-white colour; the fluid fraction was 
clear and of the same colour as the whole BCF, from which it was 
prepared. The upper layer, consisting of overlay solution and 
particles, was removed using a Pasteur pipette, and then made up to 
5 ml. This then gave the particles in a volume equal to that of the 
original BCF sample from which they derived. Analyses for 5 ’-nucleotidase, 
cathepsin D, and cholesterol were then made, as before, in order to 
determine whether they could be found in the particles which were 
completely (rather than partially, as above) separated from the fluid
fraction. The e.m. appearance of the particles is shown in Fig.27. j
6.2.1 5 *-Nucleotidase
The levels of the enzyme in the dialysed fractions and the
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original whole fluid (unseparated BCF) are given in Table 20. The
*
majority of the activity was lost, and was not regained during dialysis. 
In two BCFs which had some remaining activity, it was greater in the 
particle-fraction than the fluid fraction. This may be because the 
activity in the particles is more stable than that in the fluid- 
fraction. But it does serve to demonstrate that there is activity in 
the particles.
6.2.2 Cathepsin D
Cathepsin D was assayed in order to determine whether the 
activity found in the partially purified particles (see above) was 
found in the completely separated particle-fraction.
The assay results are also in Table 20, and show the majority 
of the enzyme to be in the fluid-fraction in all cases, but some 
activity is seen in the particles.
6.2.3 Cholesterol
The levels of free and esterified cholesterol in both fractions, 
as well as total cholesterol level, were assayed this time. This 
was done in order to see whether the cholesterol composition was the 
same as that in milk (see p. 14), and whether that in the particle- 
fraction could be membrane-derived.
Both the free and esterified cholesterol levels for the 
fractions are given in Table 21. The extraction method was used, 
and was found to give recoveries of 85 to 90%.
The particles were found to contain the majority of the 
cholesterol in BCF; from 7 to 31% was in the fluid-fraction. Of the
cholesterol, in the whole fluid from 90 to 97% was in the free form, 
in the particle-fraction from 86 to 92%. The estimation of free 
cholesterol was checked by assaying a control serum, for which a free
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♦ I
presumably due to inactivation by the sodium bromide
TABLE 20 Activity of 5'-nucleotidase and cathepsin D in
particle- Arid fluid-fraCtioriS of BCF, separated 
by flotation.
5*-Nucleotidase (mlU/ml) Cathepsin D(AE/ml/hr)
Particle-
fraction
Fluid- 
fraction
Whole
fluid
Particle-
fraction
Fluid- 
fraction
Whole
fluid
BCF sample 1 0 0 16.0 0.02 0.10 0.11
2 0 0 12.0 0.08 0.11 0.26
3 1.0 0 6.4 0.33 0.88 1.20
4 1.8 0.3 16.2 0.16 0.36 0.56
TABLE 21 Levels of free and esterified cholesterol in particle-
and fluid-fractions of BCF.
Whole fluid Particle-fraction Fluid-fraction
Total Free %Free Total Free %Free Total
1 3.22 3.11 (97) 3.22 2.78 (86) 0.42
2 7.18 _* (-) 4.95 4.48 (91) 2.22
3 3.88 3.62 (93) 3.31 3.03 (92) 0.39
4 2.97 2.68 (90) 2.81 2.50 (89) 0.22
All values mg/ml 
♦Assay spoiled.
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value of 30% of total was obtained, the supplier’s quoted value for 
which was 35%
6.3 DENSITY GRADIENT CENTRIFUGATION
Since the use of sodium bromide, in the flotation method (see 
above), spoiled some assays, an alternative medium was selected.
Sucrose was chosen, since it is commonly used for this purpose, and 
its properties for such use are well-documented. It was also decided 
that a density gradient should be used, as this would allow the density 
of the particles to be determined, as well as to show any distribution 
of the assayed components within the particle-fraction. The particles 
had been shown to float on most BCF specimens when centrifuged at 
high speed, and so the specimens had to be made denser than the gradient 
and layered under it, rather than simply applied to the top of the 
gradient.
Results of the analyses to estimate protein, cholesterol and 
5’-nucleotidase in the fractions from the first two density gradient 
separations of 6 BCFs are presented graphically in Figures 48 and 49.
The light-scattering of the gradient during pump-out (measured as 
absorbance at 600 nm) for Run 1 is shown in Fig. 47. The assays of 
the protein and cholesterol of plasma and milk separations are in 
Figure 51. The density gradient separation of a large concentrated 
BCF sample was assayed for cholesterol, protein, 5'-nucleotidase, Na*
•f
K - dependent ATPase, acid and alkaline phosphodiesterases, glucose- 
6-phosphatase, and succinate dehydrogenase. The results for these 
assays are tabulated in Table 22, and are shown graphically in
Figure 50. In all cases, fraction 1 is the light end of the gradient.
6.3.1 Breast cyst fluids
In all samples the fluids showed a separation into two major
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Fig. 47 Absorbance at 600 nm of the gradients of BCF separations,
Run No. 1. Three different fluids were centrifuged, and 
are designated A, B and C (also in Fig. 48). Fraction No. 1. 
is the light end of the gradient in all cases (also in 
Figs. 48 to 51).
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Fig. 48 Assay of 5’-nucleotidase (A-A), cholesterol (-- ),
and protein (o—o) in BCF separated by density gradient 
centrifugation. Run No. 1. For explanation of A, B
and C, see legend to Fig. 47. Protein (Prot.) and
cholesterol (Choi.) are in mg/ml, 5 '-nucleotidase 
(5'-Nuc.) is in mlU/ml.
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Fig. 49 Assay of 51-nucleotidase (A—A) , cholesterol (---), and
protein (o—o) in BCF separated by density gradient 
centrifugation. Run No. 2. The three BCF samples 
were different from those used in run No. 1, and are 
designated D, E and F. Units are as in legend to Fig. 48.
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components; a particle-fraction and a fluid-fraction. The latter
remained at the bottom of the gradient as a clear fluid of the same
colour as the original whole BCF, representing the original sample
after removal of the particle-fraction. This was found, after the
separation, to be in the lighter portion of the gradient, and appeared
as a rather diffuse band. On closer examination this was found to
consist of many very narrow, denser bands, of a whitish colour(see also Fig.27}
The fractions of the gradients also showed this separation quite 
clearly, particularly in the cholesterol assays. The major peak of 
cholesterol is in the region corresponding to the particle-fraction 
(fractions 2 to 5 or 6 in Rim 1, and 3 to 10 in Run 2). This fraction 
is shown by a peak in the light scattering curve for the fluids in 
Rim 1 (Fig. 47), and could also be seen as milkiness in the fractions 
of the gradient.
The assays reveal the majority of the protein to be in the 
fluid-fraction, with only trace amounts in the particle fraction, 
making, nonetheless, a distinct peak. In most separations this peak 
can be seen to lag behind the cholesterol peak, suggesting the 
particles at the denser end of the peak had a somewhat higher protein 
content than those at the lighter end.
The same phenomenon can also be seen with 5'-nucleotidase 
distribution. There is a peak of activity, in most cases, at the 
denser end of the particle-fraction. However, the enzyme assays were 
slightly suspect owing to low levels of activity, and for this reason 
a run was made using a large sample of BCF, concentrated to boost the 
enzyme levels.
The results for the large sample (Fig. 50) are rather clearer, 
but do not conflict with those of the first two runs. The sample was
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Fig. 50 Assay of protein, cholesterol, and enzymes in a concentrated 
large sample of BCF, separated by density gradient 
centrifugation (see also Table 22). The enzymes are 
5'-nucleotidase (5’-Nuc.), ATPase, glucose-6-phosphatase 
(G-6-Pase), acid phosphodiesterase (Acid P ’d ’ase), and 
alkaline phosphodiesterase (Aik.P’d’ase). Protein (Prot.)
and cholesterol (Choi.) are in mg/ml, all enzymes in mlU/ml,
and fraction density (Dens.) is in g/ml.
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TABLE 22 (continued)
5'-Nucleotidase 65%
Glucose-6-phosphatase 50%
ATPase 41%
Acid phosphodiesterase 28%
Alkaline
phosphodiesterase 67%
(from Hartman et^  ail. , 1974)
240
run in three tubes, as for the previous individual samples, but the 
corresponding fractions from all tubes were pooled, after checking 
that each of the triplicates had nearly identical refractive indices. 
Thus, three times the usual volume of each gradient fraction was 
obtained, allowing a greater range of assays to be performed.
The cholesterol peak in the particle-fraction appeared in 
fractions 3 to 10, corresponding to a density range of 1.04 to 1.14, with 
a maximum at density 1.10. Again, the corresponding slight peak of 
protein was at the denser end of the cholesterol peak, with a 
maximum at density 1.12. The majority of the protein was in the fluid- 
fraction.
The p.m. marker enzymes, 5'-nucleotidase and ATPase, both show 
peaks at a higher density than the cholesterol peak, at density 1.14 
to 1.16 and 1.13 to 1.14 respectively. The majority of both enzymes, 
however, is in the fluid-fraction.
Glucose-6-phosphatase (in liver a marker for e.r. membranes - see 
also p.252) showed a rather random distribution, which casts some doubt 
on the validity of the results, but has a peak at a lower density 
(about 1.11) in the particle fraction than the enzymes mentioned above. 
Again, the majority of the activity is in the fluid-fraction.
Acid and alkaline phosphodiesterase (a lysosomal and a p.m. 
marker, respectively) had a remarkably similar distribution pattern, 
with a peak corresponding exactly with that of cholesterol, and a 
slightly larger peak in the fluid-fraction. The similarity of the 
distribution of the two enzymes suggests the possibility that the 
activity is due to one enzyme (possibly the acid phosphodiesterase) 
operating at both pH values, rather than both enzymes being present.
If this were the case, it would explain why alkaline phosphodiesterase
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does not have a peak at a density corresponding to that of the.other 
p.m. markers, since the activity would be due to acid phosphodiesterase. 
The acid phosphodiesterase would suggest that disrupted or altered 
lysosomes are present in the particle-fraction (not intact lysosomes, 
since no activation of lysosomal enzymes could be obtained by freeze- 
thawing BCF) .
An alternative explanation is that both acid and alkaline 
phosphodiesterase are present, and have a very similar distribution 
in the gradient fractions. Unfortunately, insufficient sample 
remained to test whether alkaline phosphodiesterase was present by 
means of assays incorporating inhibitors specific for this enzyme 
(e.g. EDTA).
Succinate dehydrogenase was not detected in the whole fluid 
sample and was therefore not assayed in the fractions. The assay 
technique was verified by using controls of roughly homogenised 
mammary gland tissues, which gave a positive reaction.
6.3.2 Milk
The milk and blood plasma specimens were run as controls, to 
compare with the results for BCF. The aim.was mainly to see whether 
or not a particle-fraction was present in either milk or plasma.
Both human skimmed-milk samples showed the entire protein 
content to be in the fluid-fraction (Fig. 51), with the exception of 
a small peak at the top of the gradient in sample B. This was due to 
protein in a small amount of cream, which had been left in the sample 
due to inefficient skimming. It was floating on top of the gradient, 
and "tailed” considerably during pumping-out, and therefore appears 
in fractions 2 and 3.
Cholesterol showed a very varied and erratic distribution, but
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Fig. 51 Assay of Protein (o-o), and cholesterol (---) in two
samples of human skimmed milk and one sample of plasma, 
separated by density gradient centrifugation. Samples 
A and B are skimmed milk, sample C is plasma. Both 
protein (Prot.) and cholesterol (Choi.) are in mg/ml.
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was present in very low concentration. There was no cholesterol peak 
like that found in BCF runs due to the particle-fraction.
No 5'-nucleotidase assays were made, since the enzyme was not 
detectable in the starting material used for the separations.
6.3.3 Blood plasma
The plasma sample also showed no cholesterol peak like that of 
BCF, and nearly all the protein was in the fluid-fraction (Fig. 51). 
The results for 5'-nucleotidase assay were discarded as unreliable, 
due to the very low levels of activity. The sample concentration 
was 3.1 mlU/ml.
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D I S C U S S I O N  
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D I S C U S S I O N
1. PATIENT DATA
The patient data show that the group from which BCF was obtained 
for this study was the same age range as that found by other workers 
(Haagensen, 1971; Bonser, et al., 1961). The majority of patients are 
in the age range of 40 to 50 years, and are perimenopausal.
Parity and previous history of breast feeding seem to have no 
influence on production of cysts, but in the younger women, cysts tend 
to be post-lactational.
The size of cysts and the colour and milkiness of their contents 
was found to be very variable. It was originally felt that the depth 
of colour of BCF may increase with age. However, if this is the case, 
and some evidence has been obtained for it, then age is not related to 
cyst volume, since there is very little gradation of increasing colour 
with increasing volume. Therefore, it may perhaps be that all cysts 
do not continuously enlarge, but some may reach a finite size, where 
intra-cyst pressure prevents further secretion. This suppression of 
the secretory process due to alveolar distension is known to occur in 
lactation (Cowie & Tindal, 1971).
2. PROTEINS
The electrophoretic pattern of pure-type BCF proteins is unlike 
that of any other body fluid. It bears some resemblance to that of 
mature human milk, in that the latter has almost no y-rglobulin.
However, BCF has no discrete bands, unlike milk.
It is possible that the pure-type BCF electrophoretic pattern 
resembles that of apocrine skin gland secretion but, owing to the 
difficulty of collecting the latter in pure form, this has not been 
tested.
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The number of proteins present in the pure-type BCF varies with 
the separation method used. The best resolution was obtained with 
iso-electric focussing, which revealed at least 14 . components in such 
fluids. SDS-acrylamide-gel electrophoresis showed somewhat fewer bands. 
Some of these represent plasma proteins present in very low concentrations. 
It is also possible that some are sub-units of proteins, particularly 
in the mercaptoethanol-treated samples which are used in SDS-acrylamide- 
gel electrophoresis. If proteolysis is occurring then it is possible 
that some of the components are large peptides produced from larger 
proteins. At least one proteolytic enzyme, cathepsin D, is present 
in aspirated BCF. The pH of the fluids was found, using narrow-range 
pH papers, to be from 6 to 10 (with a mean of 7.8, and a standard 
deviation of 1.4), and this is outside the optimum pH range for 
activity of cathepsin D, which Barrett (1972) gives as being 3.0 to 
3.5. Therefore, proteolysis by this enzyme is almost certainly not 
occurring in vitro, and unless the pH changes markedly after aspiration, 
neither does it occur in vivo. However, the presence of one lysosomal 
protease suggests that others may be present, and some of them have 
optimum pH values much closer to the pH range of BCF (Barrett, 1972).
The BCF-protein molecular weights estimated by SDS-gel 
electrophoresis are in the same range as the values found in BCF by 
Pearlman eit a!L. (1973), employing the same method; however, they found 
fewer bands.
The proteins of BCF appear to be mainly glycoproteins, as 
suggested by PAS staining, their low pi values, and difficulty in 
precipitating them with perchloric acid. At least some of these 
proteins are precipitated by Cetrimide (cetyltrimethylammonium 
bromide) which is a known precipitant of some polysaccharides
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(Havez et'al., 1971) and glycoproteins.
The only milk protein found in BCF was lactoferrin and this is 
not specific to milk, being found in other fluids including bronchial 
secretions, saliva, bile, semen and polymorphonuclear leucocytes 
(Masson et al., 1969). With Immunoelectrophoresis, the BCF lactoferrin 
was found to have a higher mobility than that in milk. In bovine 
milk, lactoferrin is reported (Hekman, 1971) to have a lower electro­
phoretic mobility than the pure protein due to binding to other proteins. 
Thus, if the same phenomenon occurs with human lactoferrin then BCF 
lactoferrin may either be bound to a different protein from that in 
milk, or be in unbound form.
The source of lactoferrin in BCF is not known. Since at least 
some polymorphonuclear leucocytes are often found in the fluids, it is 
possible that the protein originates from them. •
The occurrence of some serum proteins in BCF, at very low levels, 
was shown by the presence of corresponding antibodies in anti-(BCF).
These could be removed from the antiserum by adding plasma proteins.
Not all serum proteins are present, and assuming they are derived from 
plasma there must be selective passage of certain proteins across the 
cyst epithelium, or else degradation of some proteins inside the cyst. 
Degradation would seem more likely, the range of serum-type BCF 
electrophoretic patterns suggesting different degrees of proteolysis 
rather than variations of selective passage. However, there is no 
evidence that the serum-types are eventually transformed to pure- 
types (for definition of pure- and serum-types, see p.176). It is 
suggested that they are a different form of cyst, or a cyst which later 
develops an inflammatory reaction, possibly due to damage to the cyst 
wall. In support of this view is the correlation of serum-type
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electrophoretic patterns with the presence of numerous leucocytes in 
the fluid. In addition, Bonser et al. (1961) found,that inflammatory 
reactions can occur in cysts following damage to the cyst wall, leading 
to the entry of polymorphs and lymphocytes. They found this to have 
occurred in 29 of a series of 100 cysts which they examined histologically. 
This proportion is very close to the percentage of BCF specimens which 
are serum-type (24% in the present study, see p.176 and Table 2).
Among the more remarkable features of the pure-type BCF is the 
very low level of immunoglobulins. The reason for their virtual 
absence is uncertain. Either they do not appear in the cyst, or else, 
if present, they are subsequently degraded. The latter explanation 
seems less likely, as one would expect reasonable levels to be present 
if there were a continuing passage of immunoglobulins into the cyst, 
competing with the degradative process. Further, it would be reasonable 
to expect the ratio of IgG to IgA to approximate to that of plasma, as 
this is the most likely source of the immunoglobulins; they differ 
markedly. The absence of other serum proteins in pure-type fluids is 
an additional argument against such a passage.
The predominant immunoglobulin in exocrine secretions, including 
milk (see p. 11), is IgA, and this contrasts with the observation that 
IgG is the major immunoglobulin in 65% of the pure-type fluids 
investigated. Limited immunohistochCmical results using antisera to 
IgG and IgA suggest that there is an absence of immunocytes producing 
these immunoglobulins in cystic areas of breast. This lack of 
immunocytes would explain the lack of secretory IgA, particularly so if 
Brandtzaeg's (1977) model is correct. The evidence thus points to 
the cyst being a somewhat closed system to immunoglobulins from plasma,
the levels being further reduced by the lack of local production.
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Thus, pure-type BCF bears little resemblance to serum. It is 
like mature milk in its lack of cathodically migrating material (i.e.
IgG) on electrophoresis, but it is unlike milk, because it lacks milk 
proteins, triglycerides and lactose, and by its overall electrophoretic 
pattern.
The proteins present are mostly of relatively low molecular 
weight, SDS-acrylamide-gel electrophoresis showing them to be between 
20,000 and 80,000. But in the fluid, some of the proteins may exist 
in aggregated form, since some are excluded from Sephadex G-200 
(molecular weight fractionation range 5,000 to 800,000), although 
these may be adhering to the particulate material of BCF.
3. PARTICLES
The particles in BCF are responsible for the milk appearance 
of the fluid. The whole fluid may be separated into a white-coloured 
particle-fraction and a clear fluid-fraction, that has the same colour 
as the original whole BCF.
The degree of "milkiness" (estimated visually) of BCF is 
inversely related to the levels of most chemical constituents, and 
especially to depth of colour, of the fluids. This would have important 
implications if milkiness was related to the age of the cyst. If 
colour increases with cyst age then so would some chemical constituents, 
whereas the amount of particles (milkiness) would decrease. Obviously 
there is some difficulty in estimating milkiness in the more coloured 
fluids since it is obscured by dark colours, but not enough to 
account for its strong negative association with colour.
The noticeable exception to this general negative association
is cholesterol, which is strongly positively related to milkiness.
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This is to be expected since the particle-fraction also contains the 
majority of the cholesterol of BCF. Hence this constituent would 
decrease with cyst age if colour increased. Whilst this could be 
further evidence for degeneration of cyst contents, it might also be 
that the cholesterol is used in anabolic processes for further cell 
growth or steroid hormone production. Also, if degenerative 
destruction of cells was occurring, the number of particles would 
increase with cyst age, since they are membrane-derived.
There is little doubt that some of the particles are of membranous 
origin. Their appearance in the electron microscope is very suggestive 
of membranes, and indeed is similar to that of the "fluff fraction" of 
bovine skimmed milk (Patton & Jensen, 1976) which is largely plasma 
membrane, including microvilli, of mammary epithelium (see also p. 14).
It is of relevance that most of the milk cholesterol, though at much 
lower levels than in BCF, is in this fraction (Plantz & Patton, 1973) 
and also is almost entirely unesterified, as in BCF particles. The 
particle-fraction of BCF contains membranes from a wide range of 
cellular organelles as judged by their appearance (D. J. Morre, 
personal communication, commenting on the electron micrographs of 
negatively stained particles made in this study. See Fig. 27).
They presumably derive from cells of the cyst epithelium, although in 
some fluids leucocytes may be a further contributory source. It is 
unlikely that connective tissue cells are involved, especially since 
assays for hydroxyproline and proline hydroxylase (kindly performed by 
Dr. C. I. Levene) were negative in three BCF samples.
The significant problem is not whether the particles are 
membranous, but why they arise and how. Their density is of little 
help in answering these two questions, being over a broad range and
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somewhat below the levels of cell membranes in general. This must be 
due to either their gaining less dense, or losing more dense, material. 
The latter possibility seems more likely, and it is suggested that the 
particles are membranes from which some of the protein has been removed, 
leaving an entity with proportionally higher lipid content, which 
thereby still retains its original gross structure. Thus, for 
example, if the membrane was in the form of closed vesicles, the outer 
protein layer of the membrane may be removed, leaving the lipid and 
inner protein layer which can still maintain the structure. The very 
high ratio of cholesterol to protein (from 26:1 to 5:1 in the particles 
of the large-sample density gradient rim) would support such an 
hypothesis. Martel et^  al. (1973) found the value for human MFGM to be 
0.62:1. This hypothesis would also explain the large range of particle 
densities (i.e. from dense, intact membranes, to the protein-depleted, 
and thus lipid-rich, membranes having a lower density) and hence also 
their appearance, after centrifugation of particles in a density 
gradient, as a series of closely packed but discrete bands.
The other possibility for the altered density, the gaining of 
low-density material, could be explained either by a presumably non­
specific adherence of lipid (probably cholesterol), or by the particles 
being secreted cholesterol bounded by membrane. The latter suggestion 
should be investigable by gently rupturing the vesicles and estimating 
cholesterol in the supernatant and the remaining membranes.
The association of Na , K -dependent ATPase and 5'-nucleotidase 
with the particles, as demonstrated in the assays following density 
gradient centrifugation, is further evidence for the presence of plasma 
membrane in that fraction. Both the enzymes are plasma membrane 
markers. However, although Martel-Pradal and Got (1972) found other
_______________________    251_
* ■  ...
It should be noted that although most cell membranes contain cholesterol,
the levels in e.r. are relatively very low or even zero (Thines-Sempoux,1974)
p.m. marker enzymes in human skimmed milk, they only obtained 
5'-nucleotidase activity in the cream (i.e. associated with milk fat 
globule membrane). This suggests that the enzyme is removed from, 
or activated in, the membranes of human skimmed milk. This would 
not seem to be the case with the particles in BCF.
The fact that the peak of activity of both p.m.-marker enzymes 
occurs at the denser end of the BCF particle fraction, as do most of 
the other enzymes, further supports the protein-removal hypothesis.
This region also has a higher protein:cholesterol ratio, and densities 
more appropriate to cell membranes. Therefore, it probably represents 
the more intact membranes, and it is logical that membrane marker 
enzymes should locate there rather than in the less-dense region, since 
the protein-removal hypothesis would suggest that membranes in that 
region have had much of their protein (and therefore most enzymes) 
removed.
Acid and alkaline phosphodiesterases have virtually identical 
distributions, which differ from those of the other enzymes assayed 
in corresponding exactly with the cholesterol peak (i.e. maximal 
activity occurs at a lower density). It is not certain whether or not 
the identical distribution is due to one enzyme acting at both incubation 
pH values. Unfortunately, insufficient material remained to repeat the 
assay with an inhibitor of alkaline phosphodiesterase, such as EDTA, in 
order to resolve this problem. . It is possible that the enzyme(s) may be 
non-specifically binding to the particles; this would account for the 
activity being separated from the peak of activity of the other enzymes.
Although glucose-6-phosphatase is present, its low activity makes 
conclusions uncertain. If the enzyme is a marker for endoplasmic 
reticulum, then the presence of that organelle is suggested. There
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is some doubt as to the presence, or intracellular localisation, of 
glucose-6-phosphatase in tissues other than liver (Reid, 1971), 
where it is a marker for endoplasmic reticulum, though also found 
in Golgi complex (reviewed by Morre e t a l ., 1973). Keenan et al. (1974) 
suggest its activity in rat and bovine mammary gland is too variable
for it to be of any use as a marker. However, Martel-Pradal and
\
Got (1972) claim it to be a marker for this organelle, in their study 
of membranes in skimmed human milk.
Some of the particles bear a strong resemblance to lipoprotein 
secretory vesicles, such as those demonstrated in liver by Glaumann 
et al. (1975). They are best seen in the thin section of material in 
a cyst lumen (Fig. 28), and identical structures are also seen in the 
'pink' cells (Fig. 24). This is further evidence that secretion is 
occurring.
4. CHEMICAL COMPONENTS
It had been hoped that assay of some chemical constituents of
BCF would provide clues to its source. In fact, the results are
rather inconclusive. In part this is due to the wide range of levels 
found for many constituents and the lack of correlations between them.
The values for total protein are low compared with serum.
However, it is somewhat dangerous to compare total protein values 
in two different fluids on an absolute scale, since although the 
methods used are accurate enough, the results are standardised 
using serum protein (or proteins) and, as previously mentioned, the 
pure-type BCF proteins are not at all like those of serum. The 
AutoAnalyzer uses the biuret method, and the results for BCF agree 
well with a manual Lowry procedure, but the absolute values may be 
open to criticism. The same argument is applicable to albumin
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estimation, but for a different reason. The AutoAnalyzer uses a 
well-tried dye-binding technique which is adequate for serum; BCF may 
contain interfering factors which could take up the dye or cause it to 
bind non-specifically to other proteins.
The calcium levels suggest free diffusion of unbound plasma 
calcium only into pure-type cysts, but both the bound and free forms 
into the serum-type. The relatively low levels are another point of 
dissimilarity with milk.
The high levels of cholesterol are largely due to the particles, 
although some remains in the fluid fraction after removal of particles. 
It is occasionally found in the crystalline form, floating on top of 
the fluids.
The high levels of urate are also interesting. If this 
compound is arising from catabolism of purines within the cyst then 
it may be a useful indicator of cyst age, assuming breakdown occurs 
at a consistent rate. It may be of relevance that the levels show 
a moderate positive association with depth of colour. Also, in the 
serum-type fluids the level is much closer to that of serum, suggesting 
restricted access to plasma in pure-type cysts but freer access to 
plasma in the serum-type. It seems unlikely that urate enters the 
pure-type cysts from plasma, since this would require an active 
process to counteract the concentration gradient into the cyst. 
Therefore, it must be produced in the cyst. However xanthine oxidase, 
which would be required for urate production from purines, is 
reported not to be found in human breast tissue although it is 
present in the mammary glands of other mammals. No activity of 
the enzyme could be found in BCF either, but this does not necessarily 
mean it was not present, at some stage, in the fluid or the cells.
In general, it may be said that the mean levels of chemical 
constituents in the serum-type cysts tend to be closer to those of 
serum (especially total protein, albumin, urate and alkaline 
phosphatase) than mean levels of the same constituents in pure-type 
fluids. In these latter fluids, the levels are nearer to those of 
milk. The most noticeable exception is cholesterol, but this is 
present in a rather specialised form relative to that in plasma.
In fact, the mean level in the serum-types is higher than that for 
pure-types; but this may merely be a reflection of the smaller, 
sample number for the former type, or their high content of leucocytes. 
It must also be emphasised that these remarks apply to the mean 
levels, not individual values, which are highly variable for most 
parameters.
The correlations between the chemical components assayed are 
also not very revealing as to the source of BCF. Some of these 
probably arise because the two parameters are both related to a third. 
These, therefore, are chance rather than causal relationships, and 
it is difficult to select them from the rest.
Since the bilirubin in plasma is bound to albumin, their 
correlation in BCF suggests that both originate from blood. Possibly 
the same applies to BUN, which also correlates well with albumin. 
However, the previously mentioned probable impermeability of pure-type 
cysts suggests that the presence of these constituents must be due 
to an active process, rather than passive diffusion. Urate is 
negatively associated with albumin, and this would bear out the 
hypothesis that it is formed in situ and does not originate from 
plasma. Colour is positively correlated with BUN, urate and bilirubin 
and this would dontnstrate, if urate was related to cyst age, that the
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fluid becomes more deeply coloured as the cyst ages. Milkiness is 
negatively associated with BCF colour and thus would decrease with 
age of the cyst.
Ion levels are rather more informative, especially the high 
levels of potassium, as also reported by Fleisher'et'-al. (1973).
Since intracellular potassium concentration is higher than extracellular, 
the conclusion is that the element arises in BCF due to cellular 
breakdown. Therefore, potassium levels should indicate the degree 
of such breakdown and, assuming this occurs at a consistent and 
constant rate, should correlate with other postulated indicators of 
cyst age mentioned above. If this were so it would help in several 
ways: to see if cysts increase in size with age, to help rationalise
the high variability of levels of many chemical constituents of BCF - 
especially enzymes - and to enable determination of which other 
constituents are related to cyst age and whether they increase or 
decrease. Unfortunately, no good correlations were obtained between 
the various parameters and ion levels.
The steroid levels in BCF were unremarkable except for the 
breast cancer patient who had high levels of 5a-dihydrotestosterone 
(DHT) in*a previous breast cyst. Another patient who later developed 
breast carcinoma also had high levels of DHT in previous cysts from 
both breasts. Since the serum DHT level of both these patients was 
normal, it must be inferred that steroid synthesis was occurring in 
the breast in these cases. That such a process happens in other 
cases is not certain, but Miller et_ jil. (1973), using radioactively 
labelled precursors, found synthesis of testosterone and DHT to occur 
in normal human breast tissue, and large amounts of DHT in two 
fibroadenomas. It would be of great interest to know whether such
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high levels of DHT in BCF is an early indicator of carcinoma. Cystic 
disease of the breast may be associated with fibroadenoma, so Miller's 
explanation would obviously have to be considered. Their results 
conflict with the work of Jenkins and Ash (1972) who found no DHT 
in normal breast, but active production in cancerous breast tissue. 
Further work is necessary to clarify this issue.
The other steroids are possibly plasma-derived, occurring 
in BCF at roughly the same levels as in plasma. Srivastava et al. 
(1977) found similar levels, in BCF and serum, of PRL and TSH, and 
lower levels of LH and FSH in BCF than in serum.
The results for assays of steroid hormones in serum and urine 
showed no difference between cyst patients and age-matched controls. 
This would seem to contradict the results of England et al. (1974) who 
showed slight elevation of 17$-oestradiol in cyst patients, but our 
sample was only one third of the size of theirs and was not assessable 
statistically for minor variations. It is certainly true that any 
hormonal imbalance in these patients is not marked.
The high but variable levels of CEA were of the same range 
as found by Fleisher e^t jal_. (1974). They found the material to elute 
from a Sephadex G-200 common with the main protein peak and deduced 
the molecular weight as being at least 200,000. This, they suggest, 
is either a polymer, or the immunoreactive molecule attached to 
another protein. Whether the entity is really CEA, or another 
glycoprotein cross-reacting with the antiserum, is open to debate, 
but with the high proportions of glycoprotein in BCF proteins the 
latter seems possible. The levels of CEA-like material do not 
correlate with other parameters, but if it really is CEA the 
relationship to subsequent carcinoma should be worth investigating.
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5. THE EVIDENCE FOR SECRETION OF BCF
The original hypothesis of this study was that BCF represented, 
at least partly, a secretion by the cells lining the cyst. Though 
some of the results obtained suggest an origin for some constituents 
of BCF from plasma, evidence has also been presented which is in 
favour of the pure-type cysts being a system isolated from plasma, or 
tissue fluid, except by active processes. The remaining evidence 
will therefore be presented as being indicative that secretion into 
cysts occurs, even if the nature of the secreted material is not 
fully characterised.
1) The 'pink1 epithelium in the breast, and lining cysts, 
is very similar histologically to that in the secretory coil of 
apocrine skin glands. This similarity is noticeable using special, 
as well as general, stains. The ultrastructure of the two cell 
types is almost identical, and both possess the more unusual features 
such as the large osmiophilic bodies. This identity then is more 
than just chance.
2) The functional similarity of the 'pink' cells and 
apocrine skin gland cells, is shown by their identical reactions with 
antiserum to BCF. This is further good evidence of a close relation­
ship between the two cell types which current thinking tends to deny. 
Whether this relationship is functional and could throw some light
on the reason for, or even the validity of the existence of, 'pink' 
cell metaplasia, or whether it merely shows a degradation of the 
breast cells to a type which has the same embryological origin as 
apocrine skin gland cells, is not clear. If nothing else, it is
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certainly further evidence that the breast is a modified skin gland, 
as first suggested by Benda . (1894). Possibly, the ’pink* cell is a 
resting breast cell type which secretes all the time but becomes 
obvious at the menopause when the secretion may be retained in cysts.
The immunological reactions also show a similarity of BCF to 
apocrine skin gland secretion. The latter is responsible for the 
'sweat' odour produced by its bacteriological decomposition. It is 
of interest that BCF commonly has a strong ’sweaty' odour which is 
very marked on heating. It is extremely unlikely that the initially 
sterile BCF is degraded by microorganisms on storage at -20°C, and 
thus it is suggested that BCF and apocrine gland secretion are 
chemically similar, and that the method of odour production may not 
be solely due to bacterial action but perhaps also to change of 
physical conditions, such as pH. With BCF, the odour is especially 
marked on heating and after lipid extraction, when it seems to be in 
the lipid fraction.
3) The ultrastructure of the 'pink* cell shows many 
characteristics of a secretory cell type, including well developed 
endoplasmic reticulum, many mitochondria and a prominent Golgi complex. 
This was first demonstrated by Pier et ajU (1970) and is confirmed in 
the present study. Also present are the dense osmiophilic bodies, 
corresponding to the PAS-positive granules found in light microscopy, 
and which could be secretory granules, or may be altered mitochondria. 
In addition, the presence of lipoprotein secretory vesicles of the type 
which is seen in liver cells is further evidence that secretion is 
occurring. Structures resembling them are also seen in the particle- 
fraction of BCF. This suggests that the particles may be a mixture of
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secretion product and membranes; the latter could be the BCF equivalent 
of the "fluff fraction" (see p.14) of milk.
4) There exists in BCF at least two specific proteins not 
found in milk or plasma, and for which therefore the only possible 
source is the epithelial cells of the cyst. It could be argued that 
they are due to degeneration of cellular elements and not secretion, 
but in that case it would be expected that they would be found in 
other tissues or normal intact breast cells. Immunohistological 
evidence denies this.
5) Anti-(BCF) reacts with sections of breast containing 
cysts or areas of 'pink* epithelium. The reaction does not occur in 
cells of 'normal' ducts or alveoli even in the same section. It shows 
reaction with the material in the lumina both of ducts adjacent to 
cysts and the cysts themselves (as would be expected since this was 
the source antigen). The cap of the cell is strongly reactive, but 
whether this is due to material adherent to the outer surface of the 
plasma membrane or in small vesicles just below it, as seen in the 
electron microscope, is uncertain at the light microscope level.
There is some suggestion that in apocrine skin glands these vesicles 
may contain secretory material (Hibbs, 1962; Yasida et al., 1962; 
Munger, 1965); therefore it would be of great value to determine 
whether the antiserum is indeed reacting with the contents of such 
vesicles.
There is some weak overall staining of the cytoplasm but the 
region of strong staining within the cell is an area apical to the 
nucleus and of the same size or slightly larger. This area has a
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rather tortuous appearance using the light microscope, and from its 
position would seem to be the Golgi complex. This is well developed 
and appears in the same position when examined with the electron 
microscope, and as an unstained, or weakly stained, region by light 
microscopy. Assuming it is the Golgi complex, the problem is now 
whether the antiserum is reacting with the membranes or the contents. 
If the contents are reacting and they are secretory products, the 
question then arises, why any vesicles which may be moving from the 
Golgi complex to the apical plasma membrane show no reaction. One 
possibility is that the vesicles are very small and in the light 
microscope can only be seen en masse under the plasma membrane, as 
already mentioned.
The Golgi complex is known (Campbell & Von der Decken, 1974) 
to be the site of incorporation of at least some carbohydrate groups 
into glycoproteins^which are the major protein type found in BCF.
In some cases, the carbohydrate addition may be initiated in smooth 
endoplasmic reticulum since this contains some glycosyl transferases. 
Such a process occurring in 'pink' cells, may account for some of 
the weak cytoplasmic reaction with anti-(BCF).
The 'packaging' of secretion into vesicles for transport to 
the plasma membrane also occurs in the Golgi complex (Allison, 1974). 
The vesicle membrane fuses with plasma membrane to allow passage of 
secretion out of the cell. Hence the vesicle and "mature" Golgi 
membranes must have a composition identical, or very similar, to 
that of plasma membrane (Lucy, 1974; Keenan et al., 1974). If the
anti-(BCF) was reacting with Golgi membranes, rather than contents, 
it would be expected to react also with plasma membrane. This has 
only occurred in one area of one section, using immunofluorescence, 
and, except for the cell cap reaction, has not been seen since. On
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this evidence it would seem that the reaction with anti-(BCF) is 
directed against the content, as opposed to membranes, of the Golgi 
complex.
6) There are two types of fluid, and the ’serum-type' 
electrophoretic pattern correlates with the presence in the fluid of 
large numbers of leucocytes, including lymphocytes. Whether the 
latter indicates leakage of blood through cyst walls following damage, 
or secretion into the cysts is difficult to determine, but evidence 
previously discussed suggests it is not an active process. This is 
also borne out by the fact that in many cases, the serum-type fluids 
have a gross appearance generally identical to that of pure-types, as 
well as an electrophoretic pattern related to that of pure-types; 
thus ’normal’ cyst fluid production must also be occurring (see also 
pp. 176, 192, 247 & 248).
7) Lastly, there is the fact that cysts are formed and increase 
in size, and often have a high internal pressure. If secretion does 
not occur, then the fluid must accummulate by a passive diffusion
t:
process, often to attain large volumes. That such a mechanism could 
operate against the high intracystic pressure is unlikely, and an 
active process must be involved.
It would be of great value to attempt to determine the 
'permeability' of cysts using labelled substances of various molecular 
weights. Thus, for example, a range of radioactively labelled human 
peptides and proteins (or even inert, artificial polymers) and ions 
could be injected intravenously into cyst patients, and their 
concentrations estimated in BCF aspirated after a set time. From these
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results, valuable information on partition between BCF and serum of 
the various sizes and types of compound could be obtained. The 
largest size of molecule which may enter the cyst by diffusion could 
thus be determined. Obviously the ethical considerations would have 
to be seriously discussed before undertaking such an investigation.
6. CONCLUSIONS
This then is the evidence for secretion. It is reasonably 
strong evidence although the final proof, by demonstration through 
electron microscopy, of the process actually occurring, has not been 
obtained. But this does not weigh too heavily against the other 
evidence. It is possible that the 'pink' cells have a latent period - 
when secretion ceases due to pressure on the epithelium - as do the 
cells of skin apocrine glands (Hurley & Shelley, 1960)(see p. 47) 
and lactating breast epithelium (Cowie & Tindal, 1971). This would 
reduce the chance of seeing the secretory process occurring, 
especially without examining larger numbers of specimens, and using 
high magnification if the secretory vesicles are very small.
There is also some evidence for degenerative change occurring 
in breast cysts. It could be argued that the proteins in BCF 
result from at least partial proteolysis of, possibly, plasma 
proteins, leaving only those most resistant to such degradation 
(i.e. glycoproteins). However, if this is so, they must be broken 
down sufficiently to completely alter their antigenicity to prevent 
them reacting with anti-(whole human serum). Also, this would not 
explain the presence of the two BCF-specific proteins, unless the 
degradation is extended to cell organelles and membranes. The 
particle-fraction may represent degeneration of cells, as could the
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high concentrations of urate. But neither DNA nor RNA could be 
detected in BCF, which seems unaccountable if cellular breakdown is 
occurring, unless they are very rapidly degraded. So perhaps the 
two BCF-specific proteins could be cell membrane proteins somehow 
removed from the membranes, rather than a secretion product. But 
why, then, does the antiserum not react with cell membranes, as 
discussed above? The evidence points to the two proteins being 
secretions.
The presence of cathepsin D is important in this matter. The 
enzyme seems to be free in the fluid rather than in intact lysosomes, 
since it was not activated by the classical methods of de Duve ert al. 
(1955), though whether released by the lysosomes, or freed by their 
osmotic rupture in the cyst fluid, is uncertain. Nonetheless, some 
proteolysis is probably occurring, and this perhaps accounts for some 
of the variability of many constituents found during this study, 
particularly the enzymes (see also p. 206).
In summary, many of the results point towards some of the 
components of BCF being secreted by the 'pink* epithelial cells.
Perhaps the strongest evidence is the location of BCF-specific proteins 
in the Golgi complex, and the functional relationship (shown by 
identical reaction) of ’pink’ cells to those in a skin gland which 
is known to be secretory. Few results go against secretion. However 
it cannot be denied that some degradative processes are occurring.
It is therefore suggested that BCF is, at least partly, a 
secretion by the ’pink' cells, with some coincident degenerative 
changes, and that these cells may be an alteration of normal breast 
epithelial cells to a more basic, or less specialised, cell type. 
Possibly Higginson & McDonald (1949) are right, and 'pink' cells are
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present in the breast all the time (see p. 37).
This study has been undertaken to see how breast cyst fluid 
is formed. Evidence that the 'pink1 cell is the actively secreting 
cell involved in this process is provided. The cell is a constituent 
found in the condition of cystic disease of the human female breast, 
and it is suggested that the function assigned may shed some light 
on the mechanism whereby such cysts may develop.
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